Page last updated: 2024-08-22

angiotensin ii and transforming growth factor beta

angiotensin ii has been researched along with transforming growth factor beta in 553 studies

Research

Studies (553)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	139 (25.14)	18.2507
2000's	237 (42.86)	29.6817
2010's	143 (25.86)	24.3611
2020's	34 (6.15)	2.80

Authors

Authors	Studies
Chambaz, EM; Feige, JJ; Keramidas, M	1
Rong, H; Sambhi, MP; Swaminathan, N; Wang, H	1
Owens, GK; Stouffer, GA	1
Bühler, FR; Hahn, AW	1
Dzau, VJ; Gibbons, GH; Pratt, RE	1
Mason, JI; Naville, D; Rainey, WE	1
Magness, RR; Mason, JI; Oka, K; Rainey, WE	1
Bühler, FR; Hahn, AW; Resink, TJ; Scott-Burden, T	1
Horikoshi, S; Klotman, PE; Kopp, JB; McCune, BK; Ray, PE; Sporn, MB	1
Bernhardt, J; Bühler, FR; Ferracin, F; Hahn, AW; Resink, TJ	1
Grady, EF; Griffin, CA; Kalinyak, JE; Schambelan, M; Sechi, LA	1
Brecher, P; Chobanian, AV; Eastman, E; Saouaf, R; Takasaki, I	1
Dzau, VJ; Itoh, H; Pratt, RE	1
Makino, J; Okamoto, H; Takano, M; Yayama, K	1
Lehmann, K; Powell, JS	1
Dillmann, WH; Kim, NN; Lee, AA; Printz, MP; Villarreal, FJ	1
Ishidoya, S; Klahr, S; Morrissey, J	1
Chevalier, RL; Chung, KH; Gomez, RA	1
Neusser, M; Tepel, M; Zhu, Z; Zidek, W	1
Lee, LK; Lovett, DH; Meyer, TW; Pollock, AS	1
Mueller, E; Stahl, RA; Wolf, G; Ziyadeh, FN	1
Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Iwao, H; Kim, S; Miura, K; Ohta, K; Omura, T; Yukimura, T	1
Absher, M; Fisher, SA	1
Chien, KR; Hunter, JJ; Lembo, G	1
Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Yukimura, T	1
Helmchen, U; Schroeder, R; Stahl, RA; Wolf, G; Zahner, G; Ziyadeh, FN	1
Border, WA; Ketteler, M; Noble, NA	1
Hamaguchi, A; Iwao, H; Kawamura, M; Kim, S; Miura, K; Ohta, K; Omura, T; Wanibuchi, H; Yukimura, T	1
Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Takaori, K; Yukimura, T	1
Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Kim, S; Miura, K; Ohta, K; Omura, T; Wada, T; Yukimura, T	3
Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Omura, T; Tanaka, M; Tominaga, K; Yukimura, T	1
Bégeot, M; Jaillard, C; Lebrethon, MC; Naville, D; Saez, JM	1
Bégeot, M; Langlois, D; Ouali, R; Penhoat, A; Saez, JM; Viard, I	1
Goedbloed, MA; Lamers, JM; Sharma, HS; van Heugten, HA; Verdouw, PD	1
Benatti, L; Fabbrini, MS; Patrono, C	1
Grohé, C; Maass, A; Neyses, L; Oberdorf, S; Sukhatme, VP; Vetter, H	1
Chua, BH; Chua, CC; Diglio, CA; Siu, BB	1
Brecher, P; Chobanian, AV; Crawford, DC	1
Everett, AD; Fisher, A; Gomez, RA; Tufro-McReddie, A	1
Border, WA; Kagami, S; Miller, DE; Noble, NA	1
Creedon, DJ; Tuttle, JB	1
Ko, Y; Nickenig, G; Sachinidis, A; Stiebler, H; Vetter, H; Wieczorek, AJ	1
Izumo, S; Sadoshima, J	1
Sakata, Y	1
Friedman, SL; Housset, CN; Rockey, DC	1
Franco-Saenz, R; Gupta, P; Mulrow, PJ	1
Dzau, VJ; Gibbons, GH; Itoh, H; Mukoyama, M; Pratt, RE	1
Gibbons, GH; Koibuchi, Y; Lee, WS; Pratt, RE	1
Akioka, K; Hanatani, A; Iwao, H; Kim, S; Omura, T; Takeda, T; Takeuchi, K; Teragaki, M; Toda, I; Yoshiyama, M	1
Kopp, JB; Martínez-Maldonado, M; Montero, A; Pimentel, JL; Sundell, CL; Wang, S	1
Dillmann, WH; Lee, AA; McCulloch, AD; Villarreal, FJ	1
Stahl, RA; Wolf, G; Zahner, G; Ziyadeh, FN	1
Schroeder, R; Stahl, RA; Wolf, G; Zahner, G	1
Fogo, A; Ichiki, T; Inagami, T; Kakuchi, J; Labosky, PA; Naftilan, AJ; Niimura, F; Oikawa, T; Okubo, S; Yoshida, H	1
Heidland, A; Ling, H; Paczek, L; Vamvakas, S	1
Betteridge, LJ; Clunn, GF; Hughes, AD; Patel, MK; Schachter, M; Sever, PS; Shaw, RJ	1
Langlois, D; Ouali, R; Penhoat, A; Saez, JM; Viard, I	1
DiPette, DJ; Wang, DH; Yao, A; Zhao, H	1
Gonzales, N; Lanting, L; Nadler, J; Natarajan, R	1
Harada, K; Ogura, T; Oishi, T; Ota, Z; Yamauchi, T	1
Berden, JH; Bruijn, JA; Daha, MR; Löwik, CW; Tamsma, JT; van den Born, J; van den Heuvel, LP; van der Woude, FJ; van Det, NF; Verhagen, NA	1
Chevalier, RL	1
Anderson, PW; Correale, JD; Graf, K; Hsueh, WA; Law, RE; Tian, J; Xi, XP; Yang, D; Zhang, XY	1
Chambaz, EM; Defaye, G; Feige, JJ; Galtier, A; Keramidas, M; Liakos, P	1
Choi, KH; Han, DS; Kang, SW; Lee, HY	1
Barrett, JD; Eggena, P; Lam, K; Leung, FW; Leung, JW; Scremin, OU; Seno, K; Zhu, JH	1
Bertani, T; Colosio, V; Corna, D; Donadelli, R; Facchinetti, D; Luzzana, E; Maffi, R; Remuzzi, G; Testa, D; Zoja, C	1
Border, WA; Kagami, S; Kuhara, T; Kuroda, Y; Noble, NA; Okada, K	1
Chung, UG; Fujita, T; Hirakata, M; Hori, Y; Joki, N; Kaname, S; Katoh, T; Kurokawa, K; Noda, M; Okazaki, T; Takuwa, Y	1
Berden, JH; Bruijn, JA; Daha, MR; Tamsma, JT; van der Woude, FJ; van Det, NF; Verhagen, NA	1
Noble, NA; Peters, H	1
Cooper, ME; Cox, A; Dziadek, M; Gilbert, RE; Roe, CJ; Wu, LL	1
Hampton, T; Li, J; Morgan, JP; Simons, M	1
Campbell, SE; Katwa, LC	1
Craven, PA; DeRubertis, FR; Studer, RK	1
Espinosa, E; Liu, G; Lüscher, TF; Oemar, BS	1
Border, WA; Noble, NA; Peters, H	4
Agocha, A; Eghbali-Webb, M; Lee, HW	1
Andoh, TF; Bennett, WM; Shihab, FS; Tanner, AM	1
Border, WA; Noble, NA	3
Lee, AA; McCulloch, AD	1
Cavaillon, JM; Charlemagne, D; Corda, S; Fitting, C; Gandolfini, MP; Marotte, F; Mebazaa, A; Payen, D; Peynet, J; Rappaport, L; Samuel, JL	1
Hostetter, TH; Junaid, A; Rosenberg, ME	1
Chevalier, RL; Wolstenholme, JT; Yoo, KH	1
Harada, M; Igaki, T; Itoh, H; Kuwahara, K; Masuda, I; Miyamoto, Y; Nakagawa, O; Nakao, K; Ogawa, E; Ogawa, Y; Saito, Y; Tanaka, I; Yamashita, J; Yoshimasa, T	1
Fukuda, R; Imura, Y; Matsuo, T; Nagano, H; Nishikawa, K; Noda, M; Ohta, M; Shibouta, Y	1
Egido, J; Ruiz-Ortega, M	1
Endoh, M; Fukuda, N; Hu, WY; Izumi, Y; Kanmatsuse, K; Kishioka, H; Kubo, A; Satoh, C; Soma, M	1
Dzau, VJ; Gibbons, GH; Horiuchi, M; Kaneda, Y; Morishita, R; Ogihara, T	1
Abbate, M; Benigni, A; Bruzzi, I; Capitanio, M; Corna, D; Donadelli, R; Oldroyd, S; Remuzzi, G; Zoja, C	1
Fogo, A; Hogan, BL; Ichikawa, I; Matsusaka, T; Niimura, F; Okubo, S	1
Wolf, G	3
Heidland, A; Ling, H; Schenk, O; Sebeková, K; Vamvakas, S	1
McCarty, MF	1
Gardner, DG; Liang, F	1
de Jongste, JC; McKay, S; Saxena, PR; Sharma, HS	1
Chevalier, RL; Thornhill, BA; Wolstenholme, JT; Yoo, KH	1
Campbell, SE; Dhalla, AK; Kandala, JC; Katwa, LC; Sun, Y; Tyagi, SC; Weber, KT	1
Gomez, RA; Hilgers, KF; Pentz, ES	1
Ramires, FJ; Sun, Y; Zhang, J; Zhang, JQ	2
Aoki, M; Hayashi, SI; Higaki, J; Kida, I; Matsumoto, K; Moriguchi, A; Morishita, R; Nakamura, T; Nakamura, Y; Nakano, N; Ogihara, T	1
Berk, BC; Corson, MA; Gill, D; Lindner, V; Melaragno, MG; Poppa, V; Wuthrich, DA	1
Klahr, S; Morrissey, JJ	1
Chakraborty, S; Sheikh-Hamad, D; Suki, WN; Truong, LD	1
Ramirez, A; Weiss, RH	1
Gray, MO; Kalinyak, JE; Karliner, JS; Li, HT; Long, CS	1
Kawachi, H; Kimura, H; Nakamura, T; Obata, J; Ohno, S; Shimizu, F; Yoshida, Y	1
Fujimura, H; Fukamizu, A; Hisada, Y; Murakami, K; Sakurai, H; Sugaya, T; Uchida, H; Yamanouchi, M	1
Fujita, T; Ishigami, T; Iwamoto, T; Kihara, M; Kobayashi, S; Toya, Y; Umemura, S; Yabana, M	1
Burt, D; Chusney, G; Gnudi, L; Gruden, G; Thomas, S; Viberti, G; Zhou, W	1
Kakuchi, J; Motojima, M; Yoshioka, T	1
Fogo, A; Ichikawa, I; Miyazaki, Y; Tsuchida, S	1
Iwasaka, T; Maruyama, K; Masaki, H; Matsubara, H; Mori, Y; Moriguchi, Y; Murasawa, S; Nakajima, T; Oda, K; Shibasaki, Y; Tanaka, Y; Tsutsumi, Y	1
Cohen, EP; Datta, PK; Fish, BL; Lianos, EA; Moulder, JE	2
Kadowaki, T; Seko, Y; Takahashi, N; Tobe, K; Yazaki, Y	1
O'Malley, Y; Robbins, ME; Zhang, X	1
Hamaguchi, A; Iwao, H; Izumi, Y; Kim, S; Yamanaka, S; Zhan, Y	1
Orth, S; Ritz, E; Siegert, A; Wagner, J	1
Cerullo, G; Colucci, M; Gesualdo, L; Grandaliano, G; Monno, R; Ranieri, E; Rossiello, MR; Schena, FP; Semeraro, N; Ursi, M	1
Campistol, JM; Clesca, PH; Iñigo, P; Jimenez, W; Lario, S; Oppenheimer, F; Rivera, F	1
Cooper, ME; Cox, A; Gilbert, RE; Johnston, CI; Kelly, DJ; Wilkinson-Berka, JL; Wu, LL	1
Brown, MC; Molloy, CJ; Riedy, MC; Turner, CE	1
Ford, CM; Li, S; Pickering, JG	1
Meyers, CM	1
Higaki, M; Shimokado, K	1
Braun-Dullaeus, RC; Dzau, VJ; Mann, MJ; von der Leyen, HE; Ziegler, A	1
Luft, FC	1
Alavi, N; Leehey, DJ; Singh, AK; Singh, R	2
Li, J; Wang, H; Yu, L; Zhou, C	1
Lamparter, S; Sun, Y; Weber, KT	1
Avallet, O; Berthelon, MC; Langlois, D; Li, JY; Saez, JM	1
Coulombe, P; Meloche, S; Servant, MJ; Turgeon, B	1
Chevalier, RL; Thornhill, BA; Yoo, KH	1
Barr, M; Do, YS; Hsueh, WA; Kawano, H; Kawano, Y; Law, RE; Starnes, V	1
Baroni, EA; Coimbra, TM; Costa, RS; da Silva, CG	1
Sun, Y; Weber, KT	1
MacKenna, D; Summerour, SR; Villarreal, FJ	1
Fleck, E; Graf, K; Hsueh, WA; Law, RE; Neuss, M; Stawowy, P	1
Langlois, D; Le Roy, C; Li, JY; Saez, JM; Stocco, DM	1
Arnqvist, HJ; Dahlfors, G	1
Fukuda, N; Hu, WY; Jian, T; Kanmatsuse, K; Kishioka, H; Kubo, A; Nakayama, M; Satoh, C	1
Laurent, GJ; Marshall, RP; McAnulty, RJ	1
Bouillier, H; Dagher, G; Miserey, S; Perret, C; Renaud, JF; Safar, M; Samain, E	1
Amann, K; Bielenberg, GW; Ehmke, H; Gross, ML; Koch, A; Mall, G; Oberhauser, V; Orth, SR; Ritz, E; Rump, LC; Simonaviciene, A; VAN Kats, JP; Wessels, S	1
Fielitz, J; Fleck, E; Friedrich, K; Graf, K; Kupfahl, C; Neuss, M; Pink, D; Regitz-Zagrosek, V; Warnecke, C; Zurbrügg, HR	1
O'Donnell, MP	1
Acharya, A; Lei, J; Neugarten, J; Silbiger, S	1
Heidland, A; Teschner, M	1
August, P; Leventhal, B; Suthanthiran, M	1
Chatziantoniou, C; Dussaule, JC; Fakhouri, F; Tharaux, PL	1
Guo, DF; Inagami, T; Kimura, H; Naito, A; Nakamura, T; Obata, J; Shimizu, F; Takano, H; Yoshida, Y	1
Chen, J; Darracott Vaughan E, JR; Felsen, D; Kirman, I; Miyajima, A; Poppas, DP	1
Díez, J; Laviades, C; Varo, N	1
Dixon, IM; Hao, J; Jassal, DS; Jones, SC; Wang, B	1
Crook, ED; Daniels, M; Simmons, ST; Singh, LP	1
Fujiyama, S; Iba, S; Iwasaka, T; Koyama, Y; Masaki, H; Matsubara, H; Mori, Y; Moriguchi, Y; Nose-Fujiyama, A; Shibasaki, Y; Tateishi, E; Tsutsumi, Y; Uchiyama-Tanaka, Y	1
Doyle, S; Kurtzberg, L; Ledbetter, S; Pratt, BM	1
Chodobski, A; Szmydynger-Chodobska, J	1
Fukuda, N; Hu, WY; Kanmatsuse, K; Kishioka, H; Nakayama, M; Satoh, C	1
Abraham, JA; Damm, D; Garrard, LJ; Henson, M; Joly, AH; Lam, A; Schreiner, GF; Stanton, LW; White, T	1
Bieringer, M; Breu, V; Dechend, R; Fiebeler, A; Haller, H; Luft, FC; Müller, DN; Park, JK; Schmidt, F; Shagdarsuren, E	1
Klahr, S	1
Bescós, M; Campistol, JM; Campos, B; Iñigo, P; Lario, S; Oppenheimer, F; Piera, C; Rivera, F	1
Adam-Stitah, S; Haxsen, V; Ritz, E; Wagner, J	1
Ruwhof, C; Schrier, PI; van der Laarse, A; van der Valk-Kokshoom, LE; van Wamel, AJ	1
Williams, B	1
Fagard, RH; Lijnen, PJ; Petrov, VV	4
Allen, TJ; Bonnet, F; Cao, Z; Cooper, ME; Davis, B	1
Bescos, M; Campistol, JM; Iñigo, P; Larios, S; Oppenheimer, F	1
Cai, L; Ingram, A; James, LR; Ly, H; Scholey, JW; Thai, K	1
Calderone, A; Colombo, F; Mayers, P; Mercier, I; Noël, J	1
Gaffney, FA; Ichihara, S; Ichiki, T; Inagami, T; Price, E; Senbonmatsu, T	1
Abdelaziz, N; Calderone, A; Colombo, F; Mercier, I	1
Piper, HM; Schlüter, KD; Taimor, G; Wenzel, S	1
Asada, K; Iwao, H; Jin, D; Kim, S; Kondo, K; Miyazaki, M; Nishimoto, M; Sakaguchi, M; Sasaki, S; Sawada, Y; Takai, S; Yamada, M; Yuda, A	1
Fukui, H; Ikenaka, Y; Kuriyama, S; Nakatani, T; Noguchi, R; Tsujinoue, H; Yoshii, J; Yoshiji, H	1
Angus, PW; Cooper, ME; Cox, A; Gilbert, RE; Kelly, DJ; Murthi, P; Paizis, G; Rumble, JR; Schembri, JM; Smallwood, RA; Tikellis, C; Wu, LL	1
Bouzeghrane, F; Lacasse, A; Lacombe, MJ; Lapalme, G; Schnapp, LM; Thibault, G	1
Border, WA; Gaedeke, J; Noble, NA; Peters, H	1
Cao, Z; Cooper, ME	1
Border, WA; Noble, N	1
Chen, H; Li, D; Mehta, JL	1
Ardaillou, R; Chatziantoniou, C; Dussaule, JC; Fakhouri, F; Placier, S	1
Fujiyama, S; Hasagawa, T; Higashiyama, S; Iba, O; Iwasaka, T; Kosaki, A; Maruyama, K; Masaki, H; Matsubara, H; Mori, Y; Murasawa, S; Nose, A; Nozawa, Y; Shibasaki, Y; Tateishi, E; Uchiyama-Tanaka, Y	1
Okada, M; Takemura, T; Yanagida, H; Yoshioka, K	1
Carbini, LA; Nadal, JA; Scicli, AG; Scicli, GM	1
Han, HJ; Park, SH	1
Fukuda, N; Ikeda, Y; Kanmatsuse, K; Suzuki, R; Tahira, Y; Takagi, H; Teng, J	1
Li, J; Wang, H; Zhou, C	1
Brown, J; Rosado, JA; Woodard, GE	1
Helmchen, U; Stahl, RA; Thaiss, F; Wenzel, UO; Wolf, G	1
Fujihara, CK; Noronha, IL; Zatz, R	1
Griffiths, NM; Naftalin, RJ; Pedley, KC; Thiagarajah, JR	1
Schneider, MD	1
Doetschman, T; Glascock, BJ; Kimball, TR; Nieman, ML; Nix, SL; Reiser, PJ; Schultz, Jel J; Witt, SA	1
Doi, H; Katoh, M; Kurosawa, Y; Narita, H	1
Akimoto, K; Kangawa, K; Kobayashi, N; Matsuoka, H; Mori, Y; Nishikimi, T; Tadokoro, K; Wang, X; Yoshihara, F	1
Ding, G; Franki, N; Gibbons, N; Kapasi, AA; Kasinath, BS; Reddy, K; Singhal, PC	1
Aoki, M; Hashiya, N; Hiraoka, K; Kaneda, Y; Matsumoto, K; Morishita, R; Nakamura, T; Ogihara, T; Taniyama, Y; Yamasaki, K	1
Kangawa, K; Kobayashi, N; Matsuoka, H; Mori, Y; Nishikimi, T; Ono, H	1
Brodbeck, K; Häring, HU; Klopfer, K; Schleicher, ED; Weigert, C	1
Bartness, TJ; DiGirolamo, M; Hausman, DB; Hausman, GJ; Martin, RJ	1
Chen, J; Gu, Y; Lin, F; Lin, S; Ma, J; Yang, H; Zhu, W	1
Ichihara, S; Iwase, M; Izawa, H; Nagasaka, T; Nagata, K; Nakashima, N; Obata, K; Odashima, M; Somura, F; Yamada, Y; Yokota, M	1
Ruwhof, C; Schrier, PI; van der Laarse, A; van der Valk-Kokshoorn, LJ; van Wamel, AJ	1
Balboa, NE; Docherty, NG; López-Novoa, JM; Pérez-Barriocanal, F	1
Dai, C; Liu, Y; Yang, J	1
Adachi, Y; Fukamizu, A; Garbers, DL; Harada, M; Izumi, T; Kawakami, R; Kishimoto, I; Kuwahara, K; Li, Y; Nakagawa, Y; Nakanishi, M; Nakao, K; Saito, Y; Takahashi, N; Tanimoto, K	1
Ikehara, K; Inokuchi, T; Kuboki, K; Tada, H	1
Gao, C; Lei, X; Mei, C; Zhou, C	1
Amano, K; Chayama, K; Iba, O; Ishida, T; Kambe, M; Kurisu, S; Matsubara, H; Matsuura, H; Oshima, T; Ozono, R; Sugino, H; Teranishi, Y	1
Allione, A; Barberis, AM; Beltramo, E; Berardi, C; D'alu, F; Del Rizzo, P; Lacaria, A; Limone, P; Pellissetto, C; Pomero, F; Ponte, E; Porta, M	1
Bernhardt, R; Defaye, G; Feige, JJ; Lenz, D; Liakos, P	1
Bhaskaran, M; Ding, G; Franki, N; Radhakrishanan, N; Reddy, K; Singhal, PC	1
Ahn, HJ; Bang, BK; Cha, JH; Jung, JY; Kim, J; Kim, WY; Kim, YS; Li, C; Yang, CW; Yoon, SA	1
Baker, KM; Boheler, K; Dostal, DE; Lakatta, EG; Shivakumar, K	1
Klahr, S; Morrissey, J	1
Boffa, JJ; Chatziantoniou, C; Dussaule, JC; Fakhouri, F; Flamant, M; Tharaux, PL	1
Ronco, P	1
Isono, T; Kinoshita, M; Matsumoto, T; Ohnishi, M; Tsutamoto, T; Wada, A	1
Bottoms, SE; Chambers, RC; Gohlke, P; Howell, DC; Laurent, GJ; Marshall, RP; McAnulty, RJ; Unger, T	1
Kokkonen, JO; Kovanen, PT; Lindstedt, KA	1
Albertazzi, A; Anglani, F; Bernich, P; Brezzi, B; D'Angelo, A; Del Prete, D; Furci, L; Gambaro, G; Graziotto, R; Lupo, A; Magistroni, R; Maschio, G; Modena, F	1
Ahonen, J; Finckenberg, P; Ganten, D; Inkinen, K; Louhelainen, M; Luft, F; Merasto, S; Mervaala, E; Müller, D; Vapaatalo, H	1
Ciccone, E; Deelman, L; Hajnoczky, G; Henning, R; Hu, T; Kurz, B; Ma, X; Madesh, M; Sharma, K; Siva, S; Wang, L; Zhu, Y	1
Calò, LA; Davis, PA; Pagnin, E; Sartori, M; Semplicini, A	1
Hattori, Y; Jesmin, S; Kitabatake, A; Sakuma, I	1
Bolick, DT; Hatley, ME; Hedrick, CC; Nadler, JL; Srinivasan, S	1
Ardiles, LG; Aros, CA; Burgos, ME; Carpio, D; Droguett, A; Egido, J; Flores, CA; Mezzano, SA; Ruiz-Ortega, M; Vío, CP	1
Fujimiya, T; Naito, K; Shiraishi, K; Yoshida, K	1
Hishida, A; Ikegaya, N; Suzuki, H; Yamamoto, T	1
Cuervo, R; Palau, JM	1
Kohno, N; Masaki, T; Naito, T; Nikolic-Paterson, DJ; Tanji, C; Yorioka, N	1
Chen, G; Ip, SP; Lai, PB; Leung, PS; Suen, PM; Yip, CK	1
Atkinson, JB; Brown, NJ; Eren, M; Gleaves, LA; Painter, CA; Schoenhard, JA; Vaughan, DE	1
Chen, WB; Fischer, JW; Kruse, ML; Petrik, C; Stoll, M; Stöter, K; Tiede, K; Ungefroren, H; Unger, T	1
Blonski, M; Couser, WG; Durvasula, RV; Griffin, S; Hiromura, K; Mundel, P; Petermann, AT; Pichler, R; Pippin, J; Shankland, SJ	1
Cao, B; Feng, QH; Li, S; Li, XZ	1
Fukasawa, C; Hara, M; Harigai, M; Kamatani, N; Kawaguchi, Y; Nishimagi, E; Sugiura, T; Takagi, K	1
Ban, S; Inoue, T; Kanno, Y; Kikuta, T; Kobayashi, T; Okada, H; Suzuki, H; Watanabe, Y	1
Li, X; Meng, Y; Wu, PS; Yang, XS; Zhang, ZS; Zou, JL	1
Imaizumi, T; Kai, H; Kuwahara, F; Tokuda, K	1
Amiri, F; Benkirane, K; Cohn, JS; Diep, QN; Endemann, D; Schiffrin, EL	1
Ebihara, A; Hirata, Y; Iimuro, S; Iwata, H; Kangawa, K; Nagai, R; Niu, P; Shindo, T; Suematsu, Y; Takeda, N; Zhang, Y	1
Cowley, AW; Mori, T	1
Dai, ZQ; Li, YH; Ma, YJ; Song, JP; Yang, F; Zhong, P	1
Sarkar, S; Sen, S; Vellaichamy, E; Young, D	1
Michel, JB	1
Akiyama-Uchida, Y; Ashizawa, N; Imanishi, R; Kawano, H; Kuroda, H; Nakashima, M; Ohtsuru, A; Saenko, VA; Seto, S; Yamashita, S; Yano, K	1
Chen, SL; Wang, JM; Zhu, ZS	1
Cheng, LJ; Huang, HC; Liang, Y	1
Bathgate, RA; Du, XJ; Layfield, SL; Mak, J; Mookerjee, I; Samuel, CS; Tregear, GW; Unemori, EN	1
Aizawa, Y; Kodama, M; Ma, M; Tachikawa, H; Takahashi, T; Watanabe, K; Wen, J; Yamaguchi, K	1
Makino, H; Nakamura, Y	1
Baker, KM; Booz, GW; Chernin, MI; Dostal, DE; Haiderzaidi, S; Kumar, R; Sanghi, S; Schreiber, T	1
Nattel, S	1
Bobik, A	1
Cardin, S; Hanna, N; Leung, TK; Nattel, S	1
Egashira, K; Hiasa, K; Ishibashi, M; Takeshita, A; Tan, C; Zhao, Q	1
Dong, J; Fujii, S; Furumoto, T; Goto, D; Imagawa, S; Kitabatake, A; Mishima, T; Nakai, Y; Sobel, BE; Zaman, AK	1
Rosenkranz, S	1
Chou, MY; Chueh, PJ; Huang, CY; Kuo, WW; Tseng, CT; Yang, JJ	1
Kolachana, P; Lawsin, LM; Moore, J; Perlman, A; Ringel, MD; Saji, M	1
Aizawa, T; Ishizaka, N; Iso-O, N; Nagai, R; Noiri, E; Ohno, M; Saito, K; Sata, M	1
Anderson, I; Border, WA; Huang, Y; McCourt, M; Noble, NA; Yu, L	1
Hattori, Y; Matsuda, N	1
Bohnemeier, H; Cleutjens, JP; Crijns, HJ; Paul, M; Pinto, YM; Pokharel, S; Schunkert, H; Sharma, UC; Tian, XL; van Geel, PP	1
Aizawa, T; Ishizaka, N; Iso-o, N; Mori, I; Nagai, R; Noiri, E; Ohno, M; Saito, K; Sata, M	1
Bucala, R; Cooper, ME; Fukami, K; Iida, S; Imaizumi, T; Inagaki, Y; Kato, S; Motomiya, Y; Okuda, S; Takeuchi, M; Tamaki, K; Ueda, S; Yamagishi, S	1
Ando, J; Ikeda, H; Ishizaka, N; Mori, I; Nagai, R; Noiri, E; Ohno, A; Ohno, M; Saito, K; Sata, M	1
González-Núñez, D; Natarajan, R; Poch, E; Solé, M	1
Diaz-Araya, G; Fagard, RH; Lijnen, PJ; Petrov, VV	1
Abe, Y; Kimura, S; Kiyomoto, H; Kobori, H; Kohno, M; Miyata, K; Miyatake, A; Nagai, Y; Nishiyama, A; Ozawa, Y; Shokoji, T; Yao, L; Yukimura, T	1
Ferrannini, E; Santini, E; Solini, A	1
Busca, G; Castoldi, G; di Gioia, CR; Redaelli, S; Sperti, G; Stella, A; van de Greef, WM	1
Choi, SY; Ishibashi, N; Jung, SI; Kim, JM; Kim, SJ; Kim, YS; Koo, BH; Lee, JB; Min, BW; Shirouzu, K; Son, GS; Um, JW; Whang, CW	1
Bataller, R; Brenner, DA	1
Meldrum, KK; Misseri, R	1
Asada, Y; Cao, YN; Eto, T; Hatakeyama, K; Imamura, T; Kato, J; Kitamura, K; Masuyama, H; Tsuruda, T	1
Chen, Q; Li, X; Meng, Y; Wu, PS; Yang, XS; Zhou, GS	1
Jin, D; Katsuoka, Y; Miyazaki, M; Muramatsu, M; Okamoto, Y; Sakaguchi, M; Shibahara, N; Takai, S; Ueda, H	1
Tsutsui, H	1
Chen, HC; Chuang, LY; Guh, JY; Hung, WC; Lee, CI; Yang, YL	1
Aizawa, Y; Inoue, M; Kashimura, T; Kodama, M; Ma, M; Saito, Y; Shirai, K; Suresh, PS; Tachikawa, H; Wahed, MI; Watanabe, K	1
Bulbuller, N; Cetiner, M; Gogebakan, O; Ilhan, N; Ilhan, YS; Kirkil, C	1
Chen, S; Danesh, FR; Gandhi, NK; Iglesias-de la Cruz, MC; Izquierdo-Lahuerta, A; Lee, JS; Wang, A; Wolf, G; Ziyadeh, FN	1
Matsuda, H; Matsumoto, K; Mizuno, S; Nakamura, T; Sawa, Y	1
Egido, J; Esteban, V; Rodríguez-Vita, J; Ruiz-Ortega, M; Rupérez, M; Sánchez-López, E	1
Bechara, RI; Brown, LA; Guidot, DM; Hart, CM; Joshi, PC; Palacio, A; Pelaez, A; Raynor, R	1
DU, XJ; Mookerjee, I; Samuel, CS; Tregear, GW; Unemori, EN	1
Aihara, K; Akaike, M; Azuma, H; Fujimura, M; Hashizume, S; Ikeda, Y; Izawa, Y; Kato, M; Kato, S; Kawano, H; Matsumoto, T; Sato, T; Suzaki, Y; Tamaki, T; Yagi, S; Yoshizumi, M	1
Chen, RH; Chen, YM; Chiang, WC; Lai, CF; Lin, SL; Tsai, TJ; Wu, KD	1
Ahn, KO; Choi, YH; Chung, BH; Ito, S; Kim, J; Li, C; Lim, SW; Sugawara, A; Sun, BK; Yang, CW; Yang, JH; Yoon, KH	1
Deschamps, AM; Spinale, FG	1
Liu, GS; Wang, H; Xue, H; Zhang, YL	1
Chao, YM; Kuan, P; Shyu, KG; Wang, BW	1
Kuwano, K	1
Escobar, GP; Flack, EC; Goshorn, DK; Leonardi, RA; Lindsey, ML; Mains, IM; Mingoia, JT; Payne, JF; Sheats, NJ; Squires, CE	1
Nagaria, AM; Reddy, S; Savin, VJ; Sharma, M; Sharma, R; Wiegmann, TB	1
Bailey, M; Denver, R; Krum, H; Martin, J	1
Chen, CM; Chou, HC; Hsu, HH; Wang, LF	1
Hara, M; Ishizaka, N; Matsuzaki, G; Mori, I; Nagai, R; Ohno, M; Saito, K; Sata, M	1
Berman, JS; Goldstein, RH; Kuang, PP; Li, X; O'Regan, A; Serlin, DM; Subramanian, M	1
Cheng, L; Jiang, LQ; Krawczyk, M; Lakatta, EG; Monticone, R; Pintus, G; Spinetti, G; Talan, M; Wang, M; Zhang, J; Zhao, D	1
Hashimoto, N; Saito, Y; Seki, N; Suzuki, Y; Yagui, K	1
Berecek, KH; Murphy-Ullrich, JE; Poczatek, MH; Zhou, Y	1
Ahn, KO; Bang, BK; Choi, BS; Kim, J; Kim, JS; Kim, JY; Kim, YS; Li, C; Lim, SW; Yang, CW; Yang, HJ	1
Oliver, JA	1
Border, W; Huang, Y; Kasting, J; McQuillan, D; Noble, NA; Owens, RT; Wongamorntham, S; Yu, L	1
Aoki, H; Hama, K; Kita, H; Mashima, H; Ohnishi, H; Osawa, H; Sato, K; Sugano, K; Tamada, K; Yamamoto, H; Yasuda, H	1
Ahn, YB; Cha, BY; Hong, OK; Jeong, IK; Kim, JW; Kim, MJ; Ko, SH; Son, HY; Song, KH; Yoon, KH	1
Gaedeke, J; Neumayer, HH; Peters, H	1
Brezniceanu, ML; Chan, JS; Chen, R; Fantus, IG; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Liu, F; Whiteside, CI; Zhang, SL	1
He, Y; Huang, Y; Lu, LM; Yao, T; Zhou, L; Zhu, YC	1
Sorescu, D	1
Burns, KD; Su, Z; Zimpelmann, J	1
Buckenberger, JA; Elton, TS; Lee, EJ; Martin, MM; Schmittgen, TD	1
Abe, Y; Guo, P; Ishizawa, M; Kimura, S; Kohno, M; Miyatake, A; Mizushige, K; Murakami, K; Nagai, Y; Namba, T; Nishiyama, A; Noma, T; Ohmori, K; Rahman, M	1
Cha, DR; Han, JY; Han, KH; Han, SY; Jee, YH; Kang, YS; Kim, HK; Kim, YS	1
Abdallah, Y; Helmig, S; Piper, HM; Schäfer, C; Schlüter, KD; Wenzel, S	1
Abe, Y; Baba, R; Fan, YY; Fujita, M; Hosomi, N; Kimura, S; Kohno, M; Miyatake, A; Nagai, Y; Nishiyama, A; Sun, GP	1
Hirata, A; Igarashi, M; Kadomoto, Y; Tominaga, M	1
Canessa, O; Cao, G; Cavallero, S; Della Penna, S; Fernández, BE; Gorzalczany, S; Kuprewicz, A; Pandolfo, M; Rosón, MI; Toblli, JE	1
Lim, H; Zhu, YZ	1
Cheng, B; Fu, X; Liu, H	1
Bolton, TA; Grobe, JL; Katovich, MJ; Lingis, M; Machado, JM; Mecca, AP; Raizada, MK; Shenoy, V; Speth, RC	1
Fujita, T; Goto, A; Kobayashi, N; Matsuoka, H; Onozato, ML; Tojo, A	1
Kashihara, N; Maeshima, Y; Makino, H; Maruyama, K; Okamoto, K; Okazaki, Y; Satoh, M; Sugaya, T; Sugiyama, H; Uchida, HA; Yamasaki, Y	1
Chatziantoniou, C; Dussaule, JC	1
Border, WA; Huang, Y; Noble, NA	1
Fintha, A; Huszár, T; Masszi, A; Mucsi, I; Rosivall, L; Sebe, A; Terebessy, T	1
Manabe, I	1
Lu, J; Qu, ZL; Ren, XY; Ruan, QR; Zhu, DH; Zhu, M	1
Adrogue, HJ; Huang, XR; Lan, HY; Soltero, L; Wang, W; Zhang, P	1
Belmadani, S; Berecek, KH; Bernal, J; Dell'italia, L; Murphy-Ullrich, JE; Pallero, MA; Wei, CC	1
Aggarwal, A; Ahimastos, AA; D'Orsa, KM; Dart, AM; Formosa, MF; Kingwell, BA; Savarirayan, R; White, AJ	1
Aihara, K; Akaike, M; Azuma, H; Ikeda, Y; Ise, T; Ishikawa, K; Iwase, T; Matsumoto, T; Sumitomo, Y; Yagi, S; Yoshida, S	1
Cartier, C; Carvajal, G; Egido, J; Esteban, V; Plaza, JJ; Rodrígues-Díez, R; Rodriguez-Vita, J; Ruiz-Ortega, M; Rupérez, M; Sánchez-López, E	1
Moini, M; Owji, N; Sagheb, MM	1
Chan, LY; Eddy, AA; Lai, KN; Leung, JC; Tang, SC	1
He, J; Ke, J; Liu, HC; Ma, YX	1
Wynn, TA	1
Wolf, G; Ziyadeh, FN	1
Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE	1
Baker, KM; Kumar, R; Singh, VP	1
Kagami, S; Kobori, H; Kondo, S; Morioka, T; Oite, T; Shimizu, M; Takamatsu, M; Urushihara, M	1
Chander, PN; Chun, TY; Kim, JW; Pratt, JH; Stier, CT	1
Burchette, JL; Coffman, TM; Crowley, SD; Frey, CW; Gould, SK; Griffiths, R; Howell, DN; Kim, HS; Makhanova, N; Ruiz, P; Tharaux, PL; Yan, M	1
Cartier, C; Carvajal, G; Egido, J; Esteban, V; Mezzano, SA; Ortiz, A; Rodrigues-Díez, R; Rodríguez-Vita, J; Ruiz-Ortega, M; Rupérez, M; Sánchez-López, E	1
Buratini, J; Gonçalves, PB; Nicola, E; Portela, VM; Price, CA; Veiga, AM	1
Csordás, G; Hajnóczky, G; Pacher, P; Sharma, K; Zhu, Y	1
Daniel, C	1
Liu, S; Lu, H; Nikolic, D; Shi, L; Wang, S	1
Chen, G; Chen, T; Lu, Y; Wang, X; Yuan, J	1
Chen, H; Guo, J; Ho, J; Laporte, SA; Lebrun, JJ; Mancini, J; Richard, DE; Sontag, T	1
Hayashi, T; Jin, D; Kitada, K; Kitaura, Y; Matsumoto, C; Matsumura, Y; Miyamura, M; Miyazaki, M; Mori, T; Ohkita, M; Okada, Y; Takai, S; Ukimura, A; Yamashita, C	1
Cho, WH; Choi, HS; Hur, SH; Jung, GS; Kim, BW; Kim, HS; Kim, HT; Kim, JG; Kim, MK; Lee, HJ; Lee, IK; Lee, KM; Lee, KU; Lim, JO; Park, KG	1
Chung, AC; Huang, XR; Lan, HY; Yang, F	1
Anegawa, T; Hirooka, Y; Ikeda, A; Imaizumi, T; Kai, H; Kajimoto, H; Kato, S; Koga, M; Kudo, H; Mifune, H; Mori, T; Takayama, N; Yasuoka, S	1
Fan, YY; Fujisawa, Y; Hase, N; Hitomi, H; Kiyomoto, H; Kobori, H; Kohno, M; Matsuura, J; Nakano, D; Nishiyama, A; Urata, H	1
Bataller, R; Colmenero, J; De Minicis, S; Gwak, GY; Kluwe, J; Mencin, A; Osterreicher, CH; Pradere, JP; Schwabe, RF	1
Choi, HS; Kim, MK; Kim, YN; Lee, IK; Lee, KM; Lee, KU; Min, AK; Park, KG; Park, WJ; Park, YJ; Ryu, SY; Seo, HY	1
Abdollahi, H; DiMuzio, PJ; Harris, LJ; McIlhenny, S; Tulenko, TN; Zhang, P	1
Bledsoe, G; Chao, J; Chao, L; Hagiwara, M; Liu, Y; Shen, B; Yang, ZR	1
Ait-Oufella, H; Bonnin, P; Combadière, C; Herbin, O; Huang, J; Johnson, JL; Mallat, Z; Offenstadt, G; Ramkhelawon, B; Rénia, L; Taleb, S; Tedgui, A; Tharaux, PL; Wang, Y	1
Collins, AR; Hsueh, WA; Kim, J; Liu, J; Nguyen, L; Nicholas, SB; Ren, Y	1
Chen, W; Frangogiannis, NG	1
Dell, KM; Goto, M; Hoxha, N; Osman, R; Wells, RG; Wen, J	1
Chan, EC; Dilley, R; Dusting, GJ; Guo, N; Jiang, F; Narumiya, S; Peshavariya, HM; Taylor, CJ	1
Chen, RH; Ding, GX; Huang, SM; Pan, XQ; Zhang, AH	1
Bokuda, K; Ichihara, A; Itoh, H; Kinouchi, K; Kurauchi-Mito, A; Mizuguchi, Y; Narita, T; Sakoda, M; Seki, Y	1
Leask, A	2
Briones-Orta, MA; González-Espinosa, C; Macías-Silva, M; Medina-Tamayo, J; Molina-Jijón, E; Moreno-Alvarez, P; Pedraza-Chaverri, J; Sosa-Garrocho, M	1
Agrawal, AN; Axtell, R; Ding, Z; Ho, PP; Lanz, TV; Luo, J; Platten, M; Srinagesh, H; Steinman, L; Wyss-Coray, T; Zhang, H	1
Blaauw, E; Delhaas, T; Prinzen, FW; Snoeckx, LH; van Bilsen, M; van der Vusse, GJ; van Nieuwenhoven, FA; Willemsen, P	1
Jin, D; Miyazaki, M; Takai, S	2
Casarini, DE; Coelho, MS; Ferreira, DN; Furukawa, LN; Heimann, JC; Katayama, IA; Oliveira, IB; Rosa, KT	1
Lin, F; Yang, X	1
Fujita, H; Harasawa, S; Hirayama, A; Koike, M; Kushiro, T; Nagao, K; Okubo, K; Otsuka, Y	1
Ichihara, A; Itoh, H; Kinouchi, K; Kurauchi-Mito, A; Murohashi-Bokuda, K; Narita, T; Nishiyama, A; Ohshima, Y; Ryuzaki, M; Sakoda, M	1
Lee, HS	1
Civantos, E; Egido, J; Lavoz, C; Mezzano, S; Ortiz, A; Rayego-Mateos, S; Rodrigues Díez, R; Rodrigues-Díez, R; Rodríguez-Vita, J; Ruiz-Ortega, M	1
Cheng, J; Du, J; Jia, L; Li, H; Lin, X; Qi, G; Ren, J; Tian, C; Yang, M; Zheng, J	1
Fukuta, N; Kimura, M; Kudo, M; Munakata, H; Nakatani, T; Park, AM; Sakurai, T	1
Aziz, H; Bedja, D; Chen, Y; Dietz, HC; Doyle, JJ; Habashi, JP; Holm, TM; Judge, DP; Modiri, AN; Schoenhoff, F	1
Cooper, ME; Herman-Edelstein, M; Kantharidis, P; Saleem, M; Thallas-Bonke, V; Thomas, MC	1
Dietz, HC; Lindsay, ME	1
Kang, SJ; Kwak, MK; You, A	1
Azuma, J; Iekushi, K; Iwabayashi, M; Koibuchi, N; Kusunoki, H; Morishita, R; Okayama, K; Rakugi, H; Sanada, F; Taniyama, Y	1
Rüster, C; Wolf, G	1
Bouhuizen, AM; Danser, AH; de Waard, MC; Duncker, DJ; Essers, J; Lankhorst, S; Moltzer, E; Ramnath, NW; Rouwet, EV; Swagemakers, SM; te Riet, L; van der Spek, PJ; van Esch, JH; van Heijningen, PM; van Veghel, R; Vermeij, M	1
Bandhlish, A; Chander, PN; Kumar, D; Magoon, S; Malhotra, A; Sagar, A; Salhan, D; Sayeneni, S; Singhal, PC; Torri, DD	1
Ferrannini, E; Madec, S; Rossi, C; Salvati, A; Santini, E; Solini, A	1
Azhar, M; Barnett, JV; Camenisch, TD; Conway, SJ; Doetschman, T; Granzier, HL; Heimark, RL; Runyan, RB	1
Chan, LY; Chow, CW; Lai, KN; Lam, MF; Leung, JC; Lim, AI; Tang, SC	1
Eiam-Ong, S; Kanjanabuch, T; Leelahavanichkul, A; Wontanatawatot, W	1
Chen, J; Chen, JK; Harris, RC; Lee, TC; Nagai, K; Neilson, EG; Plieth, D; Tan, M; Threadgill, DW	1
Chu, ML; Dong, H; Gao, E; Gao, F; Joyce, J; Koch, W; Liu, Y; Ma, X; Markova, D; Miller, T; Tsuda, T; Wu, J; Zhang, H; Zou, Y	1
Huang, XR; Lan, HY; Liu, Z	1
Chen, HY; Huang, XR; Lan, HY; Liu, Z; Penninger, JM	1
Cai, L; Cheng, J; Cui, W; Du, J; Han, Y; Jia, L; Li, H; Li, Y; Wu, Y; Zhang, C	1
Chou, CH; Chuang, LY; Guh, JY; Lu, CY	1
Hao, S; Kolodgie, FD; Mizrahi, B; Nguyen, BT; Ozaki, CK; Savion, N; Schneiderman, J; Tao, M; Virmani, R; Yu, P	1
Falkenham, A; Lee, TD; Légaré, JF; Rosin, NL; Sopel, MJ	1
Hamano, K; Ikeda, Y; Mikamo, A; Nagasawa, A; Suzuki, R; Tsuchida, M; Yamashita, O; Yoshimura, K	1
Chen, HY; Heuchel, RL; Huang, XR; Lan, HY; Li, YQ; Liu, GX; Shi, YJ; Wei, L	1
Aihara, Y; Douhara, A; Fukui, H; Kaji, K; Kawaratani, H; Moriya, K; Namisaki, T; Noguchi, R; Shirai, Y; Yoshiji, H	1
Fan, YY; Hitomi, H; Huang, W; Kobori, H; Li, P; Masaki, T; Mori, H; Nakano, D; Nishiyama, A; Sun, YX; Zhang, L; Zhi, N; Zhu, B	1
Chang, JW; Kim, JH; Kim, JS; Kim, SB; Lee, JH; Lee, SK; Park, JS	1
Dalloz, M; Esposito, B; Mallat, Z; Pérez, N; Ponnuswamy, P; Romain, M; Taleb, S; Tedgui, A; Wang, Y; Yoshimura, A	1
Chen, YJ; Chung, CC; Kao, YH	1
Cassis, LA; Chen, X; Daugherty, A; Lu, H; Rateri, DL	1
Crocker, DE; Nishiyama, A; Ortiz, RM; Rodriguez, R; Soñanez-Organis, JG; Vázquez-Medina, JP; Viscarra, JA	1
Liu, JJ; Lu, Y; Yu, XJ	1
Nelson, C; Tang, T; Tannock, LR; Thompson, JC; Wilson, PG; Yoder, MH	1
Chen, HY; Huang, XR; Lan, HY; Li, YQ; Wei, LH; Yan, BP; Yu, CM; Zhang, Y	1
Abdul, A; Deb, DK; Heilig, CW; James, LR; Nahman, NS; Riaz, H; Salameh, J	1
Chu, ML; Dong, H; Khan, SA; Tsuda, T; Wu, J; Zhang, H	1
Cui, W; Du, J; Jia, LX; Li, TT; Liu, O; Qi, GM; Qi, YF; Yang, M; Zhang, WM	1
Chiou, TT; Hsu, CY; Huang, PC; Lee, CT; Lee, YT; Ng, HY; Tain, YL	1
Chen, X; Diao, TY; Gu, SS; Pan, H; Wong, MS; Zhang, FY; Zhang, Y	1
Gao, PJ; Jin, HY; Lu, L; Oudit, GY; Penninger, JM; Shang, QH; Song, B; Xu, YL; Zhang, ZZ; Zhong, JC; Zhou, T; Zhu, DL	1
Davis, J; Molkentin, JD	1
Abe, T; Aukema, HM; Horie, S; Kugita, M; Nagao, S; Nakanishi, K; Sasaki, M; Yamaguchi, T; Yoshihara, D	1
Daugherty, A; Davis, F; Rateri, DL	1
ap Rhys, CM; Bedja, D; Calderon, JF; Chen, Y; Cooke, SK; Dietz, HC; Gallo, EM; Gerber, EE; Habashi, JP; Huso, DL; Judge, DP; Kent, KC; Lindsay, ME; Loch, DC; Myers, L; Norris, RA; Parker, SJ; Rouf, R; Sauls, K; van Erp, C	1
Aoki, H; Aonuma, K; Furusho, A; Hamano, K; Hirakata, S; Hiroe, M; Ikeda, Y; Imaizumi, T; Imanaka-Yoshida, K; Ito, S; Kimura, T; Matsuzaki, M; Miyamoto, T; Nishida, N; Shiraishi, K; Ueno, T; Yoshida, T; Yoshimura, K	1
Chung, AC; Huang, XR; Lan, HY; Wei, LH; Yu, CM; Zhang, Y	1
Chen, Y; Iwaya, S; Oikawa, M; Takeishi, Y	1
Dietz, H	1
Beck, PL; Bracey, NA; Chun, J; Duff, HJ; Fedak, PW; Gershkovich, B; Meijndert, HC; Muruve, DA; Vilaysane, A; Wright, JR	1
Chen, Y; Meng, G; Xu, X; Yang, S; Yao, W; Zhang, W; Zhu, H	1
Cui, W; Du, J; Hao, J; Li, P; Li, Y; Ma, X; Wu, Y; Yin, Z; Zhang, C	1
Calderone, A; Chabot, A; Dupuis, J; El Khoury, N; Fiset, C; Hertig, V; Jasmin, JF; Meus, MA; Nattel, S; Naud, P; Villeneuve, L	1
Dai, Z; He, H; Huang, C; Meng, Y; Tang, Y; Wang, X; Xiao, J; Yu, S; Zhao, Q	1
Carver, KA; Gallagher, PE; Smith, TL; Tallant, EA	1
Chen, YJ; Chung, CC; Hsu, RC; Kao, YH; Liou, JP; Lu, YY	1
Geng, YJ; Huang, X; Lou, G; Lu, S; Pan, J; Shao, J; Yang, D; Zhang, J; Zhang, X; Zhou, X	1
Čulić, V	1
Jamba, A; Kagami, S; Kinoshita, Y; Kobori, H; Kondo, S; Nagai, T; Nishiyama, S; Ozaki, N; Suga, K; Urushihara, M	1
Chen, YJ; Chung, CC; Kao, YH; Lu, YY	1
Burns, KD; Gutsol, A; Touyz, R; Xiao, F; Zimmerman, DL; Zimpelmann, J	1
Cao, YG; Guo, J; Li, BY; Li, L; Li, SZ; Li, XL; Qi, HP; Shi, MM; Sun, HL; Wang, Y; Xu, W; Zhang, QH	1
Basu, R; Fan, D; Kassiri, Z; Lee, J; Sakamuri, SS; Shen, M; Wang, X	1
Bagal, S; Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A	1
Cho, JY; Cho, SN; Choi, SY; Jeong, MH; Kee, HJ; Kim, GR; Kim, HS; Kim, IK; Ryu, Y	1
Ji, X; Li, R; Liu, X; Qi, J; Qing, X; Sheng, X; Xia, Y; Xiao, J; Xing, J; Zhang, S; Zhang, X	1
Fraga-Silva, RA; Londono, FJ; Segers, P; Stergiopulos, N; Swillens, A; Trachet, B	1
Bai, D; Gao, Y; Ge, L; Lu, X; Wang, H; Yang, G	1
Bozorg Grayeli, A; Ferrary, E; Keogh, I; Kiros, N; Rudic, M; Sterkers, O; Wagner, R; Wilkinson, E; Zarkovic, K; Zarkovic, N	1
Bobik, A; Chan, CT; Diep, H; Drummond, GR; Ferens, D; Guzik, TJ; Kett, MM; Kim, HA; Krishnan, SM; Kyaw, TS; Lewis, CV; Lieu, M; Peter, K; Salimova, E; Samuel, CS; Sobey, CG; Tipping, P; Toh, BH; Vinh, A	1
Francis, J; Sriramula, S	1
Hu, J; Huang, Y; Liang, D; Liang, G; Peng, K; Qian, Y; Qiu, C; Skibba, M; Wang, Y; Xu, Z; Zhang, Y; Zou, C	1
Lei, S; Lyu, C; Shao, Y; Wang, Q; Wu, C; Yuan, Q	1
Brandon-Warner, E; Bridges, CR; Fargnoli, AS; Hajjar, RJ; Katz, MG; Kendle, AP; Schrum, LW; Williams, RD	1
Gan, X; Lu, L; Miao, N; Shen, Y; Xu, D; Xu, J; Xue, H; Zhang, W; Zhou, L	1
Chen, J; He, P; Jiang, L; Liu, Y; Tan, N; Wei, X	1
Albertini, R; Avanzini, MA; Bedino, G; Corradetti, V; Dal Canton, A; Esposito, P; Gregorini, M; Ingo, D; Libetta, C; Mantelli, M; Milanesi, S; Pattonieri, EF; Peressini, S; Rampino, T; Rocca, C; Serpieri, N; Valsania, T	1
Ding, F; Ding, J; Li, B; Li, X; Zhang, X	1
Balakrishnan, A; Cassis, LA; Chen, X; Daugherty, A; Howatt, DA; Moorleghen, JJ; Rateri, DL	1
Ban, TH; Chang, YS; Choi, BS; Jang, IA; Kim, EN; Kim, MY; Lim, JH; Park, CW; Shin, SJ; Yoon, HE	1
Di Gennaro, P; Giachi, M; Guglielmotti, A; Paccosi, S; Parenti, A	1
Chen, YH; Hou, JW; Li, CY; Li, YG; Wang, H; Wang, Q; Wang, YP	1
Ait-Aissa, K; Belmadani, S; Gabani, M; Haddox, S; Irani, K; Kassan, M; Mali, V; Matrougui, K; Radwan, E; Trebak, M; Zhang, W	1
Bin, J; Chen, Z; Hao, H; Huang, X; Kitakaze, M; Li, Q; Li, X; Liao, W; Liao, Y; Lin, H; Xie, J; Xuan, W	1
Chege Gitau, S; E, X; Guo, Z; Huangfu, L; Li, T; Li, X; Liang, H; Qian, M; Qili, M; Shan, H; Wang, L; Wu, Q; Xu, B; Xu, C; Zhao, D	1
Guo, N; Li, B; Yang, Z; Zhang, X; Zhao, S	1
Milewicz, DM; Prakash, SK; Ramirez, F	1
Baek, CH; Chang, JW; Kim, H; Lee, RB; Lee, SK; Yang, WS	1
Bi, G; Cao, K; Fang, D; He, Y; Li, Z; Song, X; Wang, F; Wei, Y; Wu, J; Yang, J; Zhang, Z	1
Bond Lau, W; Du, J; Li, P; Li, Y; Li, Z; Ma, XL; Wang, C; Wu, Y; Zhang, C	1
Deng, ZR; Guang, GC; Yan, H; Zhang, Y	1
Adachi, H; Berkowitz, DE; Biswas, D; Das, S; Dunkerly-Eyring, B; Flavell, RA; Henao-Mejia, J; Hori, D; Nomura, Y; Santhanam, L; Steenbergen, C; Steppan, J	1
Ma, ZG; Tang, QZ; Wang, SS; Xu, SC; Yuan, YP; Zhang, X	1
Gan, X; Lu, L; Miao, N; Shen, Y; Wang, B; Xu, D; Xu, J; Xue, H; Yang, L; Zhang, W; Zhou, L	1
Ait-Oufella, H; Cabuzu, D; Esposito, B; Giraud, A; Joffre, J; Kluwe, J; Lafont, A; Mallat, Z; Potteaux, S; Seguier, S; Tedgui, A; Vandestienne, M; Vilar, J; Zeboudj, L	1
Burridge, PW; Eren, M; Flevaris, P; Ghosh, AK; Gupta, S; Khan, SS; Lee, DC; Schuldt, AJT; Shah, SJ; Shapiro, AD; Vaughan, DE	1
Airhart, N; Angelov, SN; Dichek, DA; Hu, JH; Shi, M; Wei, H	1
Atobe, Y; Azushima, K; Haku, S; Haruhara, K; Ishigami, T; Kinguchi, S; Kobayashi, R; Maeda, A; Matsuda, M; Minegishi, S; Ohki, K; Ohsawa, M; Tamura, K; Toya, Y; Umemura, S; Uneda, K; Wakui, H; Yamashita, A	1
Alayoubi, S; Bardi, I; Dufton, NP; Faggian, G; Gorelik, J; Harding, SE; Kane, C; Perbellini, F; Quaife, N; Randi, AM; Scigliano, M; Sikkel, MB; Simon, A; Terracciano, CM; Tkach, S; Watson, SA	1
Bhattacharya, SK; Chen, Y; Lu, L; Sun, Y; Zhao, T; Zhao, W	1
Tellides, G	1
Ge, L; Hoa, N; Korach, KS; Levin, ER	1
Chen, DQ; Chen, H; Chen, L; Liu, D; Wang, M; Wang, MC; Zhao, H; Zhao, YY	1
Allen, TJ; Bach, LA; Biros, E; Chai, Z; Chow, B; Cooper, ME; Dai, A; Du, XJ; Golledge, J; Huynh, P; Kiriazis, H; Li, J; Nataatmadja, M; Tu, Y; Walker, P; West, M; Wilkinson-Berka, JL; Wu, T	1
Hayashi, M; Hirokawa, F; Jin, D; Masubuchi, S; Miyaoka, Y; Ozeki, M; Takai, S; Tashiro, K; Uchiyama, K	1
Cai, Y; Huang, B; Huang, J; Liu, X; Wu, B; Xiao, Y; Ye, J; Zhang, G; Zhou, Y; Zhu, L	1
Chen, J; Deng, P; Ding, X; Huang, X; Ren, L; Wang, K; Wang, S; Wu, C; Wu, J; Xia, J; Ye, P; Yue, Z; Zhang, A	1
Chen, DQ; Chen, H; Wang, MC; Yang, T; Yang, Y; Zhao, YY	1
Al-Shorbagy, MY; Ali, RM; El-Abhar, HS; Helmy, MW	1
Fujiwara, T; Hara, H; Kanaya, T; Komuro, I; Maemura, S; Takeda, N	1
Aires, A; Bolado, P; Cáceres, RA; Chavez, T; Cortajarena, AL; Madrazo, F; Maestro, D; Palanca, AR; Villar, AV	1
Ding, H; Huang, H; Zhou, Y	1
van Beusekom, CD; Zimmering, TM	1
Milewicz, DM; Ramirez, F	1
Badger, SA; Bailey, MA; Bown, MJ; Butterworth, AS; Clément, M; Danesh, J; Finigan, A; Freitag, DF; Grenier, C; Harrison, J; Harrison, SC; Kullo, IJ; Lareyre, F; Lindholt, JS; Mallat, Z; Norman, PE; Paige, E; Paul, DS; Peters, JE; Powell, J; Raffort, J; Rose-John, S; Scott, DJA; Sun, BB; Sweeting, M	1
Baladi, MG; da Silva, MB; de Lima, RS; de Souza, LE; Irigoyen, MC; Lacchini, S; Lima, CT; Silva, JCS	1
He, L; Ji, J; Tao, P	1
Bahl, A; Dhandapany, PS; Khullar, M; Kumar, A; Mittal, A; Prasad, R; Rana, S; Raut, SK; Saikia, UN; Sarkar, S; Sharma, R	1
Andersen, ND; Cavanaugh, NB; Dyle, MC; Gensicke, NM; Huang, T; Qian, L; Turek, JW	1
Cao, Y; Guo, Y; Li, Y; Liu, Y; Ping, F; Shang, J; Yao, S; Yuan, Z	1
Beckett, JD; Bedja, D; Butcher, JT; Chen, Y; Creamer, TJ; Dietz, HC; Gould, RA; Hata, S; Kim, DH; MacFarlane, EG; Mitzner, W; Nagpal, V; Rouf, R; Seman-Senderos, MA; Warren, DS	1
Chen, C; Huang, J; Huang, R; Liang, X; Liu, A; Ning, T; Nong, H; Qin, F; Tang, X	1
Chen, P; Cheng, Q; Huo, C; Li, J; Liu, J; Lu, L; Miao, N; Ni, J; Xie, H; Xu, D; Yin, F; Yu, C; Zhang, W; Zhang, Y; Zheng, P; Zhou, L; Zhou, Z	1
Brazhkina, O; Chandrabhatla, AS; Holmes, JW; Nelson, AR; Saucerman, JJ; Zeigler, AC	1
Fukushima, A; Furihata, T; Kakutani, N; Kinugawa, S; Matsumoto, J; Nambu, H; Takada, S; Yokota, T	1
Delpino, MV; Quarleri, J	1
Fu, X; Song, T; Wang, H; Wang, X; Zhao, J; Zhao, Y	1
Li, D; Li, G; Lv, D; Ouyang, J; Peng, L; Shang, F; Wang, R; Yan, J; Yang, J	1
Czubryt, MP; Garvin, AM; Hale, TM; Khokhar, BS	1
Cai, R; Liu, Y; Ren, F; Xu, Q; Yao, Y; Zhang, J; Zhou, MS	1
Guo, D; Huang, Q; Li, W; Qiao, Y; Xiao, X; Yang, Y; Yu, J; Zhao, L	1
Ding, H; Li, J; Li, Y; Mei, Y; Wang, W; Zhang, R; Zhou, H	1
Fan, XW; Fu, HX; Hu, GL; Hu, J; Kong, B; Li, L; Liu, JJ; Song, WF; Wang, SL; Wu, JT; Yan, LJ; Yang, HT; Zhang, JJ; Zhang, LM	1
Chan, YH; Chen, SW; Chou, AH; Chou, SH; Chu, PH; Ho, CT; Hsiao, FC; Hsu, ME; Kao, WWY; Lin, PJ; Tung, YC; Wu, VC	1
Chang, J; Du, J; Ge, X; Li, X; Li, YC; Liu, W; Nie, H; Sun, Y; Wei, X; Xun, Z	1
Can, J; Hao, S; Ning, Z; Qiang, X; Wu, Y	1
Li, X; Li, Y; Liu, L; Liu, X; Shi, Q	1
Alvarado-Ojeda, ZA; Arrellín-Rosas, G; Castro-Martínez, G; Cervantes-Torres, J; Costet-Mejía, A; Fragoso, G; Hernández-Téllez, B; Herrera-Ruiz, M; Jiménez-Ferrer, E; Medina-Campos, ON; Méndez-Martínez, M; Pedraza-Chaverri, J; Ramírez-Pliego, O; Rosas-Salgado, G; Santana, MA; Trejo-Moreno, C	1
Cao, L; Chen, Y; Fan, J; Liu, Y; Lu, L; Yin, Y	1
Hu, J; Liu, Y; Wang, Q; Wang, W	1
Chacar, S; Fares, N; Hajal, J; Jreije, A; Khouzami, L; Medlej-Hashim, M; Saliba, Y	1
Idrees, M; Khalid, M; Manzoor, S	1
Ge, C; He, Y; Liang, Y; Zhao, Y	1
Betazza, MC; Cianciulli, TF; Fontana Estevez, FS; Gironacci, M; González, GE; Goren, N; Medina, V; Miksztowicz, V; Morales, C; Penas, F; Selser, C; Seropian, IM; Silva, MG; Touceda, V; Villaverde, A	1
Ahıshalı, B; Akcan, U; Altunsu, D; Atis, M; Ayvaz, E; Girouard, H; Kaya, M; Sarıkaya, D; Temizyürek, A; Uğur Yılmaz, C	1
Huang, C; Luo, H; Luo, Y; Wu, H; Zhang, Y	1
Chen, PH; Chen, YJ; Chung, CC; Kao, YH; Liu, SH	1
Duan, Y; Gu, H; Jiang, M; Li, S; Wang, C; Wang, Q; Yin, S; Zhen, W	1
Bai, X; Meng, Z; Su, Y; Wang, Y; Xu, L; Yang, X; Zhuo, C	1
Chen, X; Chen, Y; Fan, S; Li, Z; Liang, G; Lin, Y; Su, X; Wang, X; Zhao, Y	1
Du, CX; Huang, CW; Ku, HC; Kuo, YH; Lee, SY	1
Ahmed, AA; Ahmed, AAE; El Morsy, EM; Mohamed, SK; Nofal, S	1
Cai, X; Li, M; Liang, Z; Yang, W; Zhong, Y	1
Cao, K; Chen, P; Cui, Y; Dai, X; Feng, D; Fu, X; Guo, S; He, J; Li, Z; Song, M; Wang, C; Wang, L; Xu, Y	1

Reviews

77 review(s) available for angiotensin ii and transforming growth factor beta

Article	Year
Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1995, Volume: 26, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Enalapril; Extracellular Matrix Proteins; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Macrophages; Monocytes; Rats; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Triazoles; Ureteral Obstruction	1995
Signaling pathways for cardiac growth and hypertrophy. Recent advances and prospects for growth factor therapy. Annals of the New York Academy of Sciences, 1995, Mar-27, Volume: 752 Topics: Angiotensin II; Animals; Cardiomegaly; Endothelins; Growth Substances; Heart; Humans; Insulin-Like Growth Factor I; Signal Transduction; Transforming Growth Factor beta	1995
Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annual review of physiology, 1995, Volume: 57 Topics: Angiotensin II; Animals; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulonephritis; Humans; Kidney Diseases; Kidney Failure, Chronic; Renin-Angiotensin System; Transforming Growth Factor beta	1995
Impaired proteolytic activity as a potential cause of progressive renal disease. Mineral and electrolyte metabolism, 1996, Volume: 22, Issue:1-3 Topics: Acidosis; Ammonia; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Dietary Proteins; Endopeptidases; Glomerulonephritis; Humans; Hypertrophy; Inflammation; Insulin-Like Growth Factor I; Kidney; Kidney Diseases; Proteins; Transforming Growth Factor beta	1996
Growth factors and apoptosis in neonatal ureteral obstruction. Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:8 Topics: Adult; Age Factors; Angiotensin II; Animals; Animals, Newborn; Apoptosis; Clusterin; Epidermal Growth Factor; Fibrosis; Gene Expression Regulation; Glycoproteins; Growth Substances; Hemodynamics; Humans; Infant; Infant, Newborn; Kidney; Kidney Diseases, Cystic; Mice; Mice, Knockout; Models, Biological; Molecular Chaperones; Proto-Oncogene Proteins c-bcl-2; Rats; Renin-Angiotensin System; Transforming Growth Factor beta; Ureteral Obstruction	1996
Angiotensin II and L-arginine in tissue fibrosis: more than blood pressure. Kidney international, 1997, Volume: 51, Issue:5 Topics: Angiotensin II; Animals; Arginine; Blood Pressure; Dietary Proteins; Fibrinolysin; Fibrosis; Humans; Transforming Growth Factor beta	1997
Transforming growth factor-beta in human glomerular injury. Current opinion in nephrology and hypertension, 1997, Volume: 6, Issue:4 Topics: Angiotensin II; Animals; Decorin; Extracellular Matrix Proteins; Genetic Therapy; Humans; Kidney Diseases; Kidney Glomerulus; Proteoglycans; Transforming Growth Factor beta	1997
Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? Seminars in nephrology, 1997, Volume: 17, Issue:5 Topics: Angiotensin II; Animals; Disease Models, Animal; Fibrosis; Humans; Hypertension, Renal; Kidney Diseases; Transforming Growth Factor beta	1997
Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:1 Pt 2 Topics: Angiotensin II; Animals; Fibrinolysin; Fibrosis; Gene Transfer Techniques; Humans; Integrins; Kidney; Kidney Diseases; Transforming Growth Factor beta	1998
Link between angiotensin II and TGF-beta in the kidney. Mineral and electrolyte metabolism, 1998, Volume: 24, Issue:2-3 Topics: Angiotensin II; Animals; Gene Expression; Humans; Kidney; Kidney Failure, Chronic; Transforming Growth Factor beta	1998
The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy. Seminars in nephrology, 1998, Volume: 18, Issue:6 Topics: Angiotensin II; Animals; Decorin; Extracellular Matrix Proteins; Fibrosis; Humans; Kidney Tubules; NF-kappa B; Nitric Oxide; Proteoglycans; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ureteral Obstruction; Vasoconstriction	1998
Cell apoptosis and proliferation in obstructive uropathy. Seminars in nephrology, 1998, Volume: 18, Issue:6 Topics: Angiotensin II; Animals; Apoptosis; Cell Division; Clusterin; Genes, p53; Glycoproteins; Humans; Kidney Tubules; Molecular Chaperones; Platelet-Derived Growth Factor; Reactive Oxygen Species; Transforming Growth Factor beta; Ureteral Obstruction	1998
Vasoactive factors and tubulointerstitial injury. Kidney & blood pressure research, 1999, Volume: 22, Issue:1-2 Topics: Angiotensin II; Animals; Eicosanoids; Endothelins; Humans; Kidney Diseases; Kidney Tubules; Natriuretic Agents; Receptors, Adrenergic; Transforming Growth Factor beta	1999
New insights into the pathogenesis of interstitial nephritis. Current opinion in nephrology and hypertension, 1999, Volume: 8, Issue:3 Topics: Angiotensin II; Animals; Antibody Formation; B-Lymphocytes; Chemokines; Disease Models, Animal; Humans; Immune Tolerance; Immunity, Cellular; Interferon-gamma; Kidney Tubules; Nephritis, Interstitial; Nitric Oxide; Proteinuria; Transforming Growth Factor beta	1999
Transforming growth factor beta-angiotensin II interaction: implications for cardiac and renal disease. Journal of molecular medicine (Berlin, Germany), 1999, Volume: 77, Issue:7 Topics: Angiotensin II; Heart Diseases; Humans; Kidney Diseases; Models, Biological; Signal Transduction; Transforming Growth Factor beta	1999
Infarct scar: a dynamic tissue. Cardiovascular research, 2000, Volume: 46, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cicatrix; Collagen; Extracellular Matrix; Fibroblasts; Humans; Myocardial Infarction; Myocardium; Necrosis; Neovascularization, Pathologic; Transforming Growth Factor beta; Wound Healing	2000
Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovascular research, 2000, Volume: 46, Issue:2 Topics: Angiotensin II; Animals; Collagenases; Extracellular Matrix; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Humans; Insulin-Like Growth Factor I; Integrins; Myocardium; Signal Transduction; Stress, Mechanical; Transforming Growth Factor beta; Ventricular Remodeling	2000
Renal tubulointerstitial fibrosis. New thoughts on its development and progression. Postgraduate medicine, 2000, Volume: 108, Issue:1 Topics: Angiotensin II; Epithelium; Fibrosis; Humans; Kidney Failure, Chronic; Kidney Tubules; Transforming Growth Factor beta	2000
[Lowered intrarenal protein degradation--an alternative path to glomerulosclerosis and tubulo-interstitial fibrosis]. Medizinische Klinik (Munich, Germany : 1983), 2000, Jul-15, Volume: 95, Issue:7 Topics: Angiotensin II; Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Kidney; Kidney Failure, Chronic; Kidney Tubular Necrosis, Acute; Proteins; Transforming Growth Factor beta	2000
Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence. Current hypertension reports, 2000, Volume: 2, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Black People; Coronary Disease; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Linear Models; Prevalence; Stroke; Transforming Growth Factor beta; White People	2000
Role of angiotensin II in diabetic nephropathy. Kidney international. Supplement, 2000, Volume: 77 Topics: Angiotensin II; Animals; Diabetic Nephropathies; Endothelial Growth Factors; Endothelins; Extracellular Matrix; Glucose; Humans; Lymphokines; Nitric Oxide; Renin-Angiotensin System; Stress, Mechanical; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000
Choroid plexus: target for polypeptides and site of their synthesis. Microscopy research and technique, 2001, Jan-01, Volume: 52, Issue:1 Topics: Angiotensin II; Animals; Brain; Cerebrospinal Fluid; Choroid Plexus; Humans; Insulin-Like Growth Factor II; Leptin; Peptides; Prealbumin; Regional Blood Flow; Transforming Growth Factor beta; Vasopressins	2001
Urinary tract obstruction. Seminars in nephrology, 2001, Volume: 21, Issue:2 Topics: Angiotensin II; Animals; Apoptosis; Fibrosis; Humans; NF-kappa B; Oxidative Stress; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation; Ureteral Obstruction	2001
Angiotensin II and the pathophysiology of cardiovascular remodeling. The American journal of cardiology, 2001, Apr-19, Volume: 87, Issue:8A Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Humans; Hypertension; Renin-Angiotensin System; Transforming Growth Factor beta	2001
Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 1 Topics: Angiotensin II; Antihypertensive Agents; Biomarkers; Disease Progression; Endothelin-1; Humans; Kidney Transplantation; Losartan; Renin-Angiotensin System; Transforming Growth Factor beta; Transplantation, Homologous	2001
Angiotensin II, TGF-beta and renal fibrosis. Contributions to nephrology, 2001, Issue:135 Topics: Angiotensin II; Animals; Disease Models, Animal; Fibrosis; Humans; Kidney; Kidney Diseases; Rats; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Transforming Growth Factor beta	2001
Role of angiotensin II in tubulointerstitial injury. Seminars in nephrology, 2001, Volume: 21, Issue:6 Topics: Angiotensin II; Animals; Chemokine CCL5; Cytokines; Humans; Kidney Tubules; Nephritis, Interstitial; NF-kappa B; Osteonectin; Osteopontin; Renin-Angiotensin System; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2001
Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseases. Seminars in nephrology, 2001, Volume: 21, Issue:6 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Fibrosis; Humans; Kidney Diseases; Liver Cirrhosis; Pulmonary Fibrosis; Renin-Angiotensin System; Transforming Growth Factor beta	2001
The inflammatory component in progressive renal disease--are interventions possible? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:3 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Fibrosis; Humans; Inflammation; Inflammation Mediators; Kidney Diseases; Models, Biological; Mycophenolic Acid; Nephritis; Renin-Angiotensin System; Transforming Growth Factor beta	2002
The biology of white adipocyte proliferation. Obesity reviews : an official journal of the International Association for the Study of Obesity, 2001, Volume: 2, Issue:4 Topics: Adipocytes; Adipose Tissue; Angiotensin II; Cell Division; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Macrophage Colony-Stimulating Factor; Obesity; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2001
Transforming growth factor-beta1 (TGF-beta1): a potential recovery signal in the post-ischemic kidney. Renal failure, 2002, Volume: 24, Issue:4 Topics: Acute Kidney Injury; Angiotensin II; Animals; Humans; Ischemia; Kidney; Reperfusion Injury; Transforming Growth Factor beta; Up-Regulation	2002
Progression of chronic renal disease. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 41, Issue:3 Suppl 1 Topics: Angiotensin II; Animals; Disease Progression; Growth Substances; Humans; Kidney Failure, Chronic; NF-kappa B; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2003
[Vasoactive peptides and the development of renal sclerosis: contribution of transgenes]. Journal de la Societe de biologie, 2002, Volume: 196, Issue:4 Topics: Angiotensin II; Animals; Collagen Type II; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Fibrosis; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Luciferases; MAP Kinase Signaling System; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renin-Angiotensin System; Sclerosis; Transforming Growth Factor beta; Transgenes	2002
[The concept of nephroprotection: toward preventive and curative therapies for renal sclerosis]. Journal de la Societe de biologie, 2002, Volume: 196, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Endothelins; Humans; Ischemia; Kidney; Kidney Failure, Chronic; Kidney Tubules, Proximal; Mice; Models, Animal; Proteinuria; Rats; Sclerosis; Transforming Growth Factor beta	2002
Association between transforming growth factor-beta and hypertension. American journal of hypertension, 2003, Volume: 16, Issue:7 Topics: Angiotensin II; Animals; Blood Pressure; Humans; Hypertension; Models, Animal; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
[Interstitial lung disease]. Medicina clinica, 2003, Oct-04, Volume: 121, Issue:11 Topics: Angiotensin II; Humans; Integrins; Lung Diseases, Interstitial; Pulmonary Fibrosis; Transforming Growth Factor beta	2003
[Renin-angiotensin system and vascular remodelling]. Medecine sciences : M/S, 2004, Volume: 20, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Arteriosclerosis; Blood Pressure; Blood Vessels; Fibrosis; Humans; Hypertension, Renovascular; Hypertrophy; Inflammation; Models, Biological; NADPH Oxidases; Reactive Oxygen Species; Receptors, Angiotensin; Renin-Angiotensin System; Transforming Growth Factor beta	2004
[Involvement of HGF in the pathogenesis of hypertension and hypertensive target-organ damage]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3 Topics: Angiotensin II; Animals; Apoptosis; Arteriosclerosis; Autocrine Communication; Down-Regulation; Endothelium, Vascular; Hepatocyte Growth Factor; Humans; Hypertension; Kidney Tubules; Paracrine Communication; Transforming Growth Factor beta	2004
Hypertension, transforming growth factor-beta, angiotensin II and kidney disease. Journal of hypertension, 2004, Volume: 22, Issue:7 Topics: Angiotensin II; Animals; Humans; Hypertension, Renal; Nephrosclerosis; Transforming Growth Factor beta	2004
TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovascular research, 2004, Aug-15, Volume: 63, Issue:3 Topics: Angiotensin II; Animals; Cardiomyopathy, Dilated; Humans; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta; Ventricular Remodeling	2004
[Mitogenic action of endothelin on fibroblasts]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9 Topics: Angiotensin II; Animals; Cell Division; Collagen; Endothelin-1; Extracellular Matrix; Fibroblast Growth Factor 2; Fibroblasts; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Liver Cirrhosis; Myoblasts, Cardiac; Myocardial Infarction; Pulmonary Fibrosis; Receptors, Endothelin; Transforming Growth Factor beta; Ventricular Remodeling	2004
Liver fibrosis. The Journal of clinical investigation, 2005, Volume: 115, Issue:2 Topics: Angiotensin II; Animals; Humans; Hypertension, Portal; Leptin; Liver Cirrhosis; Liver Failure; Transforming Growth Factor beta	2005
Mediators of fibrosis and apoptosis in obstructive uropathies. Current urology reports, 2005, Volume: 6, Issue:2 Topics: Angiotensin II; Apoptosis; Biomarkers; Female; Fibrosis; Humans; Kidney Diseases; Male; Prognosis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Ureteral Obstruction	2005
[Molecular mechanism in heart failure]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Feb-10, Volume: 94, Issue:2 Topics: Angiotensin II; Calcium; Calcium-Transporting ATPases; Collagen; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Genes, Immediate-Early; Heart Failure; Humans; Microtubules; Myocardial Contraction; Oxidative Stress; Protein Kinase C; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Ribosomal Protein S6 Kinases; Ryanodine Receptor Calcium Release Channel; Transforming Growth Factor beta; Ventricular Remodeling	2005
Disruptions and detours in the myocardial matrix highway and heart failure. Current heart failure reports, 2005, Volume: 2, Issue:1 Topics: Angiotensin II; Disease Progression; Endothelin-1; Extracellular Matrix; Heart Failure; Humans; Hypertrophy, Left Ventricular; Integrins; Matrix Metalloproteinases; Myocardial Infarction; Myocardium; Transforming Growth Factor beta; Ventricular Remodeling	2005
[Pulmonary fibrosis and apoptosis]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Jul-10, Volume: 94, Issue:7 Topics: Angiotensin II; Animals; Apoptosis; Caspases; Cell Cycle Proteins; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Endothelial Cells; Epithelial Cells; Fas Ligand Protein; Fibroblasts; Fibrosis; Humans; Lung; Membrane Glycoproteins; Pulmonary Fibrosis; Reactive Oxygen Species; Regeneration; Transforming Growth Factor beta; Tumor Suppressor Protein p53	2005
Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes. Frontiers in bioscience : a journal and virtual library, 2006, Jan-01, Volume: 11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Chromatography; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Glucose; Hyperglycemia; Immunoblotting; Insulin; Insulin Resistance; Kidney; Male; Models, Statistical; Obesity; Proteinuria; Radioimmunoassay; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation	2006
Pharmacological management of renal fibrotic disease. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Disease Progression; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fibrosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Diseases; Practice Guidelines as Topic; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Transforming Growth Factor beta	2006
Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney international, 2006, Volume: 70, Issue:11 Topics: Angiotensin II; Humans; Kidney; Kidney Failure, Chronic; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta	2006
Role of transforming growth factor-beta in the progression of heart failure. Cellular and molecular life sciences : CMLS, 2006, Volume: 63, Issue:22 Topics: Angiotensin II; Animals; Cardiac Output, Low; Chronic Disease; Disease Progression; Heart Diseases; Humans; Myocardium; Signal Transduction; Transforming Growth Factor beta; Ventricular Remodeling	2006
Reversal of renal disease: is it enough to inhibit the action of angiotensin II? Cell death and differentiation, 2007, Volume: 14, Issue:7 Topics: Angiotensin II; Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Extracellular Matrix Proteins; Fibrosis; Hepatocyte Growth Factor; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; Transforming Growth Factor beta	2007
Functional renin receptors in renal mesangial cells. Current hypertension reports, 2007, Volume: 9, Issue:2 Topics: Angiotensin II; Animals; Humans; Kidney Diseases; Mesangial Cells; Mitogen-Activated Protein Kinases; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Vacuolar Proton-Translocating ATPases	2007
[Cardiac fibrosis]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Apr-28, Volume: 65 Suppl 4 Topics: Angiotensin II; Fibroblasts; Fibrosis; Humans; Myocardium; Transforming Growth Factor beta	2007
Cellular and molecular mechanisms of fibrosis. The Journal of pathology, 2008, Volume: 214, Issue:2 Topics: Angiotensin II; Chemokines; Chemotaxis; Cytokines; Disease Progression; Fibroblasts; Fibrosis; Humans; Immunity, Innate; Interleukins; Th1 Cells; Th2 Cells; Transforming Growth Factor beta	2008
Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Current diabetes reviews, 2008, Volume: 4, Issue:1 Topics: Angiotensin II; Diabetic Nephropathies; Endothelial Cells; Endothelium, Vascular; Humans; Kidney Glomerulus; Membrane Proteins; Models, Biological; Podocytes; Proteinuria; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2008
The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart failure reviews, 2010, Volume: 15, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Angiotensin II; Fibroblasts; Fibrosis; Heart Failure, Diastolic; Humans; Inflammation; Muscle Cells; Phagocytes; Reactive Oxygen Species; Risk Factors; Transforming Growth Factor beta; United States; Ventricular Remodeling	2010
Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circulation research, 2010, Jun-11, Volume: 106, Issue:11 Topics: Angiotensin II; Animals; Cardiovascular Agents; Connective Tissue Growth Factor; Drug Design; Endothelin-1; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Heart Diseases; Humans; Myocardium; Platelet-Derived Growth Factor; Signal Transduction; Transforming Growth Factor beta	2010
Chymase as an important target for preventing complications of metabolic syndrome. Current medicinal chemistry, 2010, Volume: 17, Issue:28 Topics: Angiotensin II; Animals; Atherosclerosis; Chymases; Diabetes Complications; Diabetic Retinopathy; Fatty Liver; Humans; Hypertension; Matrix Metalloproteinase 9; Metabolic Syndrome; Mice; Transforming Growth Factor beta	2010
TGF-β signaling in aortic aneurysm: another round of controversy. Journal of genetics and genomics = Yi chuan xue bao, 2010, Volume: 37, Issue:9 Topics: Angiotensin II; Animals; Aortic Aneurysm; Disease Models, Animal; Humans; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2010
Pathogenic role of TGF-β in the progression of podocyte diseases. Histology and histopathology, 2011, Volume: 26, Issue:1 Topics: Angiotensin II; Animals; Biomechanical Phenomena; Connective Tissue Growth Factor; Denys-Drash Syndrome; Diabetic Nephropathies; Glomerular Basement Membrane; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hypertension, Renal; Kidney Diseases; Models, Biological; Paracrine Communication; Podocytes; Signal Transduction; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2011
Targets of chymase inhibitors. Expert opinion on therapeutic targets, 2011, Volume: 15, Issue:4 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chymases; Digestive System Diseases; Enzyme Inhibitors; Fibrosis; Humans; Intestinal Diseases; Matrix Metalloproteinase 9; Molecular Targeted Therapy; Transforming Growth Factor beta	2011
Lessons on the pathogenesis of aneurysm from heritable conditions. Nature, 2011, May-19, Volume: 473, Issue:7347 Topics: Angiotensin II; Animals; Aortic Aneurysm; Disease Models, Animal; Elastin; Humans; Muscle, Smooth, Vascular; Transforming Growth Factor beta	2011
Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Connective Tissue Growth Factor; Epithelial-Mesenchymal Transition; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Nephrosclerosis; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Transforming Growth Factor beta	2011
Transforming growth factor beta signaling in adult cardiovascular diseases and repair. Cell and tissue research, 2012, Volume: 347, Issue:1 Topics: Aging; Angiotensin II; Animals; Cardiac Rehabilitation; Cardiovascular Diseases; Epithelial-Mesenchymal Transition; Gene Expression; Genetic Variation; Humans; Mitogen-Activated Protein Kinases; Mutation; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2012
An update on RAAS blockade and peritoneal membrane preservation: the ace of art. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2011, Volume: 94 Suppl 4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Epithelial Cells; Humans; Kidney Failure, Chronic; Mineralocorticoid Receptor Antagonists; Peritoneal Dialysis; Peritoneum; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents	2011
Androgen modulates cardiac fibrosis contributing to gender differences on heart failure. The aging male : the official journal of the International Society for the Study of the Aging Male, 2013, Volume: 16, Issue:1 Topics: Androgens; Angiotensin II; Female; Fibrosis; Heart Failure; Humans; Male; Myocardium; Oxidative Stress; Sex Factors; Taiwan; Transforming Growth Factor beta; Young Adult	2013
Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms. Current opinion in pharmacology, 2013, Volume: 13, Issue:2 Topics: Angiotensin II; Animals; Aortic Aneurysm; Humans; Transforming Growth Factor beta	2013
[Research progress of molecular mechanisms on cardiac remodeling]. Sheng li ke xue jin zhan [Progress in physiology], 2013, Volume: 44, Issue:1 Topics: Angiotensin II; Atrial Remodeling; Humans; Phosphatidylinositol 3-Kinases; Signal Transduction; Somatomedins; Transforming Growth Factor beta; Ventricular Remodeling	2013
GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy. American journal of nephrology, 2013, Volume: 38, Issue:1 Topics: Angiotensin II; Animals; Connective Tissue Growth Factor; Diabetic Nephropathies; Glucose; Glucose Transporter Type 1; Humans; Hyperglycemia; Signal Transduction; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2013
Myofibroblasts: trust your heart and let fate decide. Journal of molecular and cellular cardiology, 2014, Volume: 70 Topics: Actins; Angiotensin II; Cell Differentiation; Endothelin-1; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Heart; Humans; Mechanotransduction, Cellular; Mitogen-Activated Protein Kinases; Myofibroblasts; Serum Response Factor; Transforming Growth Factor beta	2014
Getting to the heart of the matter: new insights into cardiac fibrosis. Circulation research, 2015, Mar-27, Volume: 116, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Atrophy; Cicatrix; Connective Tissue Growth Factor; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Humans; Hypoxia; Models, Cardiovascular; Molecular Targeted Therapy; Myocardium; Myofibroblasts; Platelet-Derived Growth Factor; Pyridones; Rats; Signal Transduction; Transforming Growth Factor beta	2015
The pathophysiology of otosclerosis: Review of current research. Hearing research, 2015, Volume: 330, Issue:Pt A Topics: Angiotensin II; Animals; Autoimmunity; Collagen; Genetic Predisposition to Disease; Hearing Loss; HLA Antigens; Humans; Inflammation; Measles virus; Otosclerosis; Oxidative Stress; Parathyroid Hormone; Reactive Oxygen Species; Stapes; Transforming Growth Factor beta	2015
Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models. Annual review of medicine, 2017, 01-14, Volume: 68 Topics: Angiotensin II; Animals; Antihypertensive Agents; Aortic Aneurysm, Thoracic; Aortic Dissection; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Losartan; Marfan Syndrome; Mechanoreceptors; Mice; Muscle, Smooth, Vascular; Signal Transduction; Transforming Growth Factor beta	2017
TGF-β Signaling-Related Genes and Thoracic Aortic Aneurysms and Dissections. International journal of molecular sciences, 2018, Jul-21, Volume: 19, Issue:7 Topics: Angiotensin II; Animals; Aortic Aneurysm, Thoracic; Fibrillin-1; Humans; Loeys-Dietz Syndrome; Signal Transduction; Transforming Growth Factor beta	2018
Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections. Arteriosclerosis, thrombosis, and vascular biology, 2019, Volume: 39, Issue:2 Topics: Acute Disease; Angiotensin II; Animals; Aortic Aneurysm, Thoracic; Aortic Dissection; Humans; Losartan; Mice; Signal Transduction; Transforming Growth Factor beta	2019
Computational model predicts paracrine and intracellular drivers of fibroblast phenotype after myocardial infarction. Matrix biology : journal of the International Society for Matrix Biology, 2020, Volume: 91-92 Topics: Angiotensin II; Animals; Cell Differentiation; Collagen; Computer Simulation; Endothelin-1; Extracellular Matrix; Fibroblasts; Gene Expression Regulation; Humans; Interleukin-1; Models, Biological; Myocardial Infarction; NF-kappa B; Paracrine Communication; Phenotype; Rats; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Wound Healing	2020
RAS inhibition in resident fibroblast biology. Cellular signalling, 2021, Volume: 80 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Epigenesis, Genetic; Fibroblasts; Fibrosis; Humans; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta	2021

Trials

6 trial(s) available for angiotensin ii and transforming growth factor beta

Article	Year
Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy. Kidney international, 1999, Volume: 56, Issue:2 Topics: Adult; Aged; Angiotensin II; Antihypertensive Agents; Blood Pressure; Chronic Disease; Endothelins; Female; Fibrosis; Follow-Up Studies; Graft Rejection; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Losartan; Male; Middle Aged; Pilot Projects; Proteinuria; Transforming Growth Factor beta; Transplantation, Homologous; Vasoconstrictor Agents	1999
Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:4 Topics: Albuminuria; Angiotensin II; Antihypertensive Agents; Collagen; Collagen Type I; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Peptide Fragments; Peptides; Procollagen; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome	2000
Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients. Journal of the American Society of Nephrology : JASN, 2001, Volume: 12, Issue:4 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Endothelin-1; Female; Hemodynamics; Humans; Kidney; Kidney Transplantation; Losartan; Male; Middle Aged; Renal Circulation; Renin; Transforming Growth Factor beta; Transforming Growth Factor beta1	2001
Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy. Diabetes research and clinical practice, 2006, Volume: 72, Issue:2 Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genotype; Humans; Male; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Transforming Growth Factor beta	2006
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes. Endocrine journal, 2006, Volume: 53, Issue:4 Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Proteinuria; Transforming Growth Factor beta	2006
Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA, 2007, Oct-03, Volume: 298, Issue:13 Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aorta; Arteries; Blood Flow Velocity; Blood Pressure; Double-Blind Method; Echocardiography; Female; Humans; Male; Marfan Syndrome; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Perindopril; Transforming Growth Factor beta; Ultrasonography, Doppler; Vasodilation	2007

Other Studies

470 other study(ies) available for angiotensin ii and transforming growth factor beta

Article	Year
Inhibition of adrenocortical steroidogenesis by alpha 2-macroglobulin is caused by associated transforming growth factor beta. Molecular and cellular endocrinology, 1992, Volume: 84, Issue:3 Topics: Adrenal Cortex; Adrenocorticotropic Hormone; alpha-Macroglobulins; Angiotensin II; Animals; Cattle; Cells, Cultured; Hydrocortisone; Radioimmunoassay; Transforming Growth Factor beta	1992
Increased EGF binding and EGFR mRNA expression in rat aorta with chronic administration of pressor angiotensin II. Biochemical medicine and metabolic biology, 1992, Volume: 48, Issue:1 Topics: Angiotensin II; Animals; Aorta; Epidermal Growth Factor; ErbB Receptors; Male; Rats; Rats, Inbred Strains; RNA, Messenger; Transforming Growth Factor beta	1992
Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circulation research, 1992, Volume: 70, Issue:4 Topics: Angiotensin II; Animals; Cells, Cultured; DNA; Epidermal Growth Factor; Fibroblast Growth Factor 2; Mitogens; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rats; Rats, Inbred SHR; Transforming Growth Factor beta	1992
[Angiotensin II and its effects on vascular structure]. Klinische Wochenschrift, 1992, Volume: 69 Suppl 29 Topics: Angiotensin II; Animals; Cell Differentiation; Cells, Cultured; Extracellular Matrix; Humans; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rats; Signal Transduction; Transforming Growth Factor beta	1992
Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. The Journal of clinical investigation, 1992, Volume: 90, Issue:2 Topics: Angiotensin II; Animals; Cell Division; Cells, Cultured; DNA Replication; Gene Expression; Hyperplasia; Hypertrophy; In Vitro Techniques; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; RNA, Messenger; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta	1992
Regulation of 3 beta-hydroxysteroid dehydrogenase in adrenocortical cells: effects of angiotensin-II and transforming growth factor beta. Endocrine research, 1991, Volume: 17, Issue:1-2 Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Cortex; Adrenocorticotropic Hormone; Angiotensin II; Animals; Blotting, Northern; Cattle; Cells, Cultured; Fluorescent Antibody Technique; Gene Expression Regulation; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Transforming Growth Factor beta	1991
Ovine fetal adrenal synthesis of cortisol: regulation by adrenocorticotropin, angiotensin II and transforming growth factor-beta. Endocrinology, 1991, Volume: 129, Issue:4 Topics: Adrenal Glands; Adrenocorticotropic Hormone; Angiotensin II; Animals; Fetus; Hydrocortisone; Osmolar Concentration; Steroid 17-alpha-Hydroxylase; Transforming Growth Factor beta	1991
Induction of thrombospondin expression in vascular smooth muscle cells by angiotensin II. Journal of cardiovascular pharmacology, 1990, Volume: 16 Suppl 7 Topics: Angiotensin II; Animals; Blotting, Northern; Gene Expression; Muscle, Smooth, Vascular; Platelet Membrane Glycoproteins; Rats; Rats, Inbred SHR; RNA; Thrombospondins; Transcription, Genetic; Transforming Growth Factor beta	1990
Water deprivation stimulates transforming growth factor-beta 2 accumulation in the juxtaglomerular apparatus of mouse kidney. The Journal of clinical investigation, 1991, Volume: 88, Issue:6 Topics: Angiotensin II; Animals; Dehydration; Female; Hyperplasia; Juxtaglomerular Apparatus; Mice; Renin; Transforming Growth Factor beta	1991
Stimulation of autocrine platelet--derived growth factor AA-homodimer and transforming growth factor beta in vascular smooth muscle cells. Biochemical and biophysical research communications, 1991, Aug-15, Volume: 178, Issue:3 Topics: Angiotensin II; Animals; Blotting, Northern; Blotting, Western; Cells, Cultured; Endothelins; Macromolecular Substances; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Species Specificity; Transforming Growth Factor beta; Vasoconstrictor Agents	1991
Expression of AT2 receptors in the developing rat fetus. The Journal of clinical investigation, 1991, Volume: 88, Issue:3 Topics: Angiotensin II; Animals; Autoradiography; Embryonic and Fetal Development; Female; Fetus; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Transforming Growth Factor beta	1991
Fibronectin biosynthesis in the rat aorta in vitro. Changes due to experimental hypertension. The Journal of clinical investigation, 1991, Volume: 88, Issue:4 Topics: Age Factors; Angiotensin II; Animals; Aorta; Fibronectins; Hypertension; In Vitro Techniques; Male; Protein Biosynthesis; Rats; Rats, Inbred SHR; RNA, Messenger; Transforming Growth Factor beta	1991
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. The Journal of clinical investigation, 1990, Volume: 86, Issue:5 Topics: Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cell Division; Cell Line; Cyclic GMP; Down-Regulation; Hypertrophy; Muscle, Smooth, Vascular; Protein Kinase C; Rats; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Transforming Growth Factor beta	1990
Role of angiotensin II in the transforming growth factor-beta 1 expression of rat kidney in anti-glomerular basement membrane antiserum-induced glomerulonephritis. Biological & pharmaceutical bulletin, 1995, Volume: 18, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Basement Membrane; Benzimidazoles; Biphenyl Compounds; Glomerulonephritis; Kidney; Kidney Cortex; Kidney Glomerulus; Male; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta	1995
Effect of cilazapril on the proliferative response after vascular damage. Journal of cardiovascular pharmacology, 1993, Volume: 22 Suppl 4 Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Animals; Cell Adhesion Molecules; Cell Division; Cells, Cultured; Cilazapril; Dose-Response Relationship, Drug; Extracellular Matrix; Male; Membrane Glycoproteins; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thrombospondins; Transforming Growth Factor beta	1993
Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts. The American journal of physiology, 1995, Volume: 269, Issue:3 Pt 1 Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Fibroblasts; Heart; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tissue Distribution; Transforming Growth Factor beta	1995
Regulation of renal growth factors and clusterin by AT1 receptors during neonatal ureteral obstruction. The American journal of physiology, 1995, Volume: 268, Issue:6 Pt 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Biphenyl Compounds; Blotting, Northern; Clusterin; DNA; Epidermal Growth Factor; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycoproteins; Imidazoles; Kidney; Losartan; Molecular Chaperones; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Renin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Ureteral Obstruction	1995
Transforming growth factor beta 1 modulates angiotensin II-induced calcium influx in vascular smooth muscle. European journal of clinical investigation, 1995, Volume: 25, Issue:5 Topics: Angiotensin II; Animals; Aorta, Thoracic; Calcium; Cells, Cultured; Cytosol; Hypertension; Male; Muscle, Smooth, Vascular; Naphthalenes; Protein Kinase C; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta	1995
Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. The Journal of clinical investigation, 1995, Volume: 96, Issue:2 Topics: Angiotensin II; Animals; Base Sequence; Disease Progression; Endothelium, Vascular; Extracellular Matrix Proteins; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Hypertrophy; Kidney Glomerulus; Male; Molecular Sequence Data; Nephrectomy; Rats; Rats, Wistar; Renal Circulation; RNA, Messenger; Transforming Growth Factor beta	1995
Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. The Journal of clinical investigation, 1993, Volume: 92, Issue:3 Topics: Angiotensin II; Animals; Base Sequence; Cell Division; Cells, Cultured; Gene Expression; Kidney Tubules, Proximal; Mice; Molecular Sequence Data; Oligodeoxyribonucleotides; Protein Biosynthesis; RNA; RNA, Messenger; Transforming Growth Factor beta	1993
Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. The Journal of pharmacology and experimental therapeutics, 1995, Volume: 273, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Enalapril; Extracellular Matrix Proteins; Gene Expression Regulation; Hypertension; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta	1995
Norepinephrine and ANG II stimulate secretion of TGF-beta by neonatal rat cardiac fibroblasts in vitro. The American journal of physiology, 1995, Volume: 268, Issue:4 Pt 1 Topics: Angiotensin II; Animals; Animals, Newborn; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Heart; Myocardium; Norepinephrine; Rats; Recombinant Proteins; RNA, Messenger; Transforming Growth Factor beta	1995
Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension (Dallas, Tex. : 1979), 1995, Volume: 25, Issue:6 Topics: Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Base Sequence; Body Weight; Cardiomegaly; Collagen; Gene Expression; Heart; Male; Molecular Sequence Data; Phenotype; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta	1995
ANG II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop. The American journal of physiology, 1995, Volume: 268, Issue:5 Pt 2 Topics: Angiotensin II; Animals; Cell Division; Cell Line; Cells, Cultured; Kidney Medulla; Loop of Henle; Mice; Mitogens; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta	1995
Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation, 1995, Jul-01, Volume: 92, Issue:1 Topics: Angioplasty, Balloon; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arteries; Base Sequence; Benzimidazoles; Biphenyl Compounds; Collagen; Fibronectins; Gene Expression Regulation; Genes, Immediate-Early; Immunohistochemistry; Male; Molecular Sequence Data; Ornithine Decarboxylase; Rats; Rats, Sprague-Dawley; Tetrazoles; Transforming Growth Factor beta	1995
Role of angiotensin II in extracellular matrix and transforming growth factor-beta 1 expression in hypertensive rats. European journal of pharmacology, 1994, Sep-15, Volume: 269, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Blotting, Northern; Captopril; Collagen; Extracellular Matrix; Gene Expression Regulation; Heart Ventricles; Hypertension; Male; Organ Size; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta	1994
Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney international, 1994, Volume: 46, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Enalapril; Extracellular Matrix Proteins; Gene Expression; Hemodynamics; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta	1994
AT1 receptor-mediated stimulation by angiotensin II of rat aortic fibronectin gene expression in vivo. British journal of pharmacology, 1994, Volume: 113, Issue:3 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Fibronectins; Gene Expression Regulation; Male; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta	1994
Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats. Blood pressure. Supplement, 1994, Volume: 5 Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cerebrovascular Disorders; Extracellular Matrix; Gene Expression; Hypertension, Renal; Kidney; Kidney Glomerulus; Male; Phenotype; Prodrugs; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger; Sclerosis; Tetrazoles; Transforming Growth Factor beta	1994
Regulation of corticotropin and steroidogenic enzyme mRNAs in human fetal adrenal cells by corticotropin, angiotensin-II and transforming growth factor beta 1. Molecular and cellular endocrinology, 1994, Volume: 106, Issue:1-2 Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Glands; Adrenocorticotropic Hormone; Angiotensin II; Cells, Cultured; Cholesterol Side-Chain Cleavage Enzyme; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Gene Expression Regulation; Humans; Hydrocortisone; Receptors, Corticotropin; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Steroids; Transforming Growth Factor beta	1994
Peptide hormone and growth factor regulation of nuclear proto-oncogenes and specific functions in adrenal cells. The Journal of steroid biochemistry and molecular biology, 1994, Volume: 50, Issue:5-6 Topics: Adrenal Glands; Adrenocorticotropic Hormone; Alkaloids; Angiotensin II; Animals; Calcium; Cattle; Gene Expression Regulation; Genes, fos; Genes, jun; Growth Substances; In Vitro Techniques; Insulin-Like Growth Factor I; Staurosporine; Transforming Growth Factor beta; Trifluoperazine	1994
Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts. Biochemical and biophysical research communications, 1994, Nov-30, Volume: 205, Issue:1 Topics: Angiotensin II; Animals; Animals, Newborn; Cell Division; Female; Fibroblasts; Genes, Immediate-Early; Heart; Myocardium; Pregnancy; Rats; Rats, Wistar; RNA, Messenger; Transcription Factors; Transforming Growth Factor beta	1994
Regulation of endothelin-1 biosynthesis. Annals of the New York Academy of Sciences, 1994, Apr-18, Volume: 714 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Platelets; Bradykinin; Cell Hypoxia; Endothelin-1; Endothelins; Gene Expression Regulation; Humans; Insulin; Protein Biosynthesis; Protein Precursors; Protein Processing, Post-Translational; RNA, Messenger; Stress, Mechanical; Thrombin; Transcription, Genetic; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasopressins	1994
Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension (Dallas, Tex. : 1979), 1994, Volume: 24, Issue:2 Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Desoxycorticosterone; Enalapril; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Rats; Rats, Wistar; Renin; RNA, Messenger; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta	1994
Mitogenic signals control translation of the early growth response gene-1 in myogenic cells. Biochemical and biophysical research communications, 1994, Aug-15, Volume: 202, Issue:3 Topics: Angiotensin II; Animals; Base Sequence; Becaplermin; Cells, Cultured; DNA-Binding Proteins; Early Growth Response Protein 1; Endothelins; Fibroblast Growth Factor 2; Immediate-Early Proteins; Insulin; Mice; Molecular Sequence Data; Muscles; Oligodeoxyribonucleotides; Phenylephrine; Platelet-Derived Growth Factor; Protein Biosynthesis; Proto-Oncogene Proteins c-sis; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factors; Transforming Growth Factor beta; Zinc Fingers	1994
Angiotensin II induces TGF-beta 1 production in rat heart endothelial cells. Biochimica et biophysica acta, 1994, Aug-11, Volume: 1223, Issue:1 Topics: Angiotensin II; Animals; Cells, Cultured; Endothelium, Vascular; Heart; Myocardium; Rats; RNA, Messenger; Transforming Growth Factor beta	1994
Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circulation research, 1994, Volume: 74, Issue:4 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Fibronectins; Gene Expression; Male; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta	1994
Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension (Dallas, Tex. : 1979), 1994, Volume: 23, Issue:5 Topics: Angiotensin II; Animals; Aortic Coarctation; Atrial Natriuretic Factor; Biphenyl Compounds; Cardiomegaly; Gene Expression Regulation; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles; Transforming Growth Factor beta	1994
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. The Journal of clinical investigation, 1994, Volume: 93, Issue:6 Topics: Angiotensin II; Animals; Cells, Cultured; Extracellular Matrix Proteins; Glomerular Mesangium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta	1994
Pharmacology of nerve growth factor output by target cells. Annals of the New York Academy of Sciences, 1993, Aug-27, Volume: 692 Topics: Angiotensin II; Animals; Aorta; Arginine Vasopressin; Becaplermin; Cells, Cultured; Colforsin; Culture Media, Serum-Free; Dactinomycin; Drug Synergism; Kinetics; Muscle, Smooth, Vascular; Nerve Growth Factors; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Recombinant Proteins; Transforming Growth Factor beta	1993
Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-beta on platelet-derived growth factor-BB, basic fibroblastic growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cel American journal of hypertension, 1993, Volume: 6, Issue:6 Pt 1 Topics: Angiotensin II; Animals; Aorta; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Drug Synergism; Epidermal Growth Factor; Female; Fibroblast Growth Factor 2; Insulin; Insulin-Like Growth Factor I; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rats; Rats, Inbred WKY; Thymidine; Transforming Growth Factor beta; Tritium	1993
Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circulation research, 1993, Volume: 73, Issue:3 Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Cells, Cultured; Fibroblasts; Gene Expression Regulation; Genes, fos; Hyperplasia; Myocardium; Rats; Receptors, Angiotensin; Transforming Growth Factor beta	1993
[Mesangial cells and growth factors]. Nihon Jinzo Gakkai shi, 1993, Volume: 35, Issue:5 Topics: Angiotensin II; Arginine Vasopressin; Glomerular Mesangium; Growth Substances; Humans; Platelet-Derived Growth Factor; Transforming Growth Factor beta	1993
[Tissue factors contributing to cardiac hypertrophy in cardiomyopathic hamsters (BIO14.6): involvement of transforming growth factor-beta 1 and tissue renin-angiotensin system in the progression of cardiac hypertrophy]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1993, Volume: 68, Issue:1 Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cells, Cultured; Cricetinae; Guinea Pigs; Male; Mesocricetus; Myocardium; Peptidyl-Dipeptidase A; Phosphatidylinositols; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta	1993
Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. The Journal of clinical investigation, 1993, Volume: 92, Issue:4 Topics: Adipocytes; Angiotensin II; Animals; Carbon Tetrachloride Poisoning; Cells, Cultured; Collagen; Cytochalasin B; Endothelins; Liver; Liver Cirrhosis, Experimental; Male; Microscopy, Electron, Scanning; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Serotonin; Thrombin; Transforming Growth Factor beta	1993
Transforming growth factor-beta 1 inhibits aldosterone biosynthesis in cultured bovine zona glomerulosa cells. Endocrinology, 1993, Volume: 132, Issue:3 Topics: Aldosterone; Angiotensin II; Animals; Cattle; Cell Survival; Cells, Cultured; Corticosterone; Desoxycorticosterone; Kinetics; Mineralocorticoid Receptor Antagonists; Potassium; Pregnenolone; Transforming Growth Factor beta; Zona Glomerulosa	1993
Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. The Journal of clinical investigation, 1993, Volume: 91, Issue:5 Topics: 3T3 Cells; Amino Acid Sequence; Angiotensin II; Animals; Aorta; Cell Division; Cells, Cultured; Fibroblast Growth Factor 2; Gene Expression; Genes, fos; Genes, jun; Genes, myc; Humans; Kinetics; Mice; Molecular Sequence Data; Muscle, Smooth, Vascular; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Platelet-Derived Growth Factor; Rats; Transforming Growth Factor beta	1993
Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II. Hypertension (Dallas, Tex. : 1979), 1993, Volume: 21, Issue:6 Pt 2 Topics: Angiotensin II; Animals; Biological Assay; Cell Division; Cells, Cultured; DNA; Fibroblast Growth Factor 2; Hyperplasia; Hypertrophy; Muscle, Smooth, Vascular; Rats; Rats, Inbred WKY; Transforming Growth Factor beta	1993
Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:9 Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Base Sequence; Benzimidazoles; Biphenyl Compounds; DNA, Complementary; Gene Expression; Male; Molecular Sequence Data; Myocardial Infarction; Myosin Heavy Chains; Rats; Rats, Wistar; Tetrazoles; Transforming Growth Factor beta	1995
Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney international, 1995, Volume: 48, Issue:4 Topics: Angiotensin II; Animals; Biphenyl Compounds; Gene Expression; Imidazoles; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Male; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Tissue Distribution; Transforming Growth Factor beta; Ureteral Obstruction	1995
Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:10 Topics: Angiotensin II; Animals; Cardiomegaly; Culture Media, Conditioned; Endomyocardial Fibrosis; Fibroblasts; Gene Expression Regulation; Male; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stimulation, Chemical; Transforming Growth Factor beta	1995
Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: attenuation after stable transfection with the c-mas oncogene. Kidney international, 1995, Volume: 48, Issue:6 Topics: Angiotensin II; Animals; Cell Line; Kidney Tubules, Proximal; Mice; Molecular Sequence Data; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; RNA, Messenger; Transfection; Transforming Growth Factor beta	1995
Transforming growth factor beta mediates the angiotensin-II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:2 Topics: Angiotensin II; Animals; Base Sequence; Cell Line; Collagen; Gene Transfer Techniques; Kidney Tubules, Proximal; Mice; Molecular Sequence Data; RNA, Messenger; Transforming Growth Factor beta	1996
Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. The Journal of clinical investigation, 1995, Volume: 96, Issue:6 Topics: Aging; Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Body Weight; Gene Expression; Growth Substances; Homeostasis; Kidney; Kidney Cortex; Kidney Glomerulus; Kidney Medulla; Mice; Mice, Knockout; Mice, Mutant Strains; Organ Size; Platelet-Derived Growth Factor; Restriction Mapping; RNA, Messenger; Transforming Growth Factor beta	1995
Effect of angiotension II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells. Journal of hypertension, 1996, Volume: 14, Issue:3 Topics: Angiotensin II; Calcium; Cells, Cultured; DNA; Gene Expression Regulation; Genes, fos; Humans; Muscle, Smooth, Vascular; Transforming Growth Factor beta	1996
Regulation of primary response and specific genes in adrenal cells by peptide hormones and growth factors. Steroids, 1996, Volume: 61, Issue:4 Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Angiotensin II; Animals; Cattle; Cell Differentiation; Cells, Cultured; Drug Resistance; Gene Expression Regulation, Neoplastic; Growth Substances; Humans; Insulin-Like Growth Factor I; Proto-Oncogene Mas; Proto-Oncogenes; Receptors, Angiotensin; Receptors, Corticotropin; RNA, Messenger; Transforming Growth Factor beta; Zona Fasciculata; Zona Reticularis	1996
Regulation of ANG II receptor in hypertension: role of ANG II. The American journal of physiology, 1996, Volume: 271, Issue:1 Pt 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Gene Expression; Hypertension; Imidazoles; Losartan; Male; Nephrectomy; Ramipril; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta	1996
Formation of an F2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors. The American journal of physiology, 1996, Volume: 271, Issue:1 Pt 2 Topics: Angiotensin II; Animals; Antioxidants; Cell Division; Cells, Cultured; Dinoprost; F2-Isoprostanes; Glucose; Growth Substances; Muscle, Smooth, Vascular; Phospholipases A; Platelet-Derived Growth Factor; Pyrrolidines; Quinacrine; Swine; Thiocarbamates; Time Factors; Transforming Growth Factor beta	1996
Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats. Regulatory peptides, 1996, Apr-23, Volume: 62, Issue:2-3 Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cell Division; Cilazapril; Gene Expression Regulation; Hypertension, Renovascular; Imidazoles; Kidney Glomerulus; Male; Platelet-Derived Growth Factor; Rats; Rats, Wistar; Receptors, Angiotensin; Renin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta	1996
Differential effects of angiotensin II and transforming growth factor beta on the production of heparan sulfate proteoglycan by mesangial cells in vitro. Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:7 Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cells, Cultured; Gene Expression Regulation; Glomerular Mesangium; Heparan Sulfate Proteoglycans; Heparitin Sulfate; Humans; Oligosaccharides; Proteoglycans; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta	1996
Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. Kidney international, 1996, Volume: 50, Issue:3 Topics: Angiotensin II; Animals; Blotting, Northern; Calcium-Calmodulin-Dependent Protein Kinases; Collagen; Drug Interactions; Extracellular Matrix Proteins; Fibronectins; Gene Expression; Glomerular Mesangium; Hypoglycemic Agents; Insulin; Mice; Procollagen; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Vasoconstrictor Agents	1996
ACTH angiotensin II and TGF beta participate in the regulation of steroidogenesis in bovine adrenal glomerulosa cells. Endocrine research, 1996, Volume: 22, Issue:4 Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Cattle; Cell Differentiation; Cells, Cultured; Cytochrome P-450 CYP11B2; Hydrocortisone; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Transforming Growth Factor beta; Zona Glomerulosa	1996
The effects of high glucose concentration on angiotensin II- or transforming growth factor-beta-induced DNA synthesis, hypertrophy and collagen synthesis in cultured rat mesangial cells. Yonsei medical journal, 1996, Volume: 37, Issue:5 Topics: Angiotensin II; Animals; Cells, Cultured; Collagen; DNA; Glomerular Mesangium; Glucose; Hypertrophy; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta	1996
Cigarette smoke increases gastric ulcer size in part by an angiotensin II-mediated mechanism in rats. Digestive diseases and sciences, 1997, Volume: 42, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Immunoblotting; Male; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Smoking; Somatomedins; Stomach Ulcer; Transforming Growth Factor beta	1997
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1997, Volume: 29, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chronic Disease; Extracellular Matrix Proteins; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Imidazoles; Kidney; Lisinopril; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Tetrazoles; Transforming Growth Factor beta	1997
Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney international, 1997, Volume: 51, Issue:3 Topics: Angiotensin II; Animals; Antibodies; Cells, Cultured; Cycloheximide; Fibrinolysin; Glomerular Mesangium; Neutralization Tests; Plasminogen; Plasminogen Activator Inhibitor 1; Protein Synthesis Inhibitors; Rats; RNA, Messenger; Transforming Growth Factor beta; Up-Regulation	1997
Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells. Kidney international, 1997, Volume: 51, Issue:4 Topics: Angiotensin II; Animals; Calcium Channel Blockers; Cells, Cultured; Collagen; Culture Media, Conditioned; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Fibronectins; Gene Expression; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Protein Kinase C; Protein-Tyrosine Kinases; Rats; RNA, Messenger; Stress, Mechanical; Transforming Growth Factor beta	1997
Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes, 1997, Volume: 46, Issue:5 Topics: Angiotensin II; Blotting, Northern; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Epithelium; Fibronectins; Fluorescent Antibody Technique; Glucose; Humans; Kidney Glomerulus; Polymerase Chain Reaction; Receptors, Angiotensin; RNA-Directed DNA Polymerase; RNA, Messenger; Transforming Growth Factor beta	1997
Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney international, 1997, Volume: 51, Issue:5 Topics: Angiotensin II; Animals; Blotting, Northern; Gene Expression Regulation; In Situ Hybridization; Kidney; Male; Nephrectomy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Transforming Growth Factor beta	1997
Stretch-induced VEGF expression in the heart. The Journal of clinical investigation, 1997, Jul-01, Volume: 100, Issue:1 Topics: Angiotensin II; Animals; Antibodies; Catheterization; Diastole; Endothelial Growth Factors; Endothelin Receptor Antagonists; Endothelin-1; Heart; In Vitro Techniques; Lymphokines; Male; Myocardial Ischemia; Myocardium; Peptides, Cyclic; Protein Kinase C; Rats; Rats, Sprague-Dawley; RNA, Messenger; Saralasin; Staurosporine; Transcription, Genetic; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1997
Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:7 Topics: Angiotensin II; Animals; Cattle; Cells, Cultured; Fibroblasts; Fluorescent Antibody Technique, Indirect; Gene Expression; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta	1997
Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism: clinical and experimental, 1997, Volume: 46, Issue:8 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcysteine; Angiotensin II; Animals; Antioxidants; Cells, Cultured; Enzyme Activation; Female; Glucose; Kidney Glomerulus; Phorbol 12,13-Dibutyrate; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Rats; Rats, Sprague-Dawley; Taurine; Thromboxane A2; Thromboxanes; Transforming Growth Factor beta; Vitamin E	1997
Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells. Direct stimulation and indirect inhibition via transforming growth factor-beta 1. Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:7 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cell Movement; Gene Expression; Humans; Imidazoles; Losartan; Muscle, Smooth, Vascular; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta	1997
Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor. Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:8 Topics: Adult; Angiotensin II; Apoptosis; Cell Division; Cell Hypoxia; Collagen; DNA Replication; Fibroblast Growth Factor 2; Fibroblasts; Gene Expression Regulation; Heart; Heart Septum; Humans; Male; Muscle Proteins; Myocardium; RNA, Messenger; Transforming Growth Factor beta; Triiodothyronine	1997
Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney international, 1997, Volume: 52, Issue:3 Topics: Angiotensin II; Animals; Blotting, Northern; Cyclosporine; Extracellular Matrix Proteins; Immunohistochemistry; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta	1997
Multiaxial myocardial mechanics and extracellular matrix remodeling: mechanochemical regulation of cardiac fibroblast function. Advances in experimental medicine and biology, 1997, Volume: 430 Topics: Angiotensin II; Animals; Biomechanical Phenomena; Cells, Cultured; Extracellular Matrix; Extracellular Matrix Proteins; Fibroblasts; Gene Expression; Myocardium; Rats; RNA, Messenger; Transforming Growth Factor beta	1997
Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circulation research, 1997, Volume: 81, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Atrial Natriuretic Factor; Body Fluids; Cardiomegaly; Female; Fibroblast Growth Factor 2; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Pericardium; Rats; Rats, Wistar; Transforming Growth Factor beta	1997
Interaction of angiotensin II and TGF-beta 1 in the rat remnant kidney. Journal of the American Society of Nephrology : JASN, 1997, Volume: 8, Issue:11 Topics: Angiotensin II; Animals; Antihypertensive Agents; Culture Techniques; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Kidney; Kidney Glomerulus; Losartan; Male; Nephrectomy; Organ Size; Rats; Rats, Sprague-Dawley; Reference Values; RNA; Transforming Growth Factor beta	1997
Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney. Pediatric research, 1997, Volume: 42, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Body Weight; Clusterin; Enalapril; Epidermal Growth Factor; Glycoproteins; Growth Substances; Kidney; Kidney Glomerulus; Kidney Tubules; Molecular Chaperones; Organ Size; Protein Precursors; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta	1997
Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation, 1997, Nov-18, Volume: 96, Issue:10 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cattle; Coculture Techniques; Culture Media, Conditioned; Endothelin Receptor Antagonists; Endothelin-1; Hypertrophy; Lipoproteins, LDL; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Paracrine Communication; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Transforming Growth Factor beta; Ventricular Function	1997
Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. Kidney international. Supplement, 1997, Volume: 63 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Progression; Enalapril; Fibrosis; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Kidney Failure, Chronic; Male; Nephrectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Tetrazoles; Transforming Growth Factor beta	1997
Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney international, 1997, Volume: 52, Issue:6 Topics: Angiotensin II; Animals; Calcium; Cell Communication; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Fibroblasts; Fibronectins; Fibrosis; Flow Cytometry; Gene Expression Regulation; Hyperplasia; Hypertrophy; Imidazoles; Kidney; Protein Kinase C; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta; Up-Regulation	1997
Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:2 Topics: Angiotensin II; Animals; Cell Division; Cells, Cultured; Hypertension; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Transforming Growth Factor beta; RNA, Messenger; Transforming Growth Factor beta	1998
Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site. Biochemical and biophysical research communications, 1998, Feb-13, Volume: 243, Issue:2 Topics: Angiotensin II; Animals; Cell Count; Cells, Cultured; Fibroblast Growth Factor 2; Gene Expression Regulation; Leucine; Muscle Development; Muscle, Smooth, Vascular; Oligodeoxyribonucleotides; Rats; Rats, Inbred Strains; Transcription Factor AP-1; Transfection; Transforming Growth Factor beta; Uridine	1998
Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 31, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antilymphocyte Serum; Blood Pressure; Cell Division; Creatinine; Glomerulonephritis, Membranoproliferative; Immunoglobulin G; Kidney; Kidney Glomerulus; Lisinopril; Macrophages; Male; Monocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta	1998
Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption. Kidney international, 1998, Volume: 53, Issue:3 Topics: Actins; Angiotensin II; Angiotensinogen; Animals; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerular Filtration Rate; Homeostasis; In Situ Hybridization; Kidney Concentrating Ability; Kidney Glomerulus; Kidney Tubules; Male; Mice; Mice, Knockout; Proliferating Cell Nuclear Antigen; RNA, Messenger; Transforming Growth Factor beta	1998
High-glucose media enhance the responsiveness of tubular cells to growth promoters: effect on lysosomal cathepsins and protein degradation. Mineral and electrolyte metabolism, 1998, Volume: 24, Issue:4 Topics: Angiotensin II; Cathepsins; Cell Line; Culture Media; Glucose; Growth Substances; Insulin-Like Growth Factor I; Kidney Tubules; Lysosomes; Parathyroid Hormone; Proteins; Transforming Growth Factor beta	1998
A central role for protein kinase C overactivity in diabetic glomerulosclerosis: implications for prevention with antioxidants, fish oil, and ACE inhibitors. Medical hypotheses, 1998, Volume: 50, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Diabetic Angiopathies; Diabetic Nephropathies; Enzyme Activation; Fish Oils; Heparitin Sulfate; Humans; Hyperglycemia; Kidney Glomerulus; Lipid Peroxidation; Models, Biological; Nitric Oxide; Protein Kinase C; Thromboxane A2; Transforming Growth Factor beta	1998
Autocrine/paracrine determinants of strain-activated brain natriuretic peptide gene expression in cultured cardiac myocytes. The Journal of biological chemistry, 1998, Jun-05, Volume: 273, Issue:23 Topics: Angiotensin II; Animals; Antibodies; Autocrine Communication; Cells, Cultured; Culture Media, Conditioned; Endothelin-1; Gene Expression Regulation; Genes, Reporter; Humans; Losartan; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Paracrine Communication; Peptides, Cyclic; Promoter Regions, Genetic; Rats; RNA, Messenger; Sprains and Strains; Transfection; Transforming Growth Factor beta; Ventricular Function	1998
Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. American journal of respiratory cell and molecular biology, 1998, Volume: 18, Issue:6 Topics: Angiotensin II; Blotting, Northern; Bronchi; Cells, Cultured; DNA-Binding Proteins; Early Growth Response Protein 1; Humans; Hyperplasia; Hypertrophy; Immediate-Early Proteins; Immunohistochemistry; Muscle, Smooth; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; RNA, Messenger; Time Factors; Transcription Factors; Transforming Growth Factor beta	1998
Tissue-specific regulation of growth factors and clusterin by angiotensin II. American journal of hypertension, 1998, Volume: 11, Issue:6 Pt 1 Topics: Angiotensin II; Animals; Clusterin; Epidermal Growth Factor; Glycoproteins; Infusions, Intravenous; Male; Molecular Chaperones; Organ Specificity; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta	1998
Pouch tissue and angiotensin peptide generation. Journal of molecular and cellular cardiology, 1998, Volume: 30, Issue:7 Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Angiotensins; Animals; Aspartic Acid Endopeptidases; Cathepsin D; Collagen; Gene Expression; Imidazoles; Lisinopril; Losartan; Myocardium; Peptide Biosynthesis; Peptides; Peptidyl-Dipeptidase A; Pyridines; Rats; Renin; Transforming Growth Factor beta	1998
Angiotensin-dependent gene expression in the developing rat kidney. Kidney international. Supplement, 1998, Volume: 67 Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Antihypertensive Agents; Blotting, Northern; Endothelial Growth Factors; Epidermal Growth Factor; Gene Expression Regulation, Developmental; Growth Substances; Kidney; Losartan; Lymphokines; Molecular Sequence Data; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1998
Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. Journal of molecular and cellular cardiology, 1998, Volume: 30, Issue:8 Topics: Angiotensin II; Animals; Collagen; Fibrosis; Losartan; Male; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta	1998
Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 32, Issue:3 Topics: Angiotensin II; Animals; Autocrine Communication; Cardiovascular Diseases; Carotid Arteries; Carotid Artery Injuries; Cells, Cultured; Cytokines; Endothelium, Vascular; Hepatocyte Growth Factor; Humans; Male; Muscle, Smooth, Vascular; Polymerase Chain Reaction; Rats; Rats, Inbred WKY; Transforming Growth Factor beta; Vasoconstrictor Agents	1998
Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circulation research, 1998, Oct-05, Volume: 83, Issue:7 Topics: Angiotensin II; Animals; Axl Receptor Tyrosine Kinase; Carotid Artery Injuries; Catheterization; Fibroblast Growth Factor 2; GTP-Binding Proteins; Male; Oncogene Proteins; Platelet-Derived Growth Factor; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptors, Cell Surface; Thrombin; Transforming Growth Factor beta	1998
TGF-beta- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:11 Topics: Alkaloids; Angiotensin II; Animals; Benzophenanthridines; Cell Division; Extracellular Matrix Proteins; Fibronectins; Glomerular Mesangium; Laminin; Male; Phenanthridines; Protein Kinase C; Proteoglycans; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta	1998
Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney international, 1998, Volume: 54, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Eating; Enalapril; Fibronectins; Fibrosis; Glomerulonephritis, Membranoproliferative; Kidney; Losartan; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta	1998
Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovascular research, 1998, Volume: 40, Issue:2 Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Northern; Blotting, Western; Cardiomegaly; Cells, Cultured; Coculture Techniques; Culture Media, Conditioned; Endothelin-1; Fibroblasts; Microscopy, Fluorescence; Myocardium; Paracrine Communication; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta; Vasoconstrictor Agents	1998
Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney international, 1999, Volume: 55, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Cilazapril; Collagen; Disease Models, Animal; Glomerulonephritis, Membranoproliferative; Hydralazine; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Wistar; Renal Circulation; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta	1999
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. The Journal of clinical investigation, 1999, Volume: 103, Issue:5 Topics: Angiotensin II; Animals; Anti-Glomerular Basement Membrane Disease; Chemokine CCL2; Collagen; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Angiotensin; Renin-Angiotensin System; Transforming Growth Factor beta	1999
Angiotensin II inhibits interleukin-1 beta-induced nitric oxide production in cultured rat mesangial cells. Kidney international, 1999, Volume: 55, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Cells, Cultured; Gene Expression; Glomerular Mesangium; Imidazoles; Interleukin-1; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta	1999
Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. Journal of the American Society of Nephrology : JASN, 1999, Volume: 10, Issue:4 Topics: Analysis of Variance; Angiotensin II; Blotting, Western; Cells, Cultured; Endothelial Growth Factors; Gene Expression Regulation; Glomerular Mesangium; Humans; Lymphokines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reference Values; RNA, Messenger; Stress, Mechanical; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1999
Association of TGF-beta signaling in angiotensin II-induced PAI-1 mRNA upregulation in mesangial cells: role of PKC. Biochimica et biophysica acta, 1999, Apr-01, Volume: 1449, Issue:3 Topics: Angiotensin II; Animals; Cells, Cultured; Drug Synergism; Gene Expression Regulation; Genistein; Glomerular Mesangium; Plasminogen Activator Inhibitor 1; Protein Kinase C; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Up-Regulation	1999
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy. Kidney international, 1999, Volume: 55, Issue:5 Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Animals, Newborn; Apoptosis; Cell Division; Disease Models, Animal; Epidermal Growth Factor; Gene Expression Regulation, Developmental; In Situ Hybridization; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Kidney Diseases; Kidney Medulla; Kidney Pelvis; Macrophages; Mice; Mice, Knockout; Muscle, Smooth; Peptidyl-Dipeptidase A; Platelet-Derived Growth Factor; Pressure; RNA, Messenger; Transforming Growth Factor beta; Ureter; Ureteral Obstruction	1999
Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms. Circulation research, 1999, May-14, Volume: 84, Issue:9 Topics: Angiotensin II; Animals; Base Sequence; Calcium; Calmodulin; ErbB Receptors; Fibronectins; Phorbol Esters; Protein Kinase C; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation; Transforming Growth Factor beta	1999
TGF-beta 1 production in radiation nephropathy: role of angiotensin II. International journal of radiation biology, 1999, Volume: 75, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Female; Imidazoles; Kidney Diseases; Kidney Glomerulus; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Tetrazoles; Transforming Growth Factor beta	1999
Pulsatile stretch activates mitogen-activated protein kinase (MAPK) family members and focal adhesion kinase (p125(FAK)) in cultured rat cardiac myocytes. Biochemical and biophysical research communications, 1999, May-27, Volume: 259, Issue:1 Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Adhesion Molecules; Cells, Cultured; Endothelial Growth Factors; Endothelins; Enzyme Activation; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genistein; Lymphokines; Myocardium; Naphthalenes; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Signal Transduction; Stress, Mechanical; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1999
Angiotensin II-induced modulation of rat mesangial cell phenotype. Radiation research, 1999, Volume: 151, Issue:6 Topics: Angiotensin II; Animals; Cells, Cultured; Collagenases; Fibronectins; Gelatin; Gelatinases; Glomerular Mesangium; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Phenotype; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta	1999
Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Hypertension; Male; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Phosphorylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Transcription Factor AP-1; Transforming Growth Factor beta	1999
Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-beta1 in vascular smooth muscle. Journal of molecular medicine (Berlin, Germany), 1999, Volume: 77, Issue:5 Topics: Angiotensin II; Animals; Gene Expression Regulation; Muscle, Smooth, Vascular; Rats; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta	1999
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells. Kidney international, 1999, Volume: 56, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Anti-Bacterial Agents; Antihypertensive Agents; Blotting, Northern; Cell Division; Cell Line, Transformed; Epithelial Cells; Fibrosis; Gene Expression; Humans; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Peptides; Plasminogen Activator Inhibitor 1; Protease Inhibitors; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tissue Plasminogen Activator; Transforming Growth Factor beta; Urokinase-Type Plasminogen Activator	1999
Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. The American journal of pathology, 1999, Volume: 155, Issue:2 Topics: Angiotensin II; Animals; Collagen; Immunohistochemistry; In Situ Hybridization; Kidney; Kidney Tubules; Male; Nephrectomy; Nephritis, Interstitial; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin; Transforming Growth Factor alpha; Transforming Growth Factor beta	1999
Activin A and TGF-beta stimulate phosphorylation of focal adhesion proteins and cytoskeletal reorganization in rat aortic smooth muscle cells. Experimental cell research, 1999, Aug-25, Volume: 251, Issue:1 Topics: Actins; Activins; Angiotensin II; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cell Size; Cells, Cultured; Crk-Associated Substrate Protein; Cytoskeletal Proteins; Cytoskeleton; Enzyme Activation; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Inhibins; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth, Vascular; Paxillin; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proteins; Rats; Retinoblastoma-Like Protein p130; Signal Transduction; Transforming Growth Factor beta	1999
Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:8 Topics: Angiotensin II; Collagen; Enzyme Inhibitors; Fibrinogen; Genistein; Humans; Muscle, Smooth, Vascular; Phosphorylation; Protein Kinases; Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transforming Growth Factor beta; Tyrosine; Tyrphostins	1999
Targeting TGF-beta overexpression: maximizing the antifibrotic actions of angiotensin II blockade in anti-Thy1 glomerulonephritis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14 Suppl 4 Topics: Angiotensin II; Animals; Enalapril; Glomerulonephritis; Losartan; Male; Rats; Rats, Sprague-Dawley; Thy-1 Antigens; Transforming Growth Factor beta	1999
Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells. Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:9 Topics: Amino Acids; Angiotensin II; Animals; Becaplermin; Cells, Cultured; CHO Cells; Cricetinae; Genes, Dominant; Growth Substances; Insulin-Like Growth Factor I; Leucine; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; Recombinant Proteins; Transforming Growth Factor beta	1999
A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy. The Journal of clinical investigation, 1999, Volume: 104, Issue:6 Topics: Angiotensin II; Animals; Cell Cycle; Cell Cycle Proteins; Cell Division; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Hypertrophy; Male; Microtubule-Associated Proteins; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Tumor Suppressor Proteins	1999
Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes, 1999, Volume: 48, Issue:10 Topics: Angiotensin II; Animals; Collagenases; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Glomerular Mesangium; Glucose; Losartan; Molecular Weight; Rats; Transforming Growth Factor beta	1999
Renal protective effects of blocking the intrarenal renin-angiotensin system. Hypertension research : official journal of the Japanese Society of Hypertension, 1999, Volume: 22, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Doxorubicin; Glomerulonephritis; Kidney; Male; Nephrectomy; Nephrotic Syndrome; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Transforming Growth Factor beta	1999
Angiotensin II receptor blockade during gestation attenuates collagen formation in the developing rat heart. Cardiovascular research, 1999, Volume: 43, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Birth Weight; Blotting, Western; Collagen; Female; Heart; Imidazoles; In Situ Hybridization; Losartan; Organ Size; Pregnancy; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta	1999
Transcriptional and translational regulation of angiotensin II type 2 receptor by angiotensin II and growth factors. Endocrinology, 1999, Volume: 140, Issue:11 Topics: Angiotensin II; Autoradiography; Drug Synergism; Fibroblast Growth Factor 2; Gene Expression Regulation; Growth Substances; Humans; In Situ Hybridization; Insulin-Like Growth Factor I; Protein Biosynthesis; Receptors, Angiotensin; Ribosomes; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta	1999
Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. The Journal of cell biology, 2000, Feb-07, Volume: 148, Issue:3 Topics: Angiotensin II; Animals; Aorta; Becaplermin; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cells, Cultured; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; DNA; Gene Expression Regulation; Microtubule-Associated Proteins; Mitogens; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-sis; Rats; RNA, Messenger; S Phase; Transcription, Genetic; Transforming Growth Factor beta; Tumor Suppressor Proteins	2000
Angiotensin stimulates TGF-beta1 and clusterin in the hydronephrotic neonatal rat kidney. American journal of physiology. Regulatory, integrative and comparative physiology, 2000, Volume: 278, Issue:3 Topics: Angiotensin II; Animals; Antihypertensive Agents; Clusterin; Glycoproteins; Imidazoles; Kidney; Losartan; Molecular Chaperones; Pyridines; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ureteral Obstruction; Vasoconstrictor Agents	2000
Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation, 2000, Mar-14, Volume: 101, Issue:10 Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Cell Adhesion; Cell Adhesion Molecules; Cell Division; Extracellular Matrix; Fibroblasts; Fibrosis; Heart; Humans; Middle Aged; Myocardium; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta	2000
Heparin treatment reduces glomerular injury in rats with adriamycin-induced nephropathy but does not modify tubulointerstitial damage or the renal production of transforming growth factor-beta. Nephron, 2000, Volume: 84, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Creatinine; Doxorubicin; Endothelins; Female; Fibronectins; Heparin; Immunohistochemistry; Kidney Diseases; Kidney Glomerulus; Proteinuria; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta	2000
Effect of maximal reduction of angiotensin in renal fibrosis: bad news-good news from a pediatric mouse. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 35, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Disease Models, Animal; Fibrosis; Kidney Diseases; Mice; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Transforming Growth Factor beta; Ureteral Obstruction	2000
Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis. Kidney international, 2000, Volume: 57, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diet, Protein-Restricted; Enalapril; Glomerulonephritis; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Transforming Growth Factor beta; Treatment Outcome	2000
Angiotensin II and alpha(v)beta(3) integrin expression in rat neonatal cardiac fibroblasts. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:4 Topics: Angiotensin II; Animals; Cells, Cultured; Fibroblasts; Myocardium; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Receptors, Vitronectin; Transforming Growth Factor beta	2000
Regulation by adrenocorticotropin (ACTH), angiotensin II, transforming growth factor-beta, and insulin-like growth factor I of bovine adrenal cell steroidogenic capacity and expression of ACTH receptor, steroidogenic acute regulatory protein, cytochrome P Endocrinology, 2000, Volume: 141, Issue:5 Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Cortex; Adrenocorticotropic Hormone; Angiotensin II; Animals; Cattle; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Insulin-Like Growth Factor I; Phosphoproteins; Receptors, Corticotropin; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Time Factors; Transforming Growth Factor beta	2000
Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:5 Topics: Aldosterone; Angiotensin II; Animals; Kidney Diseases; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Transforming Growth Factor beta	2000
Vascular endothelial growth factor and transforming growth factor-beta1 regulate the expression of insulin-like growth factor-binding protein-3, -4, and -5 in large vessel endothelial cells. Endocrinology, 2000, Volume: 141, Issue:6 Topics: Angiotensin II; Animals; Aorta; Cattle; Cells, Cultured; Culture Media, Conditioned; Endothelial Growth Factors; Endothelium, Vascular; Gene Expression Regulation; Insulin; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Lymphokines; RNA, Messenger; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000
Phenotypic modulation by fibronectin enhances the angiotensin II-generating system in cultured vascular smooth muscle cells. Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:6 Topics: Angiotensin II; Animals; Aorta; Blotting, Western; Cathepsin D; Cell Division; Cells, Cultured; Fibroblast Growth Factor 2; Fibronectins; Gene Expression; Kinetics; Male; Muscle, Smooth, Vascular; Peptide Fragments; Peptidyl-Dipeptidase A; Phenotype; Rats; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta	2000
Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. American journal of respiratory and critical care medicine, 2000, Volume: 161, Issue:6 Topics: Adult; Angiotensin II; Cell Division; Cell Line; Fibroblasts; Humans; In Vitro Techniques; Lung; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transforming Growth Factor beta	2000
Transforming growth factor-beta1 modulates angiotensin II-induced calcium release in vascular smooth muscle cells from spontaneously hypertensive rats. Journal of hypertension, 2000, Volume: 18, Issue:6 Topics: Angiotensin II; Animals; Binding Sites; Biological Transport; Calcium; Cells, Cultured; Enzyme Inhibitors; Hypertension; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Thapsigargin; Transforming Growth Factor beta	2000
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. Journal of the American Society of Nephrology : JASN, 2000, Volume: 11, Issue:8 Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Glomerulosclerosis, Focal Segmental; Imidazoles; Immunohistochemistry; In Situ Hybridization; Kidney; Male; Nephrectomy; Neural Inhibition; Norepinephrine; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Sympathetic Nervous System; Transforming Growth Factor beta	2000
Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovascular research, 2000, Volume: 46, Issue:3 Topics: Aged; Analysis of Variance; Angiotensin II; Cells, Cultured; Collagen; Dose-Response Relationship, Drug; Female; Fibroblasts; Fibronectins; Gene Expression; Growth Substances; Humans; Male; Middle Aged; Myocardium; Osteopontin; Polymerase Chain Reaction; RNA, Messenger; Sialoglycoproteins; Stimulation, Chemical; Time Factors; Transforming Growth Factor beta	2000
Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. American journal of physiology. Renal physiology, 2000, Volume: 279, Issue:2 Topics: Angiotensin II; Animals; Cell Line, Transformed; Collagen; Endothelin-1; Estrogen Receptor beta; Estrogens; Glomerular Mesangium; Mice; Mice, Inbred Strains; Mitogen-Activated Protein Kinases; Pyrrolidines; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Thiophenes; Transcription Factor AP-1; Transcription, Genetic; Transforming Growth Factor beta; Up-Regulation	2000
Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:3 Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Collagen; Decorin; Enzyme Activation; Enzyme Inhibitors; Extracellular Matrix Proteins; Flavonoids; Gene Expression Regulation, Enzymologic; Genes, fos; Genetic Markers; Humans; Imidazoles; Kidney; Luciferases; Male; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Proteoglycans; Proto-Oncogene Mas; Pyridines; Tetrazoles; Transcriptional Activation; Transforming Growth Factor beta	2000
Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. Journal of hypertension, 2000, Volume: 18, Issue:9 Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blotting, Northern; Fibronectins; Gene Expression; Glomerulosclerosis, Focal Segmental; Hydralazine; Hypertension, Renal; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Ribonucleases; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1	2000
Interaction of nitric oxide and transforming growth factor-beta1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. The Journal of urology, 2000, Volume: 164, Issue:5 Topics: Angiotensin II; Animals; Culture Media, Conditioned; Epithelial Cells; Flow Cytometry; Kidney Tubules; Mink; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Reverse Transcriptase Polymerase Chain Reaction; Stress, Mechanical; Transforming Growth Factor beta	2000
Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:6 Topics: Active Transport, Cell Nucleus; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Cardiomegaly; Cell Nucleus; Cells, Cultured; Collagen; Cytosol; DNA-Binding Proteins; Fibroblasts; Heart Failure; In Vitro Techniques; Losartan; Male; Myocardial Infarction; Myocardium; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Smad2 Protein; Smad4 Protein; Trans-Activators; Transforming Growth Factor beta; Vimentin	2000
Regulation of glutamine:fructose-6-phosphate amidotransferase activity by high glucose and transforming growth factor beta in rat mesangial cells. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2000, Volume: 48, Issue:6 Topics: Angiotensin II; Animals; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Fructosephosphates; Glomerular Mesangium; Glucosamine; Glucose; Glucose-6-Phosphate; Glutamine; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Insulin-Like Growth Factor I; Rats; Transforming Growth Factor beta	2000
Transactivation of EGF receptor induced by angiotensin II regulates fibronectin and TGF-beta gene expression via transcriptional and post-transcriptional mechanisms. Molecular and cellular biochemistry, 2000, Volume: 212, Issue:1-2 Topics: Angiotensin II; Animals; Animals, Newborn; Cells, Cultured; Enzyme Inhibitors; ErbB Receptors; Fibroblasts; Fibronectins; Genes, Reporter; Heart; Kinetics; Myocardium; Promoter Regions, Genetic; Protein Kinase C; Rats; Rats, Wistar; Transcription, Genetic; Transcriptional Activation; Transfection; Transforming Growth Factor beta	2000
Renal fibrosis in mice treated with human recombinant transforming growth factor-beta2. Kidney international, 2000, Volume: 58, Issue:6 Topics: Angiotensin II; Animals; Corrosion Casting; Endothelin-1; Fibrosis; Glomerular Filtration Rate; Humans; Hypoxia; Ischemia; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Procollagen; Recombinant Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta2; Vasoconstriction	2000
Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats. Journal of cardiovascular pharmacology, 2001, Volume: 37, Issue:1 Topics: Adrenergic beta-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Fibroblast Growth Factor 2; Growth Substances; Male; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Species Specificity; Transforming Growth Factor beta; Transforming Growth Factor beta1	2001
Insulin-like growth factor-binding protein-3 induces fetalization in neonatal rat cardiomyocytes. DNA and cell biology, 2000, Volume: 19, Issue:12 Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Coronary Vessels; Disease Models, Animal; Disease Progression; Endothelin-1; Gene Expression Profiling; Gene Expression Regulation; Heart Ventricles; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Myocardial Infarction; Myocardium; Myosin Heavy Chains; Nonmuscle Myosin Type IIB; Oligonucleotide Array Sequence Analysis; Rats; RNA, Messenger; Transforming Growth Factor beta; Troponin I	2000
Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2 Topics: Aldosterone; Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Body Weight; Cardiovascular Diseases; Fibroblast Growth Factor 2; Heart; Immunohistochemistry; Mineralocorticoid Receptor Antagonists; NF-kappa B; Organ Size; Platelet-Derived Growth Factor; Rats; Receptors, Mineralocorticoid; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Tetrazoles; Transcription Factor AP-1; Transforming Growth Factor beta; Valine; Valsartan	2001
Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells. Circulation research, 2001, Mar-30, Volume: 88, Issue:6 Topics: Alitretinoin; Angiotensin II; Animals; Benzoates; Cell Division; Cells, Cultured; COS Cells; DNA; Dose-Response Relationship, Drug; Gene Expression; Gene Expression Regulation; Luciferases; Muscle, Smooth, Vascular; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Retinoic Acid; Recombinant Fusion Proteins; Retinoic Acid Receptor alpha; Retinoid X Receptors; Retinoids; RNA, Messenger; Tetrahydronaphthalenes; Transcription Factor AP-1; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tretinoin	2001
Induction of heme oxygenase 1 in radiation nephropathy: role of angiotensin II. Radiation research, 2001, Volume: 155, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Enzyme Induction; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Imidazoles; Kidney; Kidney Diseases; Rats; Tetrazoles; Transforming Growth Factor beta	2001
The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy. Molecular and cellular biochemistry, 2001, Volume: 218, Issue:1-2 Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Culture Media, Conditioned; Endothelin-1; Endothelium, Vascular; Fibroblasts; Gene Expression; Genes, fos; Muscle, Smooth, Vascular; Myocardium; Rats; Rats, Wistar; RNA, Messenger; Stress, Mechanical; Transforming Growth Factor beta; Vasoconstrictor Agents	2001
Induction of cardiac fibrosis by angiotensin II. Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:10 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Collagen; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; Lisinopril; Male; Myocardium; Rats; Rats, Wistar; Telmisartan; Time Factors; Transforming Growth Factor beta	2000
Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats. Clinical science (London, England : 1979), 2001, Volume: 100, Issue:6 Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Captopril; Drug Therapy, Combination; Gene Expression; Hypertension; Irbesartan; Kidney; Rats; Rats, Inbred SHR; Renin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1	2001
Angiotensin II activates the GFAT promoter in mesangial cells. American journal of physiology. Renal physiology, 2001, Volume: 281, Issue:1 Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Enzyme Activation; Glomerular Mesangium; Glucose; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Male; Promoter Regions, Genetic; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vascular Cell Adhesion Molecule-1	2001
beta-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase. Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:6 Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Cell Division; Cells, Cultured; Cyclic AMP; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Isoproterenol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardium; Phosphatidylinositol 3-Kinases; Protein Biosynthesis; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Transforming Growth Factor beta3; Tyrphostins	2001
Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation, 2001, Jul-17, Volume: 104, Issue:3 Topics: Angiotensin II; Animals; Chronic Disease; Collagen; Diastole; Disease Models, Animal; Echocardiography; Echocardiography, Doppler; Endomyocardial Fibrosis; Fibronectins; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Systole; Transforming Growth Factor beta; Transforming Growth Factor beta1	2001
Nitric oxide attenuates the expression of transforming growth factor-beta(3) mRNA in rat cardiac fibroblasts via destabilization. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:2 Topics: Angiotensin II; Animals; Animals, Newborn; Cells, Cultured; Cyclic GMP; Drug Antagonism; Fibroblasts; Kinetics; Myocardium; Nitric Oxide; Penicillamine; Rats; Rats, Sprague-Dawley; RNA Stability; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta3	2001
Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:12 Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Heart Ventricles; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Models, Biological; Myocardium; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation; Transforming Growth Factor beta	2001
Significance of chymase-dependent angiotensin II-forming pathway in the development of vascular proliferation. Circulation, 2001, Sep-11, Volume: 104, Issue:11 Topics: Angiotensin II; Animals; Blood Vessels; Chymases; Collagen; Dogs; Endothelial Growth Factors; Fibronectins; Gene Expression Regulation; Jugular Veins; Lymphokines; Oligopeptides; Peptidyl-Dipeptidase A; RNA, Messenger; Serine Endopeptidases; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Intima; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2001
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:4 Pt 1 Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Endothelial Growth Factors; Immunohistochemistry; Liver Cirrhosis, Experimental; Lymphokines; Male; Perindopril; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2001
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. Journal of hepatology, 2001, Volume: 35, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Immunohistochemistry; In Situ Hybridization; Liver Cirrhosis, Experimental; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta	2001
Upregulation of alpha(8)beta(1)-integrin in cardiac fibroblast by angiotensin II and transforming growth factor-beta1. American journal of physiology. Cell physiology, 2001, Volume: 281, Issue:5 Topics: Angiotensin II; Animals; Antibodies, Blocking; Cell Adhesion; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Fibronectins; Fluorescent Antibody Technique; Heart; Integrins; Intercellular Signaling Peptides and Proteins; Male; Microscopy, Fluorescence; Myocardium; Peptides; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation; Vasoconstrictor Agents	2001
Angiotensin II via activation of type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cells. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antigens, CD; Cells, Cultured; Coronary Vessels; Endoglin; Endothelium, Vascular; Enzyme Inhibitors; Flavonoids; Humans; Losartan; Mitogen-Activated Protein Kinases; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Cell Surface; Receptors, Transforming Growth Factor beta; RNA, Messenger; Transcriptional Activation; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation; Vascular Cell Adhesion Molecule-1	2001
Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta. Journal of the American Society of Nephrology : JASN, 2001, Volume: 12, Issue:12 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Blood Pressure; Collagen Type I; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Gene Expression Regulation; Kidney Cortex; Male; Mice; Mice, Transgenic; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Transcriptional Activation; Transforming Growth Factor beta	2001
Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney international, 2001, Volume: 60, Issue:6 Topics: Angiotensin II; Animals; Cells, Cultured; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Fibronectins; Glomerular Mesangium; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Male; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Up-Regulation	2001
Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats. Kidney international, 2002, Volume: 61, Issue:1 Topics: Angiotensin II; Animals; Cell Count; Cell Division; Cells, Cultured; Cholesterol, LDL; Collagen Type I; Diabetes Mellitus, Type 2; Diabetic Nephropathies; DNA; Extracellular Matrix; Gene Expression; Glomerular Mesangium; Iodine Radioisotopes; Lipoproteins, LDL; Male; Matrix Metalloproteinase 2; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-myc; Rats; Rats, Inbred OLETF; Receptors, LDL; RNA, Messenger; Transforming Growth Factor beta; Vasoconstrictor Agents	2002
Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB. American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:2 Topics: Angiotensin II; Animals; Antibodies; Anticoagulants; Antihypertensive Agents; Becaplermin; Cattle; Cells, Cultured; Chemotaxis; Dipeptides; Endothelial Growth Factors; Imidazoles; Losartan; Lymphokines; Matrix Metalloproteinase 2; Microcirculation; Neovascularization, Physiologic; Pericytes; Platelet-Derived Growth Factor; Protease Inhibitors; Proto-Oncogene Proteins c-sis; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Retina; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasoconstrictor Agents	2002
The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells. American journal of physiology. Renal physiology, 2002, Volume: 282, Issue:2 Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Calcium Channel Blockers; Carcinogens; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression; Glucose; Imidazoles; Iodine Radioisotopes; Kidney Tubules, Proximal; Lipid Peroxidation; Losartan; Nifedipine; Oxidants; Oxidative Stress; Protein Kinase C; Protein Synthesis Inhibitors; Pyridines; Rabbits; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Vasoconstrictor Agents	2002
Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: different anti-proliferative effect to angiotensin-converting enzyme inhibitor. Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Cell Division; Cells, Cultured; Fibroblast Growth Factor 2; Imidazoles; Male; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Thiazepines; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
[The effects of blocking intrarenal renin-angiotensin system on the expression of transforming growth factor-beta1 mRNA and extracellular matrix components]. Zhonghua nei ke za zhi, 1999, Volume: 38, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Doxorubicin; Extracellular Matrix Proteins; Glomerulonephritis; Kidney; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1	1999
Dendroaspis natriuretic peptide-like immunoreactivity and its regulation in rat aortic vascular smooth muscle. Peptides, 2002, Volume: 23, Issue:1 Topics: Amino Acid Sequence; Angiotensin II; Animals; Aorta; Carotid Arteries; Cell Division; Cells, Cultured; DNA; Elapid Venoms; Elapidae; Endothelin-1; Endothelium, Vascular; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Kidney; Kidney Tubules; Male; Microscopy, Fluorescence; Molecular Sequence Data; Muscle, Smooth; Nitroprusside; Peptides; Protein Binding; Radioimmunoassay; Rats; Rats, Wistar; Time Factors; Transforming Growth Factor beta	2002
Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis. Kidney international, 2002, Volume: 61, Issue:3 Topics: Angiotensin II; Animals; Cell Cycle Proteins; Cell Division; Complement C3; Cyclin-Dependent Kinase Inhibitor p27; Extracellular Matrix; Glomerulonephritis, Membranoproliferative; Immunoglobulin G; Infusion Pumps; Kidney Glomerulus; Macrophages; Male; Monocytes; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transforming Growth Factor beta; Tumor Suppressor Proteins; Vasoconstrictor Agents	2002
Evidence for modulation of pericryptal sheath myofibroblasts in rat descending colon by transforming growth factor beta and angiotensin II. BMC gastroenterology, 2002, Volume: 2 Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen; Colon; Diet, Sodium-Restricted; Fibroblasts; Fibrosis; Male; Radiation Injuries; Rats; Rats, Wistar; Receptors, Transforming Growth Factor beta; Sodium, Dietary; Transforming Growth Factor beta	2002
Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1. The Journal of clinical investigation, 2002, Volume: 109, Issue:6 Topics: Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; Humans; Myocardium; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. The Journal of clinical investigation, 2002, Volume: 109, Issue:6 Topics: Angiotensin II; Animals; Cardiomegaly; Cell Size; Echocardiography; Heart; Hemodynamics; Mice; Mice, Inbred Strains; Mice, Knockout; Myocardium; Myosin Heavy Chains; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Tissue Angiotensin-converting enzyme activity plays an important role in pressure overload-induced cardiac fibrosis in rats. Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Collagen Type I; Constriction, Pathologic; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; Imidazoles; Imidazolidines; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Tissue Distribution; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Transforming growth factor-beta(1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:4 Topics: Angiotensin II; Animals; Blotting, Western; Cell Differentiation; Cell Division; Cell Size; Cells, Cultured; Fibroblasts; Lisinopril; Male; Muscle, Smooth; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1	2000
Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:6 Topics: Adrenomedullin; Angiotensin II; Animals; Creatinine; Drug Implants; Glomerulonephritis; Hormones; Hypertension; Kidney; Male; Peptides; Proteinuria; Rats; Rats, Inbred Dahl; Renal Insufficiency; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride; Time Factors; Transforming Growth Factor beta	2002
Angiotensin II induces apoptosis in rat glomerular epithelial cells. American journal of physiology. Renal physiology, 2002, Volume: 283, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies; Antihypertensive Agents; bcl-2-Associated X Protein; Cells, Cultured; DNA Fragmentation; Epithelial Cells; Fas Ligand Protein; fas Receptor; Imidazoles; Kidney Glomerulus; Losartan; Membrane Glycoproteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vasoconstrictor Agents	2002
Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:1 Topics: Angiotensin II; Animals; Blood Vessels; Cardiomyopathy, Dilated; Cricetinae; Disease Models, Animal; Fibroblasts; Fibrosis; Gene Expression Regulation; Genetic Therapy; Hepatocyte Growth Factor; Humans; Injections, Intramuscular; Mesocricetus; Plasmids; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ets; RNA, Messenger; Transcription Factors; Transforming Growth Factor beta	2002
Long-term adrenomedullin infusion improves survival in malignant hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:1 Topics: Adrenomedullin; Aldosterone; Angiotensin II; Animals; Blood Pressure; Body Weight; Desoxycorticosterone; Heart Rate; Humans; Hypertension, Malignant; Infusion Pumps; Injections, Subcutaneous; Kidney; Male; Organ Size; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; RNA, Messenger; Survival Rate; Time Factors; Transforming Growth Factor beta; Vasodilator Agents	2002
Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia. Diabetologia, 2002, Volume: 45, Issue:6 Topics: Angiotensin II; Animals; Base Sequence; beta-Galactosidase; Binding Sites; Cell Line; Gene Expression Regulation; Genes, Reporter; Glomerular Mesangium; Glucose; Humans; Hyperglycemia; Mitogen-Activated Protein Kinases; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Recombinant Proteins; Swine; Transcription Factors; Transcriptional Activation; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes. Chinese medical journal, 2002, Volume: 115, Issue:7 Topics: Amlodipine; Angiotensin II; Animals; Bosentan; Calcium Channel Blockers; Collagen Type IV; Diabetic Nephropathies; Drug Therapy, Combination; Endothelin Receptor Antagonists; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcineurin; Cardiomegaly; Echocardiography; Fibrosis; Gene Expression Regulation; Hypertension; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Stress, Mechanical; Tacrolimus; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Stretch-induced paracrine hypertrophic stimuli increase TGF-beta1 expression in cardiomyocytes. Molecular and cellular biochemistry, 2002, Volume: 236, Issue:1-2 Topics: Angiotensin II; Animals; Blotting, Northern; Cells, Cultured; Endothelin-1; Fibroblasts; Hypertrophy; Male; Muscle, Smooth; Myocardium; Paracrine Communication; Rats; Rats, Wistar; RNA; RNA, Messenger; Stress, Mechanical; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. Journal of the American Society of Nephrology : JASN, 2002, Volume: 13, Issue:10 Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cells, Cultured; Drug Synergism; Fibroblasts; Fibrosis; Genetic Therapy; Hepatocyte Growth Factor; Humans; Kidney; Kidney Tubules; Losartan; Male; Mice; Mice, Inbred Strains; Muscle, Smooth; Receptor, Angiotensin, Type 1; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction	2002
Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart. Circulation, 2002, Sep-24, Volume: 106, Issue:13 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Fibrosis; Gene Targeting; Guanylate Cyclase; Heart Rate; Heart Ventricles; Hypertension; Imidazoles; Mice; Mice, Knockout; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Organ Size; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Ventricular Remodeling	2002
Role of protein kinase C-angiotensin II pathway for extracellular matrix production in cultured human mesangial cells exposed to high glucose levels. Diabetes research and clinical practice, 2003, Volume: 59, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Collagen Type IV; Culture Media; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Glomerular Mesangium; Glucose; Humans; Indoles; Maleimides; Phorbol 12,13-Dibutyrate; Protein Kinase C; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vasoconstrictor Agents	2003
[Regulation of alpha(1) type I collagen promoter by cytokines and losartan]. Zhonghua nei ke za zhi, 2002, Volume: 41, Issue:10 Topics: Angiotensin II; Animals; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Collagen Type I; Collagen Type I, alpha 1 Chain; Cytokines; Gene Expression Regulation; Losartan; Promoter Regions, Genetic; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension (Dallas, Tex. : 1979), 2003, Volume: 41, Issue:1 Topics: Angiotensin II; Animals; Bradykinin; Coronary Vessels; Extracellular Space; Fibrosis; Heart Ventricles; Hypertrophy, Left Ventricular; Kallikreins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Nitric Oxide Synthase; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, Angiotensin; Receptors, Bradykinin; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
Failure of angiotensin II and insulin to stimulate transforming growth factor-beta1. Release from cultured bovine retinal pericytes. Diabetes & metabolism, 2002, Volume: 28, Issue:6 Pt 1 Topics: Analysis of Variance; Angiotensin II; Animals; Cattle; Cells, Cultured; Insulin; Pericytes; Retina; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Transforming growth factor beta1 inhibits aldosterone and cortisol production in the human adrenocortical cell line NCI-H295R through inhibition of CYP11B1 and CYP11B2 expression. The Journal of endocrinology, 2003, Volume: 176, Issue:1 Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Analysis of Variance; Androstenedione; Angiotensin II; Colforsin; Corticosterone; Cortodoxone; Cytochrome P-450 CYP11B2; Depression, Chemical; Humans; Hydrocortisone; RNA, Messenger; Steroid 11-beta-Hydroxylase; Transforming Growth Factor beta; Tumor Cells, Cultured	2003
Angiotensin II induces apoptosis in renal proximal tubular cells. American journal of physiology. Renal physiology, 2003, Volume: 284, Issue:5 Topics: Angiotensin II; Animals; Apoptosis; Cell Death; Cells, Cultured; Enzyme Activation; Fas Ligand Protein; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Kidney Tubules, Proximal; Membrane Glycoproteins; Mitogen-Activated Protein Kinases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transforming Growth Factor beta	2003
Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy. Transplantation, 2003, Feb-15, Volume: 75, Issue:3 Topics: Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Body Weight; Chronic Disease; Cyclosporine; Drug Synergism; Fibrosis; Gene Expression; Immunosuppressive Agents; Kidney; Kidney Diseases; Losartan; Macrophages; Male; Mycophenolic Acid; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
Differential response of cardiac fibroblasts from young adult and senescent rats to ANG II. American journal of physiology. Heart and circulatory physiology, 2003, Volume: 284, Issue:4 Topics: Aging; Angiotensin II; Angiotensinogen; Animals; Cells, Cultured; Collagen; Fibroblasts; Gene Expression Regulation; Male; Myocardium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta	2003
Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation, 2003, May-27, Volume: 107, Issue:20 Topics: Angiotensin II; Animals; Chymases; Collagen Type I; Collagen Type III; Diastole; Disease Models, Animal; Disease Progression; Dogs; Enzyme Inhibitors; Fibrosis; Heart Failure; Hemodynamics; Mast Cells; Myocardium; Peptidyl-Dipeptidase A; RNA, Messenger; Serine Endopeptidases; Transforming Growth Factor beta; Ventricular Dysfunction, Left	2003
Angiotensin II and the fibroproliferative response to acute lung injury. American journal of physiology. Lung cellular and molecular physiology, 2004, Volume: 286, Issue:1 Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Antihypertensive Agents; Bleomycin; Cell Division; Cells, Cultured; Collagen; Fibroblasts; Humans; Losartan; Lung; Peptidyl-Dipeptidase A; Procollagen; Pulmonary Fibrosis; Ramipril; Renin-Angiotensin System; Transforming Growth Factor beta	2004
Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms? Circulation, 2003, May-27, Volume: 107, Issue:20 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Chymases; Disease Models, Animal; Dogs; Enzyme Inhibitors; Extracellular Space; Heart Failure; Humans; In Vitro Techniques; Mast Cells; Mice; Myocardium; Peptidyl-Dipeptidase A; Serine Endopeptidases; Transforming Growth Factor beta	2003
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney international, 2003, Volume: 64, Issue:1 Topics: Adult; Angiotensin II; Angiotensinogen; Case-Control Studies; Collagen Type IV; Fibrosis; Gene Expression; Gene Expression Regulation; Glomerulonephritis, IGA; Humans; Kidney; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. The American journal of pathology, 2003, Volume: 163, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Calcineurin; Collagen Type I; Collagen Type III; Connective Tissue Growth Factor; Cyclosporine; Everolimus; Gene Expression Regulation; Heart; Humans; Immediate-Early Proteins; Immunosuppressive Agents; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Kidney; Male; Organisms, Genetically Modified; Rats; Rats, Sprague-Dawley; Renin; Sirolimus; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells. American journal of physiology. Renal physiology, 2003, Volume: 285, Issue:6 Topics: Angiotensin II; Animals; Antibodies; Aorta; Calcium; Calcium Channels; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypertrophy; Inositol 1,4,5-Trisphosphate Receptors; Kidney Glomerulus; Microcirculation; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Cytoplasmic and Nuclear; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Vasoconstriction; Vasoconstrictor Agents	2003
Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:8 Topics: Adult; Angiotensin II; Bartter Syndrome; Female; Humans; Inositol Polyphosphate 5-Phosphatases; Male; Membrane Transport Proteins; Middle Aged; NADPH Dehydrogenase; NADPH Oxidases; Oxidative Stress; Peroxynitrous Acid; Phosphoproteins; Phosphoric Monoester Hydrolases; Polymerase Chain Reaction; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta	2003
Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats. Arteriosclerosis, thrombosis, and vascular biology, 2003, Nov-01, Volume: 23, Issue:11 Topics: Angiotensin II; Animals; Collagen Type I; Collagen Type III; Coronary Vessels; Diabetes Mellitus, Type 2; Down-Regulation; Fibrin; Fibrosis; Insulin Resistance; Matrix Metalloproteinase 2; Matrix Metalloproteinases; Rats; Rats, Inbred OLETF; Receptor, Melatonin, MT1; Transforming Growth Factor beta	2003
Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition. Endocrinology, 2003, Volume: 144, Issue:12 Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Connective Tissue Growth Factor; Cyclic AMP Response Element-Binding Protein; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Gene Expression; Glomerular Mesangium; Glucose; Humans; Hyperglycemia; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pentoxifylline; Phosphorylation; Transforming Growth Factor beta; Vasoconstrictor Agents	2003
Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy. Kidney international. Supplement, 2003, Issue:86 Topics: Angiotensin II; Becaplermin; Fibroblasts; Glomerulonephritis, Membranous; Humans; Kidney; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Renin-Angiotensin System; Transforming Growth Factor beta; Up-Regulation	2003
Angiotensin II dependent testicular fibrosis and effects on spermatogenesis after vasectomy in the rat. The Journal of urology, 2003, Volume: 170, Issue:5 Topics: Acetylcysteine; Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Enalapril; Fibrosis; Heat-Shock Proteins; HSP47 Heat-Shock Proteins; Leydig Cells; Losartan; Male; Rats; Rats, Wistar; Spermatogenesis; Testis; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vasectomy	2003
Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression. American journal of physiology. Renal physiology, 2004, Volume: 286, Issue:2 Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Body Weight; Female; Glomerulonephritis; Imidazoles; Kidney Glomerulus; Macrophages; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Transforming Growth Factor beta; Renin; Sheep; Sodium Chloride, Dietary; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. American journal of physiology. Renal physiology, 2004, Volume: 286, Issue:2 Topics: Angiotensin II; Cells, Cultured; Endothelium, Vascular; Gene Expression; Glomerular Mesangium; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Thrombospondin 1; Transforming Growth Factor beta; Transforming Growth Factor beta1; Umbilical Veins; Vasoconstrictor Agents	2004
Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response. Regulatory peptides, 2003, Nov-15, Volume: 116, Issue:1-3 Topics: Angiotensin II; Animals; Base Sequence; Fibronectins; Gene Expression Regulation; Hepatocytes; Immunohistochemistry; Kupffer Cells; Male; Molecular Sequence Data; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta	2003
Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic mice. Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:11 Topics: Angiotensin II; Animals; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Immunohistochemistry; Lipopolysaccharides; Luminescent Proteins; Mice; Mice, Transgenic; Organ Specificity; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Tissue Distribution; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro. Cardiovascular research, 2003, Dec-01, Volume: 60, Issue:3 Topics: Angiotensin II; Animals; Animals, Newborn; Anti-Arrhythmia Agents; Autocrine Communication; Biglycan; Extracellular Matrix Proteins; Fibroblasts; Gene Expression; Losartan; Myocardial Infarction; Myocardium; Proteoglycans; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta	2003
Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney international, 2004, Volume: 65, Issue:1 Topics: Angiotensin II; Animals; Apoptosis; Capillaries; Cell Line, Transformed; Gene Expression; Hypertension, Renal; Kidney Glomerulus; Mechanotransduction, Cellular; Mice; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; RNA, Messenger; Stress, Mechanical; Transforming Growth Factor beta; Up-Regulation; Vasoconstrictor Agents	2004
[Renal protective effect of angiotensin II receptor antagonist on growth hormone-treated nephrotic rats]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2003, Volume: 41, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibiotics, Antineoplastic; Biphenyl Compounds; Blood Urea Nitrogen; Collagen Type IV; Creatinine; Disease Models, Animal; Doxorubicin; Fibronectins; Growth Hormone; Immunohistochemistry; Irbesartan; Kidney Diseases; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Serum Albumin; Tetrazoles; Transforming Growth Factor beta; Triglycerides	2003
Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis and rheumatism, 2004, Volume: 50, Issue:1 Topics: Adult; Aged; Angiotensin II; Angiotensinogen; Autocrine Communication; Blotting, Western; Cathepsin D; Cells, Cultured; Extracellular Matrix; Female; Fibroblasts; Fibrosis; Gene Expression; Humans; Immunohistochemistry; Male; Middle Aged; Procollagen; Receptor, Angiotensin, Type 1; RNA, Messenger; Scleroderma, Systemic; Skin; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
Angiotensin II type 1 receptor blockade attenuates renal fibrogenesis in an immune-mediated nephritic kidney through counter-activation of angiotensin II type 2 receptor. Biochemical and biophysical research communications, 2004, Feb-06, Volume: 314, Issue:2 Topics: Angiotensin II; Animals; Basement Membrane; Collagen; Creatinine; Kidney; Kidney Glomerulus; Male; Mice; Nephritis; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Ribonucleases; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
[Perindopril attenuates the progression of CCl4-inducing rat hepatic fibrosis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2004, Volume: 12, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Becaplermin; Blotting, Western; Carbon Tetrachloride; Liver; Liver Cirrhosis, Experimental; Male; Perindopril; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
Sub-depressor dose of angiotensin type-1 receptor blocker inhibits transforming growth factor-beta-mediated perivascular fibrosis in hypertensive rat hearts. Journal of cardiovascular pharmacology, 2003, Volume: 42 Suppl 1 Topics: Administration, Oral; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Collagen; Constriction; Disease Models, Animal; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; Fibroblasts; Hypertension; Male; Myocytes, Cardiac; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; Transforming Growth Factor beta; Ventricular Remodeling	2003
PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats. Journal of molecular and cellular cardiology, 2004, Volume: 36, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Collagen; Electrocardiography; Fenofibrate; Fibrosis; Heart; Hypertension; Inflammation; Infusions, Intravenous; Intercellular Adhesion Molecule-1; Myocardium; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage. Circulation, 2004, Apr-13, Volume: 109, Issue:14 Topics: Adrenomedullin; Angiotensin II; Angiotensinogen; Animals; Aorta, Abdominal; Cardiomegaly; Collagen Type I; Constriction; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Fibrosis; Gene Expression Regulation; Genes, fos; Genes, Lethal; Glomerulosclerosis, Focal Segmental; Heterozygote; Male; MAP Kinase Signaling System; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptides; Peptidyl-Dipeptidase A; Protein Kinase C; Proto-Oncogene Proteins c-fos; Transforming Growth Factor beta; Ventricular Remodeling	2004
Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:4 Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Blood Pressure; Carotid Arteries; Femoral Artery; Fibrosis; Hypertension; Kidney; Kidney Tubular Necrosis, Acute; Male; NF-kappa B; Pressure; Rats; Rats, Sprague-Dawley; Renal Circulation; Sodium Chloride, Dietary; Transforming Growth Factor beta	2004
Arginine-aminopeptidase in rat cardiac fibroblastic cells participates in angiotensin peptide turnover. Cardiovascular research, 2004, Mar-01, Volume: 61, Issue:4 Topics: Aminopeptidases; Angiotensin II; Animals; Arginine; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Hydrolysis; Immunoblotting; Male; Rats; Rats, Wistar; Transforming Growth Factor beta	2004
[Effects of clinorotation-induced weightlessness on growth factor and ERK signal transduction in cultured cardiac fibroblasts]. Hang tian yi xue yu yi xue gong cheng = Space medicine & medical engineering, 2003, Volume: 16 Suppl Topics: Angiotensin II; Animals; Animals, Newborn; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Fibroblast Growth Factor 2; Fibroblasts; Gravitation; Myocardium; Rats; Rotation; Transforming Growth Factor beta; Weightlessness Simulation	2003
Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes. American journal of physiology. Heart and circulatory physiology, 2004, Volume: 287, Issue:1 Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Coculture Techniques; Collagen; Cytokines; Fibroblasts; Interleukin-6; Myocardium; Myocytes, Cardiac; Paracrine Communication; Rats; Rats, Inbred WKY; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation	2004
GH suppresses TGF-beta-mediated fibrosis and retains cardiac diastolic function. Molecular and cellular endocrinology, 2004, Apr-15, Volume: 218, Issue:1-2 Topics: Angiotensin II; Animals; Cells, Cultured; Diastole; Echocardiography; Extracellular Matrix Proteins; Female; Fibroblasts; Fibrosis; Growth Hormone; Insulin-Like Growth Factor I; Matrix Metalloproteinases; Myocardium; Rats; Rats, Inbred WF; Signal Transduction; Transforming Growth Factor beta; Ventricular Remodeling	2004
Mesenteric artery remodeling and effects of imidapril and irbesartan on it in spontaneously hypertensive rats. World journal of gastroenterology, 2004, May-15, Volume: 10, Issue:10 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Female; Humans; Imidazolidines; Irbesartan; Male; Mesenteric Arteries; Proto-Oncogene Proteins c-jun; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
[Transforming growth factor beta 1 modulates connective tissue growth factor expression via Smad2 signaling pathway in podocyte in vitro]. Zhonghua yi xue za zhi, 2004, Apr-02, Volume: 84, Issue:7 Topics: Angiotensin II; Blotting, Western; Cells, Cultured; Connective Tissue Growth Factor; DNA-Binding Proteins; Flavonoids; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney Glomerulus; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad2 Protein; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology, 2004, Volume: 145, Issue:9 Topics: Amino Acid Sequence; Angiotensin II; Animals; Cardiomyopathies; Cell Differentiation; Cell Division; Cells, Cultured; Collagen; Cyclic AMP; Disease Models, Animal; Fibroblasts; Fibrosis; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Receptors, G-Protein-Coupled; Receptors, Peptide; Relaxin; RNA, Messenger; Transforming Growth Factor beta; Vasoconstrictor Agents	2004
Comparative effects of quinapril with enalapril in rats with heart failure. Pharmacology, 2004, Volume: 71, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomyopathy, Dilated; Collagen Type III; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Fibrosis; Male; Myocardium; Quinapril; Rats; Rats, Inbred Lew; RNA, Messenger; Survival Rate; Tetrahydroisoquinolines; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Pressure	2004
Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regulatory peptides, 2004, Aug-15, Volume: 120, Issue:1-3 Topics: Adenoviridae; Angiotensin II; Animals; Anti-Arrhythmia Agents; Blood Pressure; Cell Membrane; Cytoskeleton; DNA Primers; Gene Expression Regulation; Insulin-Like Growth Factor I; Losartan; Mice; Myocytes, Cardiac; Rats; Receptor, Angiotensin, Type 1; Transforming Growth Factor beta; Vasoconstrictor Agents	2004
Defining "culprit mechanisms" in arrhythmogenic cardiac remodeling. Circulation research, 2004, Jun-11, Volume: 94, Issue:11 Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Dogs; Fibrosis; Heart Atria; Heart Failure; Humans; Mice; Mice, Transgenic; Models, Animal; Myocardium; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling	2004
Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovascular research, 2004, Aug-01, Volume: 63, Issue:2 Topics: Angiotensin II; Animals; Apoptosis; Blotting, Western; Cardiac Pacing, Artificial; Cell Death; Dogs; Fibrosis; Heart Atria; Heart Failure; Heart Ventricles; Humans; Leukocytes; Mitogen-Activated Protein Kinases; Transforming Growth Factor beta; Ventricular Remodeling	2004
Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 44, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Cell Division; Chemokine CCL2; Coronary Vessels; DNA-Binding Proteins; Extracellular Matrix Proteins; Gene Expression Profiling; Genetic Therapy; Hypertrophy; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred C57BL; Myosin Heavy Chains; Natriuretic Peptide, Brain; Nonmuscle Myosin Type IIB; Nuclear Proteins; Olmesartan Medoxomil; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Media; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vasculitis; Ventricular Remodeling	2004
Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity. Journal of molecular and cellular cardiology, 2004, Volume: 37, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Collagen Type I; Coronary Disease; Coronary Vessels; Fibrosis; Heart Ventricles; Imidazoles; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 9; Mice; Mice, Obese; Obesity; Olmesartan Medoxomil; Phosphorylation; Plasminogen Activator Inhibitor 1; Tetrazoles; Thiazepines; Transforming Growth Factor beta	2004
Transforming growth factor-beta induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK. Biochemical and biophysical research communications, 2004, Nov-05, Volume: 324, Issue:1 Topics: Actins; Angiotensin II; Animals; Anthracenes; Atrial Natriuretic Factor; Cell Size; Cells, Cultured; Humans; Hypertrophy; Interleukins; MAP Kinase Kinase 7; MAP Kinase Kinase Kinases; Myocytes, Cardiac; Phenylephrine; Protein Kinase Inhibitors; Protein Kinases; Rats; Recombinant Fusion Proteins; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents	2004
Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase. Annals of clinical and laboratory science, 2004,Summer, Volume: 34, Issue:3 Topics: Angiotensin II; Animals; Butadienes; Cell Line; Chromones; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Epidermal Growth Factor; Glomerular Mesangium; Immunoblotting; Losartan; Mice; Mitogen-Activated Protein Kinase Kinases; Morpholines; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinazolines; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Tyrphostins	2004
Role of aberrant iron homeostasis in the upregulation of transforming growth factor-beta1 in the kidney of angiotensin II-induced hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:8 Topics: Angiotensin II; Animals; Collagen; Ferritins; Fibrosis; Free Radical Scavengers; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Homeostasis; Hypertension, Renal; Iron; Iron Chelating Agents; Iron Overload; Kidney; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxides; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation; Vasoconstrictor Agents	2004
Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. Kidney international, 2004, Volume: 66, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Synergism; Enalapril; Fibrosis; Glomerulonephritis; Kidney; Male; Mice; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta	2004
Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3. Circulation, 2004, Nov-09, Volume: 110, Issue:19 Topics: Activin Receptors, Type I; Angiotensin II; Animals; Animals, Genetically Modified; Binding, Competitive; Collagen; DNA-Binding Proteins; DNA, Complementary; Fibrosis; Humans; Hypertrophy, Left Ventricular; Myocardium; Oligopeptides; Peptidyl-Dipeptidase A; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Smad2 Protein; Smad3 Protein; Substrate Specificity; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004
Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:4 Topics: Aldosterone; Angiotensin II; Animals; Chemokine CCL2; Deferoxamine; Enzyme Inhibitors; Ferritins; Fibrosis; Free Radical Scavengers; Gene Expression; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Iron; Iron Chelating Agents; Male; Myocardium; Oxidative Stress; Phenylurea Compounds; Protoporphyrins; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation; Vasoconstrictor Agents	2005
AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction. Kidney international, 2004, Volume: 66, Issue:6 Topics: Angiotensin II; Animals; Cells, Cultured; DNA; DNA-Binding Proteins; Fibronectins; Glomerular Mesangium; Glycation End Products, Advanced; Humans; Male; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptor, Angiotensin, Type 1; Receptors, Immunologic; Signal Transduction; Smad Proteins; Trans-Activators; Transforming Growth Factor beta	2004
Administration of ANG II induces iron deposition and upregulation of TGF-beta1 mRNA in the rat liver. American journal of physiology. Regulatory, integrative and comparative physiology, 2005, Volume: 288, Issue:4 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blotting, Northern; Blotting, Western; Ferritins; Heme Oxygenase (Decyclizing); Homeostasis; Infusions, Intravenous; Iron; Iron Chelating Agents; Liver; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation	2005
12-Lipoxygenase metabolism in mouse distal convoluted tubule cells. Kidney international, 2005, Volume: 67, Issue:1 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Aldosterone; Angiotensin II; Animals; Arachidonate 12-Lipoxygenase; Base Sequence; Blood Platelets; Cell Line; DNA; Gene Expression Regulation, Enzymologic; Humans; Kidney Tubules, Distal; Leukocytes; Mice; RNA, Messenger; Transforming Growth Factor beta	2005
Reversal of angiotensin II-stimulated collagen gel contraction in cardiac fibroblasts by aminopeptidase inhibition. Journal of cardiovascular pharmacology, 2005, Volume: 45, Issue:1 Topics: Aminopeptidases; Angiotensin II; Animals; Cells, Cultured; Collagen; Fibroblasts; Gels; Male; Myocardium; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Hydralazine; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; NADPH Oxidases; Olmesartan Medoxomil; Prediabetic State; Rats; Rats, Inbred OLETF; Receptors, Angiotensin; Renin; Tetrazoles; Thiazepines; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta	2005
Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemia. Journal of hypertension, 2005, Volume: 23, Issue:2 Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Biphenyl Compounds; Calcium; Case-Control Studies; Cell Proliferation; Cells, Cultured; Cholesterol, LDL; Dose-Response Relationship, Drug; Endothelin-1; Female; Fibroblasts; Heterozygote; Humans; Hyperlipoproteinemia Type II; Irbesartan; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Middle Aged; Receptor, Angiotensin, Type 1; Tetrazoles; Transforming Growth Factor beta	2005
Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells. Clinical science (London, England : 1979), 2005, Volume: 108, Issue:6 Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Base Sequence; Cells, Cultured; Drosophila Proteins; Drug Implants; Frizzled Receptors; Gene Expression Regulation; Intercellular Signaling Peptides and Proteins; Male; Molecular Sequence Data; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neurotransmitter; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stimulation, Chemical; Time Factors; Transforming Growth Factor beta; Wnt Proteins	2005
Transforming growth factor-beta1 expression and the role of angiotensin-converting enzyme inhibitor on perianastomotic intimal hyperplasia in polytetrafluoroethylene graft implanted in rabbit carotid artery. The Kurume medical journal, 2004, Volume: 51, Issue:3-4 Topics: Anastomosis, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessel Prosthesis Implantation; Captopril; Carotid Artery, Common; Hyperplasia; Polytetrafluoroethylene; Rabbits; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Intima	2004
Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats. Cardiovascular research, 2005, Mar-01, Volume: 65, Issue:4 Topics: Actins; Adrenomedullin; Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiotonic Agents; Cell Differentiation; Cell Division; Cell Size; Collagen Type I; Connective Tissue; Fibroblasts; Heart Ventricles; Humans; Hypertension; Male; Myocytes, Cardiac; Peptides; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling	2005
[Effect of angiotensin II on NF-kappa B activity and expression of PDGF-BB, TGF beta 1 and COX-2 in Kupffer's cells]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2005, Volume: 13, Issue:2 Topics: Angiotensin II; Animals; Becaplermin; Cells, Cultured; Cyclooxygenase 2; Kupffer Cells; NF-kappa B; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Receptors, Angiotensin; Transforming Growth Factor beta	2005
Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:4 Topics: Acetamides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteriovenous Shunt, Surgical; Brachial Artery; Chymases; Constriction, Pathologic; Dogs; Hyperplasia; Mast Cells; Protease Inhibitors; Pyrimidines; Receptor, Angiotensin, Type 1; Serine Endopeptidases; Transforming Growth Factor beta; Tunica Intima; Tunica Media; Veins	2005
Advanced glycation end-product-induced mitogenesis and collagen production are dependent on angiotensin II and connective tissue growth factor in NRK-49F cells. Journal of cellular biochemistry, 2005, May-15, Volume: 95, Issue:2 Topics: Angiotensin II; Angiotensinogen; Base Sequence; Blotting, Northern; Blotting, Western; Cell Line; Collagen; Connective Tissue Growth Factor; DNA Primers; Glycation End Products, Advanced; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Mitosis; Oligonucleotides; RNA, Messenger; Transforming Growth Factor beta	2005
Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy. Molecular and cellular biochemistry, 2005, Volume: 269, Issue:1-2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoimmune Diseases; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomyopathy, Dilated; Cardiotonic Agents; Collagen Type III; Male; Myocarditis; Myocardium; Rats; Rats, Inbred Lew; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation	2005
Can angiotensin converting enzyme inhibitors prevent postoperative adhesions? The Journal of surgical research, 2005, May-01, Volume: 125, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Lisinopril; Male; Postoperative Complications; Rats; Rats, Wistar; Tissue Adhesions; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:7 Topics: Angiotensin II; Animals; Autoantigens; Cell Culture Techniques; Collagen Type IV; Dose-Response Relationship, Drug; Epithelial Cells; Kidney Glomerulus; Mice; Signal Transduction; Time Factors; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents	2005
Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:5 Topics: Angiotensin II; Animals; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; CHO Cells; Cricetinae; Fibrosis; Gene Expression; Hepatocyte Growth Factor; Humans; Male; Mesocricetus; Myocytes, Cardiac; Proto-Oncogene Proteins c-met; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ultrasonography; Vasoconstrictor Agents; Ventricular Remodeling	2005
Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation, 2005, May-17, Volume: 111, Issue:19 Topics: Active Transport, Cell Nucleus; Angiotensin II; Animals; Connective Tissue Growth Factor; Extracellular Matrix Proteins; Fibrosis; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Smad Proteins; Smad2 Protein; Smad4 Protein; Transforming Growth Factor beta; Up-Regulation	2005
Angiotensin II mediates glutathione depletion, transforming growth factor-beta1 expression, and epithelial barrier dysfunction in the alcoholic rat lung. American journal of physiology. Lung cellular and molecular physiology, 2005, Volume: 289, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood-Air Barrier; Endotoxemia; Ethanol; Glutathione; Lisinopril; Lung; Lung Diseases; Male; Proteins; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
Relaxin modulates fibroblast function, collagen production, and matrix metalloproteinase-2 expression by cardiac fibroblasts. Annals of the New York Academy of Sciences, 2005, Volume: 1041 Topics: Angiotensin II; Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen; Enzyme Activation; Fibroblasts; Gene Expression Regulation; Heart; Matrix Metalloproteinase 2; Myocardium; Rats; Rats, Sprague-Dawley; Relaxin; Transforming Growth Factor beta	2005
Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. The Journal of biological chemistry, 2005, Aug-19, Volume: 280, Issue:33 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; DNA-Binding Proteins; Fibrosis; Heart Rate; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 7; Myocardium; Receptors, Androgen; RNA, Messenger; Smad2 Protein; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling	2005
Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:9 Topics: Actins; Angiotensin II; Animals; Cell Line; Collagen Type I; Connective Tissue Growth Factor; Fibrosis; Gene Expression; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Male; Models, Biological; Pentoxifylline; Rats; Rats, Wistar; Signal Transduction; Smad3 Protein; Smad4 Protein; Transcriptional Activation; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction	2005
Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:8 Topics: Angiotensin II; Animals; Apoptosis; Cyclosporine; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Islets of Langerhans; Kidney; Osteopontin; Pancreatic Diseases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sialoglycoproteins; Thiazolidinediones; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
A new ATP-sensitive potassium channel opener protects the kidney from hypertensive damage in spontaneously hypertensive rats. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; ATP-Binding Cassette Transporters; Benzazepines; Endothelin-1; Extracellular Matrix; Hemodynamics; Hypertension; Immunohistochemistry; KATP Channels; Kidney; Kidney Diseases; Kidney Function Tests; Potassium Channels, Inwardly Rectifying; Propylamines; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
Regulation of discoidin domain receptor 2 by cyclic mechanical stretch in cultured rat vascular smooth muscle cells. Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:3 Topics: Angiotensin II; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Movement; Cell Proliferation; Cells, Cultured; Discoidin Domain Receptors; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-myc; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; RNA, Messenger; Stress, Mechanical; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
Altered fibroblast function following myocardial infarction. Journal of molecular and cellular cardiology, 2005, Volume: 39, Issue:4 Topics: Angiotensin II; Animals; Autoantibodies; Cell Adhesion; Cell Movement; Cell Proliferation; Collagen; Discoidin Domain Receptors; Endothelin-1; Female; Fibroblasts; Heart Ventricles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling. Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:9 Topics: Angiotensin II; Animals; Atorvastatin; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Extracellular Matrix; Fibroblasts; Heart; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Myocardium; Procollagen; Pyrroles; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling	2005
Transforming growth factor-beta1 upregulation is independent of angiotensin in paraquat-induced lung fibrosis. Toxicology, 2005, Dec-15, Volume: 216, Issue:2-3 Topics: Actins; Angiotensin II; Animals; Collagen Type I; Collagen Type III; Disease Models, Animal; Hydroxyproline; Lung; Male; Microscopy, Polarization; Paraquat; Peptidyl-Dipeptidase A; Proto-Oncogene Proteins c-myc; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Toxicity Tests; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation	2005
Lipid accumulation and transforming growth factor-beta upregulation in the kidneys of rats administered angiotensin II. Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:5 Topics: Angiotensin II; Animals; Deferoxamine; Fatty Acid Synthases; Gene Expression Regulation; In Situ Hybridization; Iron; Iron Chelating Agents; Kidney; Lipid Metabolism; Lipids; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Staining and Labeling; Sterol Regulatory Element Binding Protein 1; Superoxides; Tissue Distribution; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation	2005
Interleukin-1beta induces osteopontin expression in pulmonary fibroblasts. Journal of cellular biochemistry, 2006, Feb-15, Volume: 97, Issue:3 Topics: Angiotensin II; Animals; Animals, Newborn; Cells, Cultured; Fibroblasts; Interleukin-1; JNK Mitogen-Activated Protein Kinases; Lung; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteopontin; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2006
Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. The American journal of pathology, 2005, Volume: 167, Issue:5 Topics: Adrenergic alpha-Agonists; Aging; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Carotid Arteries; Collagen; Dipeptides; Immunohistochemistry; Losartan; Male; Matrix Metalloproteinase 2; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Culture Techniques; Phenylephrine; Protease Inhibitors; Rats; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta; Tunica Intima; Vasoconstrictor Agents	2005
Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochemical and biophysical research communications, 2006, Jan-13, Volume: 339, Issue:2 Topics: Angiotensin II; Animals; Cells, Cultured; Glucose; Heart; Kidney; Myocytes, Cardiac; Rats; Solubility; Thrombospondin 1; Transforming Growth Factor beta; Up-Regulation	2006
Effect of FTY720 on chronic cyclosporine nephropathy in rats. Transplantation, 2005, Nov-15, Volume: 80, Issue:9 Topics: Angiotensin II; Animals; Chronic Disease; Cyclosporine; Extracellular Matrix Proteins; Fibrosis; Fingolimod Hydrochloride; Immunosuppressive Agents; Kidney; Kidney Diseases; Lymphocytes; Macrophages; Male; Osteopontin; Propylene Glycols; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Sphingosine; T-Lymphocytes; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
Receptor-mediated actions of renin and prorenin. Kidney international, 2006, Volume: 69, Issue:1 Topics: Angiotensin II; Animals; Extracellular Matrix Proteins; Glomerular Mesangium; Humans; Rats; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vacuolar Proton-Translocating ATPases	2006
Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney international, 2006, Volume: 69, Issue:1 Topics: Angiotensin II; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Fibronectins; Glomerular Mesangium; Humans; Plasminogen Activator Inhibitor 1; Rats; Receptors, Cell Surface; Recombinant Proteins; Renin; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vacuolar Proton-Translocating ATPases	2006
Angiotensin II promotes the proliferation of activated pancreatic stellate cells by Smad7 induction through a protein kinase C pathway. Biochemical and biophysical research communications, 2006, Feb-17, Volume: 340, Issue:3 Topics: Adenoviridae; Angiotensin II; Animals; Blotting, Western; Carbazoles; Cell Nucleus; Cell Proliferation; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Fibrosis; Immunohistochemistry; Indoles; Maleimides; NF-kappa B; Pancreas; Protein Kinase C; Rats; RNA, Messenger; Signal Transduction; Smad3 Protein; Smad4 Protein; Smad7 Protein; Tetradecanoylphorbol Acetate; Time Factors; Transcriptional Activation; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006
High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. Journal of cellular biochemistry, 2006, May-15, Volume: 98, Issue:2 Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Fibrosis; Glucose; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Pancreas; Pancreatitis; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta	2006
Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling. Kidney international, 2006, Volume: 69, Issue:6 Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Gene Expression Profiling; Glucose; Glycoproteins; Kidney Tubules, Proximal; Male; Oligonucleotide Array Sequence Analysis; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Inbred BB; Rats, Wistar; Reactive Oxygen Species; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation	2006
All-trans retinoic acid inhibited angiotensin II-induced increase in cell growth and collagen secretion of neonatal cardiac fibroblasts. Acta pharmacologica Sinica, 2006, Volume: 27, Issue:4 Topics: Angiotensin II; Animals; Animals, Newborn; Cell Proliferation; Collagen Type I; Collagen Type III; Fibroblasts; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tretinoin	2006
Smad3 mediates angiotensin II- and TGF-beta1-induced vascular fibrosis: Smad3 thickens the plot. Circulation research, 2006, Apr-28, Volume: 98, Issue:8 Topics: Angiotensin II; Animals; Fibrosis; Inflammation; Mice; Muscle, Smooth, Vascular; Smad3 Protein; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006
Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney international, 2006, Volume: 69, Issue:12 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; JNK Mitogen-Activated Protein Kinases; Kidney Tubules, Proximal; Male; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006
MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. The Journal of biological chemistry, 2006, Jul-07, Volume: 281, Issue:27 Topics: 3' Untranslated Regions; Angiotensin II; Animals; Binding Sites; Cells, Cultured; Enzyme Activation; Fibroblasts; Gene Expression Regulation; Humans; MicroRNAs; Mitogen-Activated Protein Kinase 3; Receptor, Angiotensin, Type 1; RNA Processing, Post-Transcriptional; RNA, Antisense; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006
Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade. Journal of hypertension, 2006, Volume: 24, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Collagen; Connective Tissue Growth Factor; Diastole; Gene Expression; Heart Failure; Heart Ventricles; Hypertension; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Ion Channels; Lung; Male; Membrane Transport Proteins; Mitochondrial Proteins; Myocardium; NADPH Oxidases; Natriuretic Peptide, Brain; Organ Size; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta; Uncoupling Protein 2; Ventricular Dysfunction, Left	2006
An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:9 Topics: Angiotensin II; Animals; Blotting, Western; Cell Line; Collagen Type IV; Diabetic Nephropathies; Gene Expression; Glucose; Humans; Immunohistochemistry; In Vitro Techniques; Kidney Tubules, Proximal; Male; Matrix Metalloproteinase 2; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006
Contribution of PI 3-kinase isoforms to angiotensin II- and alpha-adrenoceptor-mediated signalling pathways in cardiomyocytes. Cardiovascular research, 2006, Jul-15, Volume: 71, Issue:2 Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Chromones; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Isoenzymes; Male; Microscopy, Fluorescence; Morpholines; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylalanine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Adrenergic, alpha; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Protein S6 Kinases; Signal Transduction; Transforming Growth Factor beta	2006
Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan. Hypertension research : official journal of the Japanese Society of Hypertension, 2006, Volume: 29, Issue:3 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Creatine; Hypertension; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Male; Nephrectomy; Organ Size; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta	2006
Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney international, 2006, Volume: 70, Issue:8 Topics: Actins; Angiotensin II; Animals; Biological Transport; Blood Pressure; Cell Respiration; Chemokine CCL5; Dose-Response Relationship, Drug; Immunohistochemistry; Inflammation; Kidney Tubules; Male; Nephritis, Interstitial; NF-kappa B; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sodium; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006
[Effect of angiotensin II on transforming growth factor beta-induced fibroblast proliferation in human skin]. Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2006, Volume: 20, Issue:9 Topics: Angiotensin II; Cell Proliferation; Cells, Cultured; Fibroblasts; Humans; MAP Kinase Signaling System; Phosphorylation; Skin; Transforming Growth Factor beta	2006
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:2 Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart; Hypertension; Male; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Time Factors; Transforming Growth Factor beta; Ventricular Remodeling	2007
Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:5 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Drug Synergism; Eplerenone; Hypertension; Indoles; Kidney; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sodium-Potassium-Exchanging ATPase; Spironolactone; Superoxide Dismutase; Transforming Growth Factor beta	2007
Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor. Clinical and experimental nephrology, 2007, Volume: 11, Issue:1 Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptors, Transforming Growth Factor beta; Renin-Angiotensin System; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2007
Angiotensin II activates plasminogen activator inhibitor-I promoter in renal tubular epithelial cells via the AT1 receptor. Acta physiologica Hungarica, 2007, Volume: 94, Issue:1-2 Topics: Angiotensin II; Animals; Cells, Cultured; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Genistein; JNK Mitogen-Activated Protein Kinases; Kidney Tubules, Proximal; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Rabbits; Receptor, Angiotensin, Type 1; Sus scrofa; Transfection; Transforming Growth Factor beta	2007
Tetramethylpyrazine inhibits agiontensin II-induced nuclear factor-kappaB activation and bone morphogenetic protein-2 downregulation in rat vascular smooth muscle cells. Sheng li xue bao : [Acta physiologica Sinica], 2007, Jun-25, Volume: 59, Issue:3 Topics: Angiotensin II; Animals; Atherosclerosis; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Immunohistochemistry; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Pyrazines; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta	2007
Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7. American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:4 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Creatinine; Disease Models, Animal; Kidney; Kidney Diseases; Male; Nephritis; NF-kappa B; Potassium; Potassium, Dietary; Rats; Rats, Sprague-Dawley; Smad7 Protein; Sodium; Transforming Growth Factor beta	2007
A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. The American journal of pathology, 2007, Volume: 171, Issue:3 Topics: Angiotensin II; Animals; Cardiomyopathies; Diabetes Mellitus, Experimental; Fibrosis; Hemodynamics; Humans; Male; Myocardium; Peptides; Rats; Rats, Inbred WKY; Smad2 Protein; Thrombospondin 1; Transforming Growth Factor beta	2007
Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency. Circulation research, 2008, Jan-04, Volume: 102, Issue:1 Topics: Angiotensin II; Animals; Cardiotonic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Oxidative Stress; Quinolines; Renal Insufficiency; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Ventricular Remodeling	2008
Inhibitory effect of interleukin-1beta on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. American journal of physiology. Renal physiology, 2008, Volume: 294, Issue:1 Topics: Angiotensin II; Animals; Cells, Cultured; Collagen Type IV; Connective Tissue Growth Factor; Drug Synergism; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interleukin-1beta; Matrix Metalloproteinase 9; Mesangial Cells; Rats; Signal Transduction; Transforming Growth Factor beta	2008
Potential benefit of angiotensin converting enzyme inhibitors for hindering progression of Graves' ophthalmopathy. Medical hypotheses, 2008, Volume: 70, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cytokines; Disease Progression; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Models, Biological; Models, Theoretical; Transforming Growth Factor beta; Treatment Outcome	2008
Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy. Kidney international, 2008, Volume: 73, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Collagen Type I; Doxorubicin; Drug Therapy, Combination; Epithelial Cells; Glomerulosclerosis, Focal Segmental; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Macrophages; Mice; Mice, Inbred BALB C; Peptidyl-Dipeptidase A; Phenotype; Placenta Growth Factor; Pregnancy Proteins; Signal Transduction; Transforming Growth Factor beta	2008
[Effects of adrenomedullin on angiotensin II-induced collagen synthesis in vascular adventitial fibroblasts]. Zhonghua xin xue guan bing za zhi, 2007, Volume: 35, Issue:9 Topics: Adrenomedullin; Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Extracellular Matrix; Fibroblasts; Gene Expression Regulation; Male; Matrix Metalloproteinase 2; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta	2007
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats. Obesity (Silver Spring, Md.), 2008, Volume: 16, Issue:4 Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2008
Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:4 Topics: Adrenergic beta-Agonists; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Benzazepines; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cells, Cultured; Collagen Type I; Dose-Response Relationship, Drug; Extracellular Matrix; Fibroblasts; Fumarates; Glucose; Heart Ventricles; Isoproterenol; Microscopy, Confocal; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Transforming Growth Factor beta; Up-Regulation	2008
Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatric nephrology (Berlin, Germany), 2008, Volume: 23, Issue:8 Topics: Adolescent; Aldehydes; Angiotensin II; Angiotensinogen; Cell Count; Cells, Cultured; Child; Endothelial Cells; Gene Expression; Glomerulonephritis, IGA; Humans; Immunohistochemistry; Kidney Glomerulus; Mesangial Cells; Renin-Angiotensin System; Transforming Growth Factor beta; Vasoconstrictor Agents	2008
Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats. American journal of physiology. Endocrinology and metabolism, 2008, Volume: 295, Issue:2 Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Fibrosis; Immunohistochemistry; Kidney; Kidney Diseases; Male; Osteopontin; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Smad2 Protein; Smad7 Protein; Transforming Growth Factor beta	2008
Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. American journal of physiology. Renal physiology, 2008, Volume: 295, Issue:2 Topics: Albuminuria; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cytoskeleton; Disease Models, Animal; Hypertension; Immunosuppressive Agents; Interferon-gamma; Kidney Diseases; Male; Mice; Mice, Knockout; Mycophenolic Acid; Sodium Chloride, Dietary; T-Lymphocytes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents	2008
Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney international, 2008, Volume: 74, Issue:5 Topics: Angiotensin II; Animals; Cell Differentiation; Cell Transdifferentiation; Cells, Cultured; Epithelial Cells; Fibrosis; Humans; Kidney; Kidney Diseases; Kidney Tubules; MAP Kinase Signaling System; Mesoderm; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2008
Regulation of angiotensin type 2 receptor in bovine granulosa cells. Endocrinology, 2008, Volume: 149, Issue:10 Topics: Angiotensin II; Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Cattle; Cells, Cultured; Estradiol; Female; Fibroblast Growth Factors; Follicle Stimulating Hormone; Follicular Atresia; Granulosa Cells; Insulin-Like Growth Factor I; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Theca Cells; Transforming Growth Factor beta; Vasoconstrictor Agents	2008
Uncoupling of ER-mitochondrial calcium communication by transforming growth factor-beta. American journal of physiology. Renal physiology, 2008, Volume: 295, Issue:5 Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Cells, Cultured; Cytosol; Endoplasmic Reticulum; Endothelins; Fluorescent Dyes; Heterocyclic Compounds, 3-Ring; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Kidney Glomerulus; Kinetics; Male; Microscopy, Confocal; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Mitochondria; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Thapsigargin; Transforming Growth Factor beta	2008
Blocking of angiotensin II is more than blocking of transforming growth factor-beta. Kidney international, 2008, Volume: 74, Issue:5 Topics: Angiotensin II; Fibrosis; Humans; Kidney Diseases; Models, Biological; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2008
Activation of renal renin-angiotensin system in upstream stimulatory factor 2 transgenic mice. American journal of physiology. Renal physiology, 2009, Volume: 296, Issue:2 Topics: Angiotensin II; Animals; Gene Knockdown Techniques; Male; Mesangial Cells; Mice; Mice, Transgenic; Renin; Renin-Angiotensin System; RNA Interference; Transforming Growth Factor beta; Upstream Stimulatory Factors	2009
Salvia miltiorrhiza depresses plasminogen activator inhibitor-1 production through inhibition of angiotensin II. The American journal of Chinese medicine, 2008, Volume: 36, Issue:5 Topics: Angiotensin II; Animals; Cell Line; Down-Regulation; Gene Expression; Mesangial Cells; Plant Extracts; Plasminogen Activator Inhibitor 1; Rats; Reactive Oxygen Species; Salvia miltiorrhiza; Transforming Growth Factor beta	2008
TGFbeta-induced GRK2 expression attenuates AngII-regulated vascular smooth muscle cell proliferation and migration. Cellular signalling, 2009, Volume: 21, Issue:6 Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; G-Protein-Coupled Receptor Kinase 2; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Transforming Growth Factor beta; Up-Regulation	2009
Chymase plays an important role in left ventricular remodeling induced by intermittent hypoxia in mice. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:1 Topics: Acetamides; Aldehydes; Angiotensin II; Animals; Body Weight; Chymases; Gene Expression; Hemodynamics; Hypoxia; Immunohistochemistry; Interleukin-6; Lipid Peroxides; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; NADP; Organ Size; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Superoxides; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ventricular Remodeling	2009
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury. Atherosclerosis, 2009, Volume: 207, Issue:2 Topics: Angioplasty, Balloon; Angiotensin II; Animals; Binding Sites; Blood Glucose; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Cilostazol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hyperplasia; JNK Mitogen-Activated Protein Kinases; Male; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Tetrazoles; Transcriptional Activation; Transforming Growth Factor beta; Tunica Intima	2009
Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:4 Topics: Angiotensin II; Animals; Cell Line; Collagen Type I; Connective Tissue Growth Factor; Disease Models, Animal; Epithelial Cells; Hypertension; Kidney Diseases; Kidney Tubules; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta; Up-Regulation	2009
Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chemokine CCL2; Chronic Disease; Disease Models, Animal; Heart Diseases; Heart Ventricles; Hypertension; Hypertrophy; Inflammation; Macrophages; Male; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Transforming Growth Factor beta; Ventricular Remodeling	2009
Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters. Journal of pharmacological sciences, 2009, Volume: 111, Issue:1 Topics: Actins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blood Urea Nitrogen; Butyrates; Chymases; Collagen Type I; Cricetinae; Disease Progression; Imidazoles; Kidney; Male; Mesocricetus; Nephritis, Interstitial; Organ Size; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Transforming Growth Factor beta; Ureteral Obstruction	2009
Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology, 2010, Volume: 138, Issue:1 Topics: Angiotensin II; Animals; Anthracenes; Carrier Proteins; Cell Division; Cells, Cultured; Disease Models, Animal; Fatty Liver; Fibroblasts; Hepatic Stellate Cells; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Mitogen-Activated Protein Kinase 9; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Transforming Growth Factor beta	2010
Orphan nuclear receptor small heterodimer partner inhibits angiotensin II- stimulated PAI-1 expression in vascular smooth muscle cells. Experimental & molecular medicine, 2010, Jan-31, Volume: 42, Issue:1 Topics: Adenoviridae; Angiotensin II; Animals; Blotting, Northern; Cells, Cultured; Electrophoretic Mobility Shift Assay; Genetic Vectors; Humans; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Rats; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Smad3 Protein; Transforming Growth Factor beta	2010
Differentiation of adult stem cells into smooth muscle for vascular tissue engineering. The Journal of surgical research, 2011, Jun-15, Volume: 168, Issue:2 Topics: Adult Stem Cells; Aged; Aged, 80 and over; Angiotensin II; Blood Vessel Prosthesis; Calcium-Binding Proteins; Calmodulin-Binding Proteins; Calponins; Cell Culture Techniques; Cell Differentiation; Collagen; Female; Humans; Male; Microfilament Proteins; Middle Aged; Myocytes, Smooth Muscle; Myosin Heavy Chains; Phenotype; Phosphorylcholine; Sphingosine; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta	2011
Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation. American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:4 Topics: Angiotensin II; Animals; Antibodies; Cell Line; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Metalloproteases; Oxidative Stress; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred WF; Reactive Oxygen Species; Tissue Inhibitor of Metalloproteinase-2; Tissue Kallikreins; Transforming Growth Factor beta	2010
TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. The Journal of clinical investigation, 2010, Volume: 120, Issue:2 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Aneurysm, Abdominal; Disease Progression; Inflammation; Male; Matrix Metalloproteinase 12; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Transforming Growth Factor beta; Ultrasonography	2010
Critical role for osteopontin in diabetic nephropathy. Kidney international, 2010, Volume: 77, Issue:7 Topics: Albuminuria; Angiotensin II; Animals; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Hypoglycemic Agents; Insulin; Kidney Glomerulus; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteopontin; PPAR gamma; Thiazolidinediones; Transforming Growth Factor beta	2010
Renin-angiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease. Journal of pediatric gastroenterology and nutrition, 2010, Volume: 50, Issue:6 Topics: Angiotensin II; Animals; Collagen; Disease Models, Animal; Disease Progression; Gene Expression; Liver; Liver Cirrhosis; Male; Peptidyl-Dipeptidase A; Polycystic Kidney, Autosomal Recessive; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Transforming Growth Factor beta	2010
Prostacyclin receptor suppresses cardiac fibrosis: role of CREB phosphorylation. Journal of molecular and cellular cardiology, 2010, Volume: 49, Issue:2 Topics: Angiotensin II; Animals; Cell Separation; Collagen; Cyclic AMP Response Element-Binding Protein; Down-Regulation; E1A-Associated p300 Protein; Epoprostenol; Fibroblasts; Fibrosis; Hyperlipidemias; Mice; Mice, Knockout; Models, Biological; Myocardium; NADPH Oxidases; Phosphorylation; Receptors, Epoprostenol; Signal Transduction; Transforming Growth Factor beta	2010
SP600125, an inhibitor of c-Jun NH2-terminal kinase, blocks expression of angiotensin II-induced monocyte chemoattractant protein-1 in human mesangial cells. World journal of pediatrics : WJP, 2010, Volume: 6, Issue:2 Topics: Angiotensin II; Anthracenes; Cells, Cultured; Chemokine CCL2; Fibronectins; Half-Life; Humans; JNK Mitogen-Activated Protein Kinases; Mesangial Cells; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Transforming Growth Factor beta	2010
Add-on blockade of (pro)renin receptor in imidapril-treated diabetic SHRsp. Frontiers in bioscience (Elite edition), 2010, 06-01, Volume: 2, Issue:3 Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Body Weight; Collagen Type I; Diabetes Mellitus, Experimental; Imidazolidines; Male; Organ Size; Prorenin Receptor; Rats; Rats, Inbred SHR; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta	2010
Angiotensin II increases mRNA levels of all TGF-beta isoforms in quiescent and activated rat hepatic stellate cells. Cell biology international, 2010, Volume: 34, Issue:10 Topics: Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Extracellular Matrix; Hepatic Stellate Cells; Luciferases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADPH Oxidases; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; RNA, Messenger; Transforming Growth Factor beta; Up-Regulation	2010
Angiotensin II sustains brain inflammation in mice via TGF-beta. The Journal of clinical investigation, 2010, Volume: 120, Issue:8 Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Chronic Disease; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Thrombospondin 1; Transforming Growth Factor beta	2010
Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes. American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:3 Topics: Angiotensin II; Animals; Cell Enlargement; Cell Size; Cells, Cultured; Culture Media, Conditioned; Insulin-Like Growth Factor I; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stress, Mechanical; Transforming Growth Factor beta	2010
Salt-induced cardiac hypertrophy and interstitial fibrosis are due to a blood pressure-independent mechanism in Wistar rats. The Journal of nutrition, 2010, Volume: 140, Issue:10 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type III; Disease Models, Animal; Drinking; Eating; Echocardiography; Fibrosis; Gene Expression; Heart Ventricles; Hydralazine; Hypertension; Losartan; Male; Myocardium; Potassium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Sodium; Sodium Chloride, Dietary; Transforming Growth Factor beta; Urine	2010
Amlodipine suppressed cardiac gene expression of brain natriuretic peptide, transforming growth factor-β₁ and fibronectin mediated by aldosterone in male stroke-prone spontaneously hypertensive rats. The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:12 Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Fibronectins; Gene Expression Regulation; Heart; Hypertension; Male; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Transforming Growth Factor beta	2010
Involvement of activated prorenin in the pathogenesis of slowly progressive nephropathy in the non-clipped kidney of two kidney, one-clip hypertension. Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:3 Topics: Angiotensin II; Animals; Disease Progression; Hypertension, Renovascular; Kidney Diseases; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Renin; Transforming Growth Factor beta	2011
Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process. PloS one, 2010, Nov-30, Volume: 5, Issue:11 Topics: Angiotensin II; Animals; Aorta; Atorvastatin; Blotting, Western; Cells, Cultured; Fibrosis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrroles; Rats; Rats, Wistar; Signal Transduction; Simvastatin; Smad Proteins; Transforming Growth Factor beta; Vasoconstrictor Agents	2010
Proinflammatory protein CARD9 is essential for infiltration of monocytic fibroblast precursors and cardiac fibrosis caused by Angiotensin II infusion. American journal of hypertension, 2011, Volume: 24, Issue:6 Topics: Angiotensin II; Animals; CARD Signaling Adaptor Proteins; Fibrosis; Inflammation; Interleukin-1beta; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Knockout; Myocardium; Myofibroblasts; NF-kappa B; Transforming Growth Factor beta	2011
Involvement of angiotensin II and reactive oxygen species in pancreatic fibrosis. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2011, Volume: 11 Suppl 2 Topics: Actins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Down-Regulation; Fibrosis; Male; p38 Mitogen-Activated Protein Kinases; Pancreas; Pancreatitis, Chronic; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Angiotensin; Renin-Angiotensin System; Transforming Growth Factor beta	2011
Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science (New York, N.Y.), 2011, Apr-15, Volume: 332, Issue:6027 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm; Aortic Rupture; Disease Models, Animal; Disease Progression; Enalapril; Losartan; MAP Kinase Signaling System; Marfan Syndrome; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptor, Angiotensin, Type 2; Signal Transduction; Transforming Growth Factor beta	2011
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy. Diabetes, 2011, Volume: 60, Issue:6 Topics: Actins; Angiotensin II; Apoptosis; Blotting, Western; Cadherins; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen; Diabetic Nephropathies; Fibronectins; Humans; Intermediate Filament Proteins; Membrane Proteins; Nerve Tissue Proteins; Nestin; Podocytes; Transforming Growth Factor beta; Vimentin	2011
Suppression of Nrf2 signaling by angiotensin II in murine renal epithelial cells. Archives of pharmacal research, 2011, Volume: 34, Issue:5 Topics: Actins; Angiotensin II; Animals; Basic-Leucine Zipper Transcription Factors; Biomarkers; Cell Line; Cell Nucleus; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Gene Expression Regulation; Glutamate-Cysteine Ligase; Glutathione; Kidney; Mice; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta	2011
Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway. Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:2 Topics: Angiotensin II; Animals; Cells, Cultured; Hepatocyte Growth Factor; Humans; Mesangial Cells; Mice; Mice, Transgenic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Transforming Growth Factor beta	2011
Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade. PloS one, 2011, Volume: 6, Issue:8 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Aorta, Thoracic; Aortic Aneurysm; Extracellular Matrix Proteins; Female; Humans; Immunohistochemistry; In Vitro Techniques; Losartan; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Phenylephrine; Pregnancy; Receptor, Angiotensin, Type 1; Smad2 Protein; Transcriptome; Transforming Growth Factor beta; Vasoconstriction; Vasoconstrictor Agents	2011
Adverse host factors exacerbate occult HIV-associated nephropathy. The American journal of pathology, 2011, Volume: 179, Issue:4 Topics: AIDS-Associated Nephropathy; Angiotensin II; Angiotensinogen; Animals; Biomarkers; Blood Pressure; Connective Tissue Growth Factor; Doxycycline; Epithelial-Mesenchymal Transition; Female; Gene Dosage; Genes, vpr; Host-Pathogen Interactions; Kidney; Male; Mice; Mice, Transgenic; Peptidyl-Dipeptidase A; Phenotype; Proteinuria; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2011
Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation. Journal of hypertension, 2011, Volume: 29, Issue:10 Topics: Angiotensin II; Cells, Cultured; Extracellular Matrix; Fatty Acids, Nonesterified; Fibrosis; Fluorobenzenes; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mesangial Cells; Metalloproteases; Pyrimidines; RNA, Small Interfering; Rosuvastatin Calcium; Sulfonamides; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta	2011
Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone. Journal of translational medicine, 2011, Oct-06, Volume: 9 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Angiotensin II; Apoptosis; Cells, Cultured; Cytochrome P-450 CYP11B2; Epithelial Cells; Female; Gene Expression Regulation; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Tubules, Proximal; Male; Mesangial Cells; Oxidative Stress; Receptor, Angiotensin, Type 2; Receptors, Mineralocorticoid; Renin-Angiotensin System; Time Factors; Transforming Growth Factor beta; Up-Regulation	2011
EGFR signaling promotes TGFβ-dependent renal fibrosis. Journal of the American Society of Nephrology : JASN, 2012, Volume: 23, Issue:2 Topics: Angiotensin II; Animals; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Kidney; LLC-PK1 Cells; Male; Mice; Mice, Inbred BALB C; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Smad2 Protein; Smad3 Protein; Swine; Transforming Growth Factor beta	2012
Loss of fibulin-2 protects against progressive ventricular dysfunction after myocardial infarction. Journal of molecular and cellular cardiology, 2012, Volume: 52, Issue:1 Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Extracellular Matrix Proteins; Gene Expression; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Signal Transduction; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Remodeling; Wound Healing	2012
Smad3 mediates ANG II-induced hypertensive kidney disease in mice. American journal of physiology. Renal physiology, 2012, Apr-15, Volume: 302, Issue:8 Topics: Actins; Albuminuria; Angiotensin II; Animals; Chemokine CCL2; Collagen Type I; Collagen Type IV; Creatinine; Female; Fibronectins; Fibrosis; Hypertension; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta; Ubiquitin-Protein Ligases	2012
Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy. Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:5 Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cytokines; Disease Models, Animal; Fibrosis; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephritis; NF-kappa B; Peptidyl-Dipeptidase A; Signal Transduction; Smad2 Protein; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta; Ubiquitin-Protein Ligases; Ureteral Obstruction	2012
Interleukin-12p35 deletion promotes CD4 T-cell-dependent macrophage differentiation and enhances angiotensin II-Induced cardiac fibrosis. Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:7 Topics: Angiotensin II; Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Polarity; Cells, Cultured; Fibrosis; Interleukin-12 Subunit p35; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocardium; NF-kappa B; Signal Transduction; Transforming Growth Factor beta	2012
Interaction between TGF-β and ACE2-Ang-(1-7)-Mas pathway in high glucose-cultured NRK-52E cells. Molecular and cellular endocrinology, 2013, Feb-05, Volume: 366, Issue:1 Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Benzamides; Cells, Cultured; Chromones; Dioxoles; Fibronectins; Gene Expression Regulation; Glucose; Janus Kinase 2; LLC-PK1 Cells; Molecular Sequence Data; Morpholines; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptor, Transforming Growth Factor-beta Type I; Receptors, G-Protein-Coupled; Receptors, Transforming Growth Factor beta; RNA, Messenger; Signal Transduction; Swine; Transcription, Genetic; Transforming Growth Factor beta; Tyrphostins	2013
Locally applied leptin induces regional aortic wall degeneration preceding aneurysm formation in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:2 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Delayed-Action Preparations; Dilatation, Pathologic; Disease Models, Animal; Humans; Leptin; Macrophages; Male; Matrix Metalloproteinase 12; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Leptin; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Ultrasonography	2013
Regulation and role of connective tissue growth factor in AngII-induced myocardial fibrosis. The American journal of pathology, 2013, Volume: 182, Issue:3 Topics: Angiotensin II; Animals; Bone Marrow Cells; Cell Differentiation; Cell Movement; Cell Proliferation; Cell Separation; Connective Tissue Growth Factor; Cytokines; Extracellular Matrix; Fibroblasts; Fibrosis; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Transforming Growth Factor beta	2013
Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms. The Journal of surgical research, 2013, Volume: 183, Issue:1 Topics: Angiotensin II; Aortic Aneurysm, Thoracic; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Smad2 Protein; Transforming Growth Factor beta; Up-Regulation	2013
Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice. PloS one, 2013, Volume: 8, Issue:1 Topics: Angiotensin II; Animals; Fibrosis; Gene Expression Regulation; Hypertension; Inflammation; Kidney; Kidney Diseases; Male; Mice; Mice, Knockout; MicroRNAs; NF-kappa B; Proteinuria; Signal Transduction; Smad3 Protein; Smad7 Protein; Sp1 Transcription Factor; Transforming Growth Factor beta	2013
Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Communication; Disease Models, Animal; Disease Progression; DNA Primers; Dose-Response Relationship, Drug; Fatty Liver; Gene Expression; Hepatic Stellate Cells; Liver Cirrhosis; Losartan; Male; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Toll-Like Receptor 4; Transforming Growth Factor beta	2013
Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2013, Volume: 45, Issue:5 Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Blood Glucose; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Kidney; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Inbred OLETF; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Time Factors; Transforming Growth Factor beta	2013
AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. American journal of physiology. Renal physiology, 2013, Mar-15, Volume: 304, Issue:6 Topics: Albumins; Aldosterone; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angiotensin II; Cell Line; Epithelial-Mesenchymal Transition; Glucose; Heme Oxygenase-1; Humans; Metformin; NADPH Oxidase 4; NADPH Oxidases; Nephrosclerosis; Pyrazoles; Pyrimidines; Reactive Oxygen Species; Ribonucleosides; Thioredoxins; Transforming Growth Factor beta	2013
Overexpression of SOCS3 in T lymphocytes leads to impaired interleukin-17 production and severe aortic aneurysm formation in mice--brief report. Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:3 Topics: Angiotensin II; Animals; Antibodies, Neutralizing; Aortic Aneurysm, Abdominal; Aortic Rupture; Bone Marrow Transplantation; Cells, Cultured; Disease Models, Animal; Genotype; Interleukin-17; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neutrophils; Phenotype; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Th17 Cells; Time Factors; Transforming Growth Factor beta; Up-Regulation; Whole-Body Irradiation	2013
Prolonged fasting activates Nrf2 in post-weaned elephant seals. The Journal of experimental biology, 2013, Aug-01, Volume: 216, Issue:Pt 15 Topics: Amino Acid Sequence; Angiotensin II; Animals; Conserved Sequence; Fasting; Female; Male; Mice; Models, Biological; Molecular Sequence Data; NADPH Oxidases; NF-E2-Related Factor 2; Rats; Seals, Earless; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Weaning	2013
Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- mice. Journal of lipid research, 2013, Volume: 54, Issue:8 Topics: Angiotensin II; Animals; Atherosclerosis; Biglycan; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Receptors, LDL; Transforming Growth Factor beta	2013
Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling. Cardiovascular research, 2013, Sep-01, Volume: 99, Issue:4 Topics: Angiotensin II; Animals; Fibrosis; Hypertension; Male; Mice; MicroRNAs; Myocardium; NF-kappa B; Smad7 Protein; Sp1 Transcription Factor; Transforming Growth Factor beta; Ventricular Remodeling	2013
Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling. Clinical science (London, England : 1979), 2014, Volume: 126, Issue:4 Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Cardiomegaly; Extracellular Matrix Proteins; Fibrosis; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Signal Transduction; Transforming Growth Factor beta; Vasoconstrictor Agents	2014
Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:6 Topics: Angiotensin II; Animals; Clopidogrel; Fibrosis; Hypertension; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Myocarditis; Myocardium; Platelet Activation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine; Transforming Growth Factor beta	2013
Renin angiotensin system blockade ameliorates lead nephropathy. Biochemical and biophysical research communications, 2013, Aug-23, Volume: 438, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Gene Expression Regulation; Glomerular Filtration Rate; Kidney Diseases; Lead Poisoning; Losartan; Male; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Transforming Growth Factor beta	2013
Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes. Journal of bone and mineral metabolism, 2014, Volume: 32, Issue:3 Topics: Acid Phosphatase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Isoenzymes; Male; Mice; Mice, Inbred DBA; NF-kappa B; Osteocalcin; Osteoclasts; Random Allocation; Renin; Renin-Angiotensin System; RNA, Messenger; Streptozocin; Tartrate-Resistant Acid Phosphatase; Tibia; Transforming Growth Factor beta; Up-Regulation	2014
Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice. Journal of translational medicine, 2013, Sep-25, Volume: 11 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biphenyl Compounds; Cardiomegaly; Cardiotonic Agents; Collagen; Connective Tissue Growth Factor; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Irbesartan; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; PPAR alpha; PPAR delta; PPAR gamma; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Tetrazoles; Transforming Growth Factor beta	2013
Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease. PloS one, 2013, Volume: 8, Issue:12 Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; Blood Pressure; Cell Proliferation; Cysts; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Hepatocytes; Humans; Kidney Function Tests; Liver; Liver Diseases; Liver Function Tests; Male; Organ Size; Polycystic Kidney, Autosomal Recessive; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan; Transforming Growth Factor beta	2013
Aortic aneurysms in Loeys-Dietz syndrome - a tale of two pathways? The Journal of clinical investigation, 2014, Volume: 124, Issue:1 Topics: Angiotensin II; Animals; Aortic Aneurysm; Female; Humans; Loeys-Dietz Syndrome; Transforming Growth Factor beta	2014
Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. The Journal of clinical investigation, 2014, Volume: 124, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Aneurysm; Cells, Cultured; Disease Progression; Female; Haploinsufficiency; Humans; Loeys-Dietz Syndrome; Losartan; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Mutation, Missense; Myocytes, Smooth Muscle; Phenotype; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta	2014
Tenascin C protects aorta from acute dissection in mice. Scientific reports, 2014, Feb-11, Volume: 4 Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Calcium Chloride; Cells, Cultured; Disease Models, Animal; Gene Expression Profiling; Hemodynamics; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Signal Transduction; Tenascin; Transforming Growth Factor beta	2014
miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling. Molecular therapy : the journal of the American Society of Gene Therapy, 2014, Volume: 22, Issue:5 Topics: Angiotensin II; Animals; Disease Models, Animal; Endomyocardial Fibrosis; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Hypertension; Mice; MicroRNAs; Molecular Targeted Therapy; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta	2014
Phosphodiesterase 3A1 protects the heart against angiotensin II-induced cardiac remodeling through regulation of transforming growth factor-β expression. International heart journal, 2014, Volume: 55, Issue:2 Topics: Angiotensin II; Animals; Blotting, Western; Cardiomyopathy, Hypertrophic; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Echocardiography; Heart Ventricles; Mice; Mice, Transgenic; Transforming Growth Factor beta; Vasoconstrictor Agents; Ventricular Remodeling	2014
A healthy tension in translational research. The Journal of clinical investigation, 2014, Volume: 124, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Awards and Prizes; Fibrillins; Humans; Loeys-Dietz Syndrome; Marfan Syndrome; Mice; Microfilament Proteins; Scleroderma, Systemic; Signal Transduction; Societies, Medical; Transforming Growth Factor beta; Translational Research, Biomedical; United States	2014
Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome. The Journal of biological chemistry, 2014, Jul-11, Volume: 289, Issue:28 Topics: Angiotensin II; Animals; Carrier Proteins; Collagen Type I; Fibrosis; Heart Diseases; Inflammasomes; Interleukin-18; Interleukin-1beta; Mice; Mice, Knockout; Mitochondrial Proteins; Myocardium; Myofibroblasts; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Signal Transduction; Smad Proteins, Receptor-Regulated; Transforming Growth Factor beta; Vasoconstrictor Agents	2014
Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF β-Smad signal pathway. PloS one, 2014, Volume: 9, Issue:5 Topics: Angiotensin II; Animals; Base Sequence; Cell Proliferation; DNA Primers; Epoprostenol; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptors, Epoprostenol; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2014
γδT Cell-derived interleukin-17A via an interleukin-1β-dependent mechanism mediates cardiac injury and fibrosis in hypertension. Hypertension (Dallas, Tex. : 1979), 2014, Volume: 64, Issue:2 Topics: Angiotensin II; Animals; Fibrosis; Hypertension; Interleukin-17; Interleukin-1beta; Interleukin-6; Mice; Myocardium; T-Lymphocytes; Transforming Growth Factor beta	2014
Nestin is a marker of lung remodeling secondary to myocardial infarction and type I diabetes in the rat. Journal of cellular physiology, 2015, Volume: 230, Issue:1 Topics: Actins; Airway Remodeling; Angiotensin II; Animals; Biomarkers; Cell Differentiation; Collagen Type I; Diabetes Mellitus, Type 1; Fibroblasts; Heart Failure; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; MicroRNAs; Myocardial Contraction; Myocardial Infarction; Nestin; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin; Transforming Growth Factor beta	2015
Renal sympathetic denervation suppresses ventricular substrate remodelling in a canine high-rate pacing model. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:3 Topics: Aldosterone; Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Catheter Ablation; Disease Models, Animal; Disease Progression; Dogs; Female; Fibrosis; Heart Failure; Heart Ventricles; Kidney; Male; Natriuretic Peptide, Brain; Sympathectomy; Time Factors; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling	2014
Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels. Microcirculation (New York, N.Y. : 1994), 2015, Volume: 22, Issue:1 Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Chronic Disease; Connective Tissue Growth Factor; Dual Specificity Phosphatase 1; Fibrosis; Hypertension; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Muscle, Skeletal; Peptide Fragments; Phosphorylation; Rats; Rats, Inbred Lew; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Vasoconstrictor Agents	2015
Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-β and angiotensin II signaling. International journal of cardiology, 2014, Sep-20, Volume: 176, Issue:2 Topics: Androgens; Angiotensin II; Animals; Cells, Cultured; Fibroblasts; Male; Myocardium; Rats; Rats, Sprague-Dawley; Signal Transduction; Testosterone; Transforming Growth Factor beta	2014
Role of microRNA-29b in angiotensin II-induced epithelial-mesenchymal transition in renal tubular epithelial cells. International journal of molecular medicine, 2014, Volume: 34, Issue:5 Topics: Actins; Angiotensin II; Animals; Cell Line; Collagen Type I; Down-Regulation; Epithelial Cells; Epithelial-Mesenchymal Transition; Kidney Tubules; MicroRNAs; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Transforming Growth Factor beta; Up-Regulation	2014
Androgens in cardiac fibrosis and other cardiovascular mechanisms. International journal of cardiology, 2015, Jan-20, Volume: 179 Topics: Androgens; Angiotensin II; Animals; Fibroblasts; Male; Myocardium; Testosterone; Transforming Growth Factor beta	2015
Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients. Pediatric nephrology (Berlin, Germany), 2015, Volume: 30, Issue:6 Topics: Adolescent; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Biomarkers; Biopsy; Child; Enzyme-Linked Immunosorbent Assay; Female; Glomerulonephritis, IGA; Humans; Immunohistochemistry; Kidney; Male; Predictive Value of Tests; Renin-Angiotensin System; Time Factors; Transforming Growth Factor beta; Treatment Outcome; Urinalysis	2015
Reply to the letter "androgens in cardiac fibrosis and other cardiovascular mechanisms". International journal of cardiology, 2015, Mar-01, Volume: 182 Topics: Androgens; Angiotensin II; Animals; Fibroblasts; Male; Myocardium; Testosterone; Transforming Growth Factor beta	2015
The effect of angiotensin-(1-7) in mouse unilateral ureteral obstruction. The American journal of pathology, 2015, Volume: 185, Issue:3 Topics: Actins; Angiotensin I; Angiotensin II; Animals; Fibronectins; Male; Mice; Muscle, Smooth; Peptide Fragments; Transforming Growth Factor beta; Ureter; Ureteral Obstruction	2015
Activation of peroxisome proliferator-activated receptor γ (PPARγ) through NF-κB/Brg1 and TGF-β1 pathways attenuates cardiac remodeling in pressure-overloaded rat hearts. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 35, Issue:3 Topics: Angiotensin II; Animals; Aorta; DNA Helicases; Gene Expression Regulation; Humans; Myocytes, Cardiac; NF-kappa B; Nuclear Proteins; PPAR gamma; Pressure; Rats; Transcription Factors; Transforming Growth Factor beta; Ventricular Remodeling	2015
Divergent roles of matrix metalloproteinase 2 in pathogenesis of thoracic aortic aneurysm. Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:4 Topics: Angiotensin II; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Calcium Chloride; Cells, Cultured; Collagen; Dilatation, Pathologic; Disease Models, Animal; Elastin; Genotype; Male; Matrix Metalloproteinase 2; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; RNA, Messenger; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Ultrasonography; Vascular Remodeling	2015
Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia. Biochemical and biophysical research communications, 2015, May-29, Volume: 461, Issue:2 Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Aorta; Blood Pressure; Diabetes Mellitus, Experimental; Hyperglycemia; Hyperinsulinism; Hypertension; Male; Peptidyl-Dipeptidase A; Rats, Wistar; Transforming Growth Factor beta; Umbelliferones	2015
Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes. Vascular pharmacology, 2015, Volume: 72 Topics: Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Epigenesis, Genetic; Fibrosis; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Indoles; Inflammation; Kidney; Male; Mice; Mice, Inbred ICR; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta	2015
Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts. PloS one, 2015, Volume: 10, Issue:4 Topics: Angiotensin II; Animals; Cell Movement; Collagen Type I; Endomyocardial Fibrosis; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Gene Expression Regulation; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MicroRNAs; Myocardium; Plicamycin; Rats; Rats, Wistar; Sp1 Transcription Factor; Transforming Growth Factor beta	2015
Performance comparison of ultrasound-based methods to assess aortic diameter and stiffness in normal and aneurysmal mice. PloS one, 2015, Volume: 10, Issue:5 Topics: Angiotensin II; Animals; Antibodies; Aorta; Aortic Aneurysm; Male; Mice; Mice, Knockout; Transforming Growth Factor beta; Ultrasonography; Vascular Stiffness	2015
Cytoplasmic translocation of HuR contributes to angiotensin II induced cardiac fibrosis. Biochemical and biophysical research communications, 2015, Aug-07, Volume: 463, Issue:4 Topics: Acetylcysteine; Angiotensin II; Animals; Collagen; Cytoplasm; Dose-Response Relationship, Drug; ELAV Proteins; Heart Diseases; Male; Mice; Mice, Inbred C57BL; Protein Transport; Reactive Oxygen Species; Transforming Growth Factor beta	2015
Obligatory Role for B Cells in the Development of Angiotensin II-Dependent Hypertension. Hypertension (Dallas, Tex. : 1979), 2015, Volume: 66, Issue:5 Topics: Adoptive Transfer; Angiotensin II; Animals; Antibodies, Anti-Idiotypic; Antigens, CD20; B-Cell Activation Factor Receptor; B-Lymphocytes; Cell Proliferation; Disease Models, Animal; Hypertension; Immunoglobulin G; Mice; Mice, Knockout; Spleen; Transforming Growth Factor beta; Vascular Stiffness	2015
Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress. PloS one, 2015, Volume: 10, Issue:9 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type III; Connective Tissue Growth Factor; Fibrosis; Heart; Hypertension; Male; MAP Kinase Signaling System; Mice; Myocardium; NADPH Oxidases; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ventricular Remodeling	2015
Novel Epidermal Growth Factor Receptor Inhibitor Attenuates Angiotensin II-Induced Kidney Fibrosis. The Journal of pharmacology and experimental therapeutics, 2016, Volume: 356, Issue:1 Topics: Actins; Angiotensin II; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cells, Cultured; Collagen Type IV; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Knockdown Techniques; Kidney Diseases; MAP Kinase Signaling System; Mesangial Cells; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; Rats; Renin-Angiotensin System; Repressor Proteins; RNA, Small Interfering; src-Family Kinases; Transforming Growth Factor beta	2016
[Valsartan inhibits angiotensin II-Notch signaling of mesangial cells induced by high glucose]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2016, Volume: 32, Issue:1 Topics: Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Dipeptides; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fibronectins; Glucose; Mesangial Cells; Rats; Receptor, Notch1; Signal Transduction; Time Factors; Transforming Growth Factor beta; Valsartan	2016
Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression. The Journal of thoracic and cardiovascular surgery, 2016, Volume: 151, Issue:4 Topics: Angiotensin II; Animals; Calcium; Cardiomyopathies; Collagen; Disease Models, Animal; Enzyme Induction; Fibronectins; Fibrosis; Genetic Therapy; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Myocardium; Myofibroblasts; Receptor, Angiotensin, Type 1; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sheep; Time Factors; Transforming Growth Factor beta	2016
Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts. International journal of molecular sciences, 2016, Jan-22, Volume: 17, Issue:2 Topics: Angiotensin II; Animals; Disease Models, Animal; Extracellular Matrix Proteins; Fibroblasts; Gene Expression Regulation; Kidney Diseases; MAP Kinase Signaling System; Metformin; Mice; Transforming Growth Factor beta; Ureteral Obstruction	2016
Mechanism of IFN-γ in regulating OPN/Th17 pathway during vascular collagen remodeling of hypertension induced by ANG II. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:11 Topics: Angiotensin II; Animals; Blood Pressure; Cell Differentiation; Cells, Cultured; Collagen Type I; Collagen Type III; Disease Models, Animal; Hypertension; Inflammation Mediators; Interferon-gamma; Interleukin-10; Interleukin-23; Mice, Inbred C57BL; Nuclear Receptor Subfamily 1, Group F, Member 1; Nuclear Receptor Subfamily 1, Group F, Member 3; Osteopontin; Procollagen; Spleen; Th17 Cells; Transforming Growth Factor beta; Vascular Remodeling	2015
Mesenchymal Stromal Cells Prevent Renal Fibrosis in a Rat Model of Unilateral Ureteral Obstruction by Suppressing the Renin-Angiotensin System via HuR. PloS one, 2016, Volume: 11, Issue:2 Topics: Aldosterone; Angiotensin II; Animals; Animals, Genetically Modified; Apoptosis; Cell Differentiation; Cell Line; Disease Models, Animal; ELAV-Like Protein 1; Fibrosis; Green Fluorescent Proteins; Humans; Immunophenotyping; Interleukin-10; Kidney; Kidney Tubules; Male; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Ureteral Obstruction	2016
The Expression Profile of Complement Components in Podocytes. International journal of molecular sciences, 2016, Mar-30, Volume: 17, Issue:4 Topics: Angiotensin II; Animals; Carrier Proteins; Cells, Cultured; Complement System Proteins; Diabetic Nephropathies; Disease Models, Animal; Humans; Interleukin-6; Male; Microfilament Proteins; Microscopy, Confocal; Podocytes; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Tandem Mass Spectrometry; Transcriptome; Transforming Growth Factor beta	2016
TGF-β Neutralization Enhances AngII-Induced Aortic Rupture and Aneurysm in Both Thoracic and Abdominal Regions. PloS one, 2016, Volume: 11, Issue:4 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Rupture; Male; Mice; Mice, Inbred C57BL; Transforming Growth Factor beta	2016
Age-Associated Changes in the Vascular Renin-Angiotensin System in Mice. Oxidative medicine and cellular longevity, 2016, Volume: 2016 Topics: 8-Hydroxy-2'-Deoxyguanosine; Aging; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Blotting, Western; Collagen Type IV; Deoxyguanosine; Enzyme-Linked Immunosorbent Assay; Fibronectins; Immunohistochemistry; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Superoxide Dismutase; Transforming Growth Factor beta; Tyrosine	2016
The chemokine (C-C motif) ligand protein synthesis inhibitor bindarit prevents cytoskeletal rearrangement and contraction of human mesangial cells. Cytokine, 2016, Volume: 85 Topics: Actins; Angiotensin II; Anti-Inflammatory Agents; Cells, Cultured; Chemokines; Cytoskeleton; Endothelin-1; Glomerular Mesangium; Humans; Indazoles; Ligands; Mesangial Cells; Propionates; Protein Synthesis Inhibitors; Transforming Growth Factor beta; Up-Regulation	2016
Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function. Journal of hypertension, 2016, Volume: 34, Issue:9 Topics: Activin Receptors, Type I; Angiotensin II; Animals; Aorta; Apoptosis; Blood Pressure; Cardiomegaly; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Haploinsufficiency; Heterozygote; Male; Mice; Myocardium; Myocytes, Cardiac; Signal Transduction; Smad2 Protein; Smad3 Protein; Stroke Volume; Transforming Growth Factor beta; Up-Regulation; Ventricular Dysfunction, Left	2016
Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:9 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Fibrosis; Genetic Predisposition to Disease; Hypertension; Male; Mice, Knockout; Muscle, Smooth, Vascular; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitrites; Phenotype; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Stromal Interaction Molecule 1; Time Factors; Transcription Factor CHOP; Transforming Growth Factor beta; Vasodilation; Vasodilator Agents	2016
FGF23 promotes myocardial fibrosis in mice through activation of β-catenin. Oncotarget, 2016, Oct-04, Volume: 7, Issue:40 Topics: Angiotensin II; Animals; beta Catenin; Cells, Cultured; Collagen; Dependovirus; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibrosis; Humans; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 4; Reperfusion Injury; RNA, Small Interfering; Transforming Growth Factor beta; Up-Regulation	2016
Overexpression of SerpinE2/protease nexin-1 Contribute to Pathological Cardiac Fibrosis via increasing Collagen Deposition. Scientific reports, 2016, 11-23, Volume: 6 Topics: Angiotensin II; Animals; Aorta; Collagen; Constriction; Disease Models, Animal; ets-Domain Protein Elk-1; Fibrosis; Gene Knockdown Techniques; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Models, Biological; Myocardium; Myofibroblasts; RNA, Messenger; Serpin E2; Transforming Growth Factor beta	2016
Substance P Inhibits the Collagen Synthesis of Rat Myocardial Fibroblasts Induced by Ang II. Medical science monitor : international medical journal of experimental and clinical research, 2016, Dec-16, Volume: 22 Topics: Angiotensin II; Animals; Cells, Cultured; Collagen; Collagen Type I; Collagen Type III; Fibroblasts; Fibrosis; Heart; Myocardium; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Smad3 Protein; Substance P; Transforming Growth Factor beta; Transforming Growth Factor beta1	2016
Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin. International journal of molecular sciences, 2017, Jan-31, Volume: 18, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Epithelial Cells; Gene Expression; Heme Oxygenase-1; Kidney Diseases; Losartan; Mice; Sirtuin 1; Thioredoxins; Transforming Growth Factor beta; Tunicamycin	2017
Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy. Journal of hypertension, 2017, Volume: 35, Issue:7 Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Down-Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Kidney; Male; Nephritis; NF-kappa B; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Telmisartan; Transforming Growth Factor beta	2017
Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling. Circulation, 2017, May-23, Volume: 135, Issue:21 Topics: Acetylation; Activating Transcription Factor 3; Angiotensin II; Animals; Binding Sites; Cells, Cultured; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Histone Deacetylase 1; Histones; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; MAP Kinase Kinase 3; Mice, Knockout; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenotype; Promoter Regions, Genetic; Protein Kinase Inhibitors; Signal Transduction; Time Factors; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Remodeling	2017
Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion. Clinical and experimental hypertension (New York, N.Y. : 1993), 2017, Volume: 39, Issue:2 Topics: Actins; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Collagen Type I; Connective Tissue Growth Factor; Echocardiography; Fibrosis; Heart; Heart Ventricles; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Vasoconstrictor Agents; Ventricular Remodeling	2017
miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling. PloS one, 2017, Volume: 12, Issue:3 Topics: Aging; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiovascular Diseases; Endothelial Cells; Extracellular Matrix; Hypertension; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Nitric Oxide; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Vascular Stiffness	2017
Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways. EBioMedicine, 2017, Volume: 18 Topics: Alkaloids; Angiotensin II; Anilides; Animals; Benzodioxoles; Cell Differentiation; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Fibroblasts; Fibrosis; Glycogen Synthase Kinase 3 beta; Heart; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardium; Myofibroblasts; Piperidines; Polyunsaturated Alkamides; PPAR gamma; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction; Transforming Growth Factor beta	2017
c-Myc promotes renal fibrosis by inducing integrin αv-mediated transforming growth factor-β signaling. Kidney international, 2017, Volume: 92, Issue:4 Topics: Angiotensin II; Animals; Extracellular Matrix; Fibroblasts; Fibrosis; Folic Acid; Integrin alphaV; Kidney; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-myc; Renal Insufficiency, Chronic; Signal Transduction; Thiazoles; Transforming Growth Factor beta; Up-Regulation; Ureteral Obstruction	2017
Gingival fibroblasts protect against experimental abdominal aortic aneurysm development and rupture through tissue inhibitor of metalloproteinase-1 production. Cardiovascular research, 2017, Sep-01, Volume: 113, Issue:11 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Gingiva; Mice, Inbred C57BL; Mice, Knockout; Protective Agents; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta	2017
Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis. Circulation, 2017, Aug-15, Volume: 136, Issue:7 Topics: Angiotensin II; Animals; Bone Morphogenetic Protein 7; Cardiomegaly; Cells, Cultured; Female; Frameshift Mutation; Humans; Magnetic Resonance Imaging, Cine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Plasminogen Activator Inhibitor 1; RNA; Sequence Analysis, RNA; Smad6 Protein; Transcription, Genetic; Transforming Growth Factor beta	2017
TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms. Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:11 Topics: Adventitia; Angiotensin II; Animals; Antibodies; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Dilatation, Pathologic; Disease Models, Animal; Female; Genetic Predisposition to Disease; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Phenotype; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Severity of Illness Index; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Transforming Growth Factor beta3; Tunica Media; Vascular Remodeling	2017
Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin. Journal of the American Heart Association, 2017, Jul-27, Volume: 6, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Age Factors; Angiotensin II; Animals; Collagen; Fibrosis; Genotype; Kidney; Longevity; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Oxidative Stress; Phenotype; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Signal Transduction; Sirtuin 1; Time Factors; Transforming Growth Factor beta	2017
Investigation of cardiac fibroblasts using myocardial slices. Cardiovascular research, 2018, 01-01, Volume: 114, Issue:1 Topics: Actins; Angiotensin II; Animals; Biomarkers; Cell Proliferation; Collagen; Dogs; Fibroblasts; Fibrosis; Humans; Mice, Transgenic; Myocardium; Phenotype; Physical Stimulation; Time Factors; Tissue Culture Techniques; Transforming Growth Factor beta; Vimentin	2018
Differential Expression of Hypertensive Phenotypes in BXD Mouse Strains in Response to Angiotensin II. American journal of hypertension, 2017, Dec-08, Volume: 31, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Fibrosis; Heart Diseases; Hypertension; Inflammation; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Phenotype; Species Specificity; Transforming Growth Factor beta; Vasoconstrictor Agents	2017
Further Evidence Supporting a Protective Role of Transforming Growth Factor-β (TGFβ) in Aortic Aneurysm and Dissection. Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:11 Topics: Angiotensin II; Aorta, Abdominal; Aortic Aneurysm; Humans; Transforming Growth Factor beta; Transforming Growth Factors	2017
Estrogen receptor beta maintains expression of KLF15 to prevent cardiac myocyte hypertrophy in female rodents. Molecular and cellular endocrinology, 2018, 07-15, Volume: 470 Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Estrogen Receptor beta; Female; Gene Expression Regulation; Kruppel-Like Transcription Factors; Male; MAP Kinase Kinase Kinases; Models, Biological; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Signal Transduction; Transforming Growth Factor beta	2018
Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2017, Dec-01, Volume: 36 Topics: Angiotensin II; Animals; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney Diseases; Mice; Phosphorylation; Podocytes; ras Proteins; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad Proteins; Smad2 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Triterpenes; Up-Regulation; Wolfiporia	2017
Diabetes Reduces Severity of Aortic Aneurysms Depending on the Presence of Cell Division Autoantigen 1 (CDA1). Diabetes, 2018, Volume: 67, Issue:4 Topics: Adult; Aged; Angiotensin II; Animals; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Aortic Rupture; Autoantigens; Collagen; Diabetes Mellitus, Experimental; Female; Gene Expression Regulation; Humans; Macrophages; Male; Matrix Metalloproteinase 12; Mice; Mice, Knockout; Mice, Knockout, ApoE; Middle Aged; Severity of Illness Index; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; Vasoconstrictor Agents	2018
A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet. Experimental animals, 2018, May-10, Volume: 67, Issue:2 Topics: Angiotensin II; Animals; Body Weight; Cholesterol, Dietary; Chymases; Cricetinae; Diet, High-Fat; Disease Models, Animal; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Organ Size; Transforming Growth Factor beta	2018
Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK/TGF-β/Smads signaling pathway. Archives of biochemistry and biophysics, 2018, 02-15, Volume: 640 Topics: Angiotensin II; Animals; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Fibronectins; Fibrosis; Flavonoids; Heart Diseases; Myocardium; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2018
MicroRNA-21 Knockout Exacerbates Angiotensin II-Induced Thoracic Aortic Aneurysm and Dissection in Mice With Abnormal Transforming Growth Factor-β-SMAD3 Signaling. Arteriosclerosis, thrombosis, and vascular biology, 2018, Volume: 38, Issue:5 Topics: Angiotensin II; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortic Rupture; Cells, Cultured; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Genetic Predisposition to Disease; JNK Mitogen-Activated Protein Kinases; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; Phosphorylation; Signal Transduction; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta	2018
Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2018, Mar-15, Volume: 42 Topics: Alisma; Angiotensin II; Animals; Cell Line; Epithelial-Mesenchymal Transition; Fibrosis; Kidney; Kidney Diseases; Phosphatidylinositol 3-Kinases; Phosphorylation; ras Proteins; Rats; Smad3 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Triterpenes; Wnt Signaling Pathway	2018
Role of Wnt4/β-catenin, Ang II/TGFβ, ACE2, NF-κB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone. European journal of pharmacology, 2018, Jul-15, Volume: 831 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; beta Catenin; Cytoprotection; Disease Models, Animal; Hydroxycholecalciferols; Intercellular Adhesion Molecule-1; Interleukin-18; Kidney; Kidney Diseases; Male; Neutrophil Infiltration; NF-kappa B; Peptidyl-Dipeptidase A; Peroxidase; Pioglitazone; Rats, Sprague-Dawley; Reperfusion Injury; Thiazolidinediones; Time Factors; Transforming Growth Factor beta; Wnt Signaling Pathway; Wnt4 Protein	2018
Reduction of cardiac TGFβ-mediated profibrotic events by inhibition of Hsp90 with engineered protein. Journal of molecular and cellular cardiology, 2018, Volume: 123 Topics: Angiotensin II; Animals; Cell Survival; Cells, Cultured; Collagen; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Fibrosis; Fluorescent Antibody Technique; HSP90 Heat-Shock Proteins; Mice; Mice, Knockout; Microscopy, Confocal; Models, Molecular; Myocardium; Peptides; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Signal Transduction; Transforming Growth Factor beta	2018
MiR-101a ameliorates AngII-mediated hypertensive nephropathy by blockade of TGFβ/Smad3 and NF-κB signalling in a mouse model of hypertension. Clinical and experimental pharmacology & physiology, 2019, Volume: 46, Issue:3 Topics: Angiotensin II; Animals; Base Sequence; Cell Line; Disease Models, Animal; Fibrosis; Hypertension, Renal; Kidney; Male; Mice; MicroRNAs; Nephritis; NF-kappa B; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta	2019
Profibrotic effects of angiotensin II and transforming growth factor beta on feline kidney epithelial cells. Journal of feline medicine and surgery, 2019, Volume: 21, Issue:8 Topics: Angiotensin II; Animals; Cat Diseases; Cats; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Kidney; Kidney Diseases; Transforming Growth Factor beta	2019
Interleukin-6 Receptor Signaling and Abdominal Aortic Aneurysm Growth Rates. Circulation. Genomic and precision medicine, 2019, Volume: 12, Issue:2 Topics: Alleles; Angiotensin II; Animals; Antibodies; Aortic Aneurysm, Abdominal; Biomarkers; Disease Models, Animal; Humans; Interleukin-6; Linear Models; Mice; Polymorphism, Single Nucleotide; Receptors, Interleukin-6; Signal Transduction; Survival Rate; Transforming Growth Factor beta	2019
Proinflammatory Role of Angiotensin II in the Aorta of Normotensive Mice. BioMed research international, 2019, Volume: 2019 Topics: Actins; Angiotensin II; Animals; Aorta; Blood Pressure; Cardiovascular Diseases; Gene Expression Regulation; Humans; Interleukin-1beta; Leukocyte Common Antigens; Mice; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type II; Saline Solution; Transforming Growth Factor beta	2019
Kangxianling decoction prevents renal fibrosis in rats with 5/6 nephrectomy and inhibits Ang II-induced ECM production in glomerular mesangial cells. Journal of pharmacological sciences, 2019, Volume: 139, Issue:4 Topics: Angiotensin II; Animals; Cells, Cultured; Collagen; Disease Models, Animal; Down-Regulation; Drugs, Chinese Herbal; Fibronectins; Fibrosis; Glomerular Mesangium; Kidney; Kidney Diseases; Male; MAP Kinase Signaling System; Mesangial Cells; Nephrectomy; Rats, Sprague-Dawley; Transforming Growth Factor beta; Up-Regulation	2019
Myocardin ablation in a cardiac-renal rat model. Scientific reports, 2019, 04-10, Volume: 9, Issue:1 Topics: Angiotensin II; Animals; Cardio-Renal Syndrome; Cardiomyopathy, Dilated; Collagen Type I; Collagen Type I, alpha 1 Chain; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Ventricles; Male; Myocytes, Cardiac; Nuclear Proteins; Rats; RNA Interference; RNA, Small Interfering; Trans-Activators; Transforming Growth Factor beta; Ventricular Function	2019
Accelerated Marfan syndrome model recapitulates established signaling pathways. The Journal of thoracic and cardiovascular surgery, 2020, Volume: 159, Issue:5 Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Cardiomyopathies; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Fibrillin-1; Genetic Predisposition to Disease; Heterozygote; Marfan Syndrome; Mice, Mutant Strains; Mutation; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Signal Transduction; Smad2 Protein; Time Factors; Transforming Growth Factor beta	2020
Ang-(1-7) treatment attenuates lipopolysaccharide-induced early pulmonary fibrosis. Laboratory investigation; a journal of technical methods and pathology, 2019, Volume: 99, Issue:12 Topics: Angiotensin I; Angiotensin II; Animals; Bronchoalveolar Lavage Fluid; Cadherins; Drug Evaluation, Preclinical; Imidazoles; Lipopolysaccharides; Lung; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Random Allocation; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Transforming Growth Factor beta; Vasodilator Agents; Vimentin	2019
Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosis. Science translational medicine, 2019, 07-17, Volume: 11, Issue:501 Topics: Angiotensin II; Animals; Bleomycin; Calcium-Binding Proteins; Calpain; Carbon Tetrachloride; Cell Line; Dogs; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Isoenzymes; Liver Cirrhosis; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; Myocardium; Protein Biosynthesis; Protein Multimerization; RNA Stability; Signal Transduction; Transforming Growth Factor beta	2019
Effect of an aqueous extract of Averrhoa carambola L. on endothelial function in rats with ventricular remodelling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 121 Topics: Angiotensin II; Animals; Averrhoa; Endothelin-1; Endothelium, Vascular; Female; Male; Myocardium; Nitric Oxide Synthase; Plant Extracts; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ventricular Remodeling	2020
RIG-I aggravates interstitial fibrosis via c-Myc-mediated fibroblast activation in UUO mice. Journal of molecular medicine (Berlin, Germany), 2020, Volume: 98, Issue:4 Topics: Angiotensin II; Animals; Biomarkers; Biopsy; Cytokines; DEAD Box Protein 58; Disease Susceptibility; Fibroblasts; Fibrosis; Gene Silencing; Immunohistochemistry; Inflammation Mediators; Interleukin-1beta; Male; Mice; Proto-Oncogene Proteins c-myc; Renal Insufficiency, Chronic; Smad Proteins; Transforming Growth Factor beta; Ureteral Obstruction	2020
Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice. Skeletal muscle, 2020, 04-25, Volume: 10, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Collagen; Fibrosis; Lisinopril; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Diseases; Myocardial Infarction; Smad Proteins; Transforming Growth Factor beta	2020
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis. Frontiers in cellular and infection microbiology, 2020, Volume: 10 Topics: Alveolar Epithelial Cells; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Host Microbial Interactions; Humans; Lung; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pulmonary Fibrosis; Receptors, Coronavirus; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2; Transforming Growth Factor beta	2020
Long non-coding RNA LICPAR regulates atrial fibrosis via TGF-β/Smad pathway in atrial fibrillation. Tissue & cell, 2020, Volume: 67 Topics: Angiotensin II; Atrial Fibrillation; Biomarkers; Cell Proliferation; Cell Survival; Fibroblasts; Fibrosis; Heart Atria; Humans; Middle Aged; RNA, Long Noncoding; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Up-Regulation	2020
Leonurine Attenuates Myocardial Fibrosis Through Upregulation of miR-29a-3p in Mice Post-myocardial Infarction. Journal of cardiovascular pharmacology, 2021, 02-01, Volume: 77, Issue:2 Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Gallic Acid; Male; Mice, Inbred C57BL; MicroRNAs; Myocardial Infarction; Myocardium; Transforming Growth Factor beta; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling	2021
Inhibition of YAP activation attenuates renal injury and fibrosis in angiotensin II hypertensive mice. Canadian journal of physiology and pharmacology, 2021, Volume: 99, Issue:10 Topics: Acute Kidney Injury; Angiotensin II; Animals; Blood Pressure; Chemokine CCL2; Fibrosis; Hypertension; Hypertension, Renal; Male; Mice; Mice, Inbred C57BL; Nephritis; Photosensitizing Agents; Protein Serine-Threonine Kinases; Signal Transduction; Transforming Growth Factor beta; Vasoconstrictor Agents; Verteporfin; YAP-Signaling Proteins	2021
Quyu Shengxin capsule (QSC) inhibits Ang-II-induced abnormal proliferation of VSMCs by down-regulating TGF-β, VEGF, mTOR and JAK-STAT pathways. Journal of ethnopharmacology, 2021, Jul-15, Volume: 275 Topics: Angiotensin II; Animals; Cell Proliferation; Computational Biology; Down-Regulation; Drugs, Chinese Herbal; Intercellular Adhesion Molecule-1; Janus Kinases; Male; Muscle, Smooth, Vascular; Primary Cell Culture; Rats, Sprague-Dawley; Signal Transduction; STAT Transcription Factors; TOR Serine-Threonine Kinases; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2021
Alarin alleviated cardiac fibrosis via attenuating oxidative stress in heart failure rats. Amino acids, 2021, Volume: 53, Issue:7 Topics: Angiotensin II; Animals; Fibrosis; Galanin-Like Peptide; Heart Failure; Male; Malondialdehyde; Myocardial Infarction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Vasoconstrictor Agents	2021
PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation. Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:14 Topics: Angiotensin II; Animals; Atrial Fibrillation; Cardiotonic Agents; Cells, Cultured; Fibrosis; Heterocyclic Compounds; Male; Mice; Mice, Inbred C57BL; Myocardium; Myofibroblasts; Proto-Oncogene Proteins; Signal Transduction; Smad3 Protein; Trans-Activators; Transforming Growth Factor beta	2021
Expression and role of lumican in acute aortic dissection: A human and mouse study. PloS one, 2021, Volume: 16, Issue:7 Topics: Acute Disease; Aminopropionitrile; Angiotensin II; Animals; Aorta; Aortic Dissection; Aortic Rupture; Biomarkers; Chronic Disease; Disease Models, Animal; Humans; Incidence; Kaplan-Meier Estimate; Lumican; Mice; Mice, Inbred C57BL; Mice, Knockout; Smad2 Protein; Transforming Growth Factor beta; Up-Regulation	2021
Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin-angiotensin system in the lung. Scientific reports, 2021, 08-16, Volume: 11, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Bleomycin; Disease Models, Animal; Ergocalciferols; Losartan; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Fibrosis; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Vitamin D	2021
LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway. Cerebrovascular diseases (Basel, Switzerland), 2022, Volume: 51, Issue:2 Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Atrial Fibrillation; Fibrosis; Humans; Male; Mice; Mice, Inbred C57BL; Smad2 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1	2022
Attenuation of Myocardial Fibrosis Using Molecular Hydrogen by Inhibiting the TGF-β Signaling Pathway in Spontaneous Hypertensive Rats. American journal of hypertension, 2022, 02-01, Volume: 35, Issue:2 Topics: Angiotensin II; Animals; Cardiomyopathies; Collagen Type I; Fibrosis; Hydrogen; Myocardium; Procollagen; Rats; Rats, Inbred SHR; Signal Transduction; Superoxide Dismutase; Transforming Growth Factor beta; Transforming Growth Factor beta1	2022
Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II. Scientific reports, 2021, 10-27, Volume: 11, Issue:1 Topics: Angiotensin II; Animals; Disease Models, Animal; Endothelium, Vascular; Infusions, Parenteral; Intercellular Adhesion Molecule-1; Interleukins; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vascular Diseases; Vascular Remodeling	2021
Angiotensin (ang) 1-7 inhibits ang II-induced atrial fibrosis through regulating the interaction of proto-oncogene tyrosine-protein kinase Src (c-Src) and Src homology region 2 domain-containing phosphatase-1 (SHP-1)). Bioengineered, 2021, Volume: 12, Issue:2 Topics: Angiotensin I; Angiotensin II; Animals; Fibrosis; Matrix Metalloproteinase 2; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fyn; Rats; Rats, Sprague-Dawley; Signal Transduction; src Homology Domains; Transforming Growth Factor beta	2021
MircroRNA-145 Attenuates Cardiac Fibrosis Via Regulating Mitogen-Activated Protein Kinase Kinase Kinase 3. Cardiovascular drugs and therapy, 2023, Volume: 37, Issue:4 Topics: Angiotensin II; Animals; Collagen; Fibrosis; Heart Failure; MAP Kinase Kinase Kinase 3; Mice; MicroRNAs; Myocardial Infarction; Myocardium; Transforming Growth Factor beta; Transforming Growth Factor beta1	2023
Calcitriol Supplementation Protects Against Apoptosis and Alleviates the Severity of Abdominal Aortic Aneurysm Induced by Angiotensin II and Anti-TGFβ. Journal of cardiovascular translational research, 2022, Volume: 15, Issue:6 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Calcitriol; Dietary Supplements; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Transforming Growth Factor beta	2022
P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis. PloS one, 2022, Volume: 17, Issue:5 Topics: Angiotensin II; Animals; Antioxidants; Carcinoma, Hepatocellular; Cytokines; Elastin; Fibrosis; Hepacivirus; Hepatitis C; Humans; Laminin; Liver Neoplasms; Rats; Receptors, Purinergic P2X4; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2022
Silencing of TLR4 Inhibits Atrial Fibrosis and Susceptibility to Atrial Fibrillation via Downregulation of NLRP3-TGF- Disease markers, 2022, Volume: 2022 Topics: Angiotensin II; Animals; Atrial Fibrillation; Collagen Type I; Down-Regulation; Fibrosis; Heart Atria; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Inbred SHR; RNA, Small Interfering; Toll-Like Receptor 4; Transforming Growth Factor beta; Transforming Growth Factor beta1	2022
Genetic Deletion of Galectin-3 Exacerbates Age-Related Myocardial Hypertrophy and Fibrosis in Mice. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2022, Aug-12, Volume: 56, Issue:4 Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Galectin 3; Gene Deletion; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Sirtuin 1; Transforming Growth Factor beta; Ventricular Remodeling	2022
Targeting the blood-brain barrier disruption in hypertension by ALK5/TGF-Β type I receptor inhibitor SB-431542 and dynamin inhibitor dynasore. Brain research, 2022, 11-01, Volume: 1794 Topics: Albumins; Angiotensin II; Animals; Benzamides; Blood-Brain Barrier; Claudin-5; Dioxoles; Dynamins; Hydrazones; Hypertension; Mice; Receptor, Transforming Growth Factor-beta Type I; Transforming Growth Factor beta	2022
Activating transcription factor 3 inhibits angiotensin II‑induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine‑rich angiogenic protein 61. Molecular medicine reports, 2022, Volume: 26, Issue:5 Topics: Activating Transcription Factor 3; Angiogenic Proteins; Angiotensin II; Cyclic AMP Response Element-Binding Protein; Cysteine; Cysteine-Rich Protein 61; Fibrosis; Humans; Myocytes, Cardiac; RNA, Messenger; Transforming Growth Factor beta	2022
Lithium Treatment Improves Cardiac Dysfunction in Rats Deprived of Rapid Eye Movement Sleep. International journal of molecular sciences, 2022, Sep-23, Volume: 23, Issue:19 Topics: Actins; Angiotensin II; Animals; Heart Diseases; Lithium; Lithium Compounds; NF-kappa B; ORAI1 Protein; Rats; Receptor, Angiotensin, Type 1; Sleep Deprivation; Sleep, REM; Transforming Growth Factor beta	2022
miR-409-3p Regulated by GATA2 Promotes Cardiac Fibrosis through Targeting Gpd1. Oxidative medicine and cellular longevity, 2022, Volume: 2022 Topics: Angiotensin II; Animals; Antagomirs; Fibrosis; GATA2 Transcription Factor; Mice; MicroRNAs; Myocardial Infarction; Myocardium; Rats; RNA, Small Interfering; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factors	2022
Gramine protects against pressure overload-induced pathological cardiac hypertrophy through Runx1-TGFBR1 signaling. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 114 Topics: Angiotensin II; Animals; Cardiomegaly; Core Binding Factor Alpha 2 Subunit; Disease Models, Animal; Indole Alkaloids; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta	2023
USP25 inhibits renal fibrosis by regulating TGFβ-SMAD signaling pathway in Ang II-induced hypertensive mice. Biochimica et biophysica acta. Molecular basis of disease, 2023, Volume: 1869, Issue:6 Topics: Angiotensin II; Animals; Deubiquitinating Enzymes; Fibrosis; Humans; Hypertension; Hypertension, Renal; Mice; Signal Transduction; Transforming Growth Factor beta; Ubiquitin Thiolesterase	2023
A novel caffeic acid derivative prevents angiotensin II-induced cardiac remodeling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 162 Topics: Angiotensin II; Animals; Caffeic Acids; Cardiomyopathies; Collagen; Fibroblasts; Fibrosis; Myocardium; Transforming Growth Factor beta; Ventricular Remodeling	2023
Targeting the adenosine monophosphate-activated protein kinase signalling pathway by bempedoic acid attenuates Angiotensin II-induced cardiac remodelling in renovascular hypertension in rats. Life sciences, 2023, Sep-15, Volume: 329 Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Captopril; Hypertension; Hypertension, Renovascular; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ventricular Remodeling	2023
COMP Improves Ang-II-Induced Atrial Fibrillation via TGF-β Signaling Pathway. Cardiovascular toxicology, 2023, Volume: 23, Issue:9-10 Topics: Angiotensin II; Animals; Atrial Fibrillation; Cartilage Oligomeric Matrix Protein; Fibrosis; Mice; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1	2023
Glycolysis Promotes Angiotensin II-Induced Aortic Remodeling Through Regulating Endothelial-to-Mesenchymal Transition via the Corepressor C-Terminal Binding Protein 1. Hypertension (Dallas, Tex. : 1979), 2023, Volume: 80, Issue:12 Topics: Angiotensin II; Animals; Aorta; Endothelial Cells; Glycolysis; Humans; Mice; NAD; Transcription Factors; Transforming Growth Factor beta; Ubiquitin-Protein Ligases	2023